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ABSTRACT 1
1 ABSTRACT 
 
Background: Nephronophthisis (NPH) is the leading genetic cause of end-stage renal disease in 
children, with patients requiring dialysis or kidney transplantation by an average age of 13. Major 
hallmarks of this disease include interstitial fibrosis, tubular basement membrane disruption, and cyst 
progression along the cortico-medullary boundary of the kidney. Currently it is not possible to slow or 
reverse disease progression, and together with other inherited cystic kidney diseases the lack of 
therapeutic options represents a significant burden for patients and on health care systems. The last 
decade of research has highlighted the importance of an antenna-like organelle called the primary 
cilium which is present on virtually all mammalian cells. In the kidney, primary cilia project from the 
apical surface of kidney epithelial cells into the tubule lumen and are thought to be important for inter-
cellular communication required for tissue maintenance. Specifically, primary cilia are involved in the 
regulation of the Wnt signaling pathway, which is activated during normal injury repair. This work 
explores the relationship between the gene products mutated in NPH, which localize to the primary 
cilium, and the regulation of the canonical Wnt signaling pathway by Jade-1, a recently identified 
ubiquitin ligase for the main effector of canonical Wnt signaling, β-catenin. 
Main Findings and Conclusions: This work demonstrates that Jade-1 localizes to the ciliary transition 
zone and interacts with members of the NPH protein complex. Nephrocystin-4 (NPHP4) specifically 
stabilizes protein levels of Jade-1 in a phosphatase-dependent manner, which increases Jade-1 nuclear 
translocation and enhances the ability of Jade-1 to negatively regulate canonical Wnt signaling. Jade-1 
is phosphorylated by casien kinase-1 α (CK1α), a member of the β-catenin destruction complex, and 
this abrogates the ability of Jade-1 to negatively regulate Wnt signaling. Exogenous β-catenin 
decreases protein levels of CK1α and Jade-1 but not NPHP4, which highlights a complex relationship 
between these proteins. The non-linear nature of Wnt signaling regulation underlines the importance 
of studying functional protein-protein relationships in context dependent manner. Within the context 
of published literature, the current data suggests that the cooperative action of NPHP4 and Jade-1 
might be most crucial to re-establish noncanonical Wnt signaling immediately following injury repair. 
Failure of this pathway could contribute to cyst formation in NPH. 
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2 ZUSAMMENFASSUNG 
Hintergrund: Die Nephronophthise (NPH) gilt als die häufigste genetische Ursache für eine terminale 
Niereninsuffizienz bei Kindern. Dabei kann bereits  durchschnittlich im Alter von 13 Jahren eine 
Nierenersatztherapie, Dialyse oder Nierentransplantation, erforderlich werden. Histopathologisch ist 
die NPH durch eine interstitielle Fibrose, Veränderungen der tubulären Basalmembran und eine 
tubuläre Atrophie mit Zystenentwicklung entlang des kortiko-medullären Übergangs gekennzeichnet. 
Bisher ist es weder möglich, den Krankheitsverlauf zu verlangsamen, noch aufzuhalten. Das Fehlen 
therapeutischer Optionen zur Behandlung der NPH und weiterer erblicher zystischer 
Nierenerkrankungen führt zu einer signifikanten Herausforderung für das Gesundheitssystems. 
Zahlreiche Studien der letzten Jahre konnten zeigen, dass in der Pathogenese der NPH und anderer 
zystischer Nierenerkrankungen primäre Zilien eine zentrale Rolle spielen. Zilien sind antennenartige 
Organellen, die von der Zelloberfläche ausgehen und auf fast allen Säugerzellen zu finden sind. In der 
Niere ragen diese primären Zilien von der apikalen Oberfläche der Nierenepithelzellen in das tubuläre 
Lumen hinein und sind in als sensorische Organellen in wichtige Signalübertragungsprozesse 
involviert. Ein wichtiger Signalweg, der durch Zilien moduliert wird, ist die Wnt-Signalkaskade, die 
insbesondere während der Nierenentwicklung und bei Reparaturvorgängen nach Gewebeschädigung 
von großer Bedeutung ist. Wichtigster Effektor der Wnt-Signalkaskade dabei ist β-catenin, das 
wiederrum von Jade-1, einer kürzlich identifizierten Ubiquitinligase, reguliert wird. Die hier 
vorliegende Arbeit untersucht das Zusammenspiel zwischen ziliären Proteinen und bekannten NPH-
Genen bei der Regulation des kanonischen Wnt-Signalwegs durch die Ubiquitinligase Jade-1 und 
dessen Rolle in der Pathogensese der NPH. 
 
Hauptaussagen und Zusammenfassung: Die vorliegende Arbeit konnte zeigen, dass Jade-1 an die 
ziliäre Transitionszone lokalisiert und dort  mit Komponenten des NPH-Proteinkomplexes interagiert. 
NPHP4 stabilisiert in Abhängigkeit von Phosphatasen spezifisch die Expression von Jade-1. Dies 
wiederum führt dazu, dass Jade-1 verstärkt in den Nukleus transloziert und so die negative Regulation 
des Wnt-Signalwegs durch Jade-1 verstärkt wird. Die Phosphorylierung von Jade-1 erfolgt durch 
CK1α, einer Hauptkomponente des β-catenin-Degradationskomplexes. Sie verhindert, dass Jade-1 
negativ auf die Wnt-Signalkaskade einwirken kann. Die Tatsache, dass exogen zugeführtes ß-catenin 
zu einer Verminderung der CK1α und Jade-1 aber nicht der NPHP4-Proteinmenge führt, lässt auf ein 
komplexes Zusammenspiel dieser Proteine schließen, das möglicherweise während der epithelialen 
Zellteilung in Heilungsprozessen zeitlich präzise reguliert wird. Im Einklang mit der publizierten 
Literatur  deuten die hier präsentierten Daten darauf hin, dass das kooperative Wirken von NPHP4 und 
Jade-1 womöglich eine entscheidende Rolle dabei spielt, nach einem Gewebe- oder Zellschaden nicht-
kanonische Wnt-Signalkaskaden zu reaktivieren. Ein Ausfall dieser NPHP4-Jade1 
Signaltransduktions-Achse könnte zur Zystenbildung beitragen. 
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3 INTRODUCTION 
 
3.1 Cystic Kidney Disease 
 
 More than 12.5 million people worldwide currently suffer from cystic kidney disease, which is 
characterized by fluid-filled cysts arising from tubular epithelial cells of the renal nephron that 
ultimately impair renal function (1; Fig 1). Currently, there are no approved drug treatments or 
preventive strategies available. As most patients ultimately reach end stage renal disease (ESRD) and 
require dialysis or kidney transplantation, these diseases continue to present a major challenge for the 
health care system.  Cystic kidney diseases are most often hereditary although acquired forms may 
arise sporadically during development or aging, and can sometimes result as a consequence of dialysis 
or pharmacological treatments (2). Hereditary (poly-) cystic kidney diseases are caused by germline 
mutations in single genes and are inherited as Mendelian traits. Age of onset, symptom severity, 
disease progression, the renal phenotype and extra-renal involvement vary widely within this disease 
group (2). The most common form of inherited cystic kidney disease is Autosomal Dominant 
Polycystic Kidney Disease (ADPKD) which has an incidence of 1:500 to 1:1000 live births and is 
characterized by the progressive formation of multiple cysts leading to grossly enlarged kidneys, with 
patients becoming symptomatic from early adulthood on and ESRD occurring in 60% of patients by 
age 70 (3, 4; Fig 1B). Recessive disorders causing polycystic kidneys include Autosomal Recessive 
Polycystic Kidney Disease (ARPKD), Nephronophthisis (NPH) and other genetic syndromes that can 
be assocciated with a renal phenotype NPH such as Joubert syndrome (JBTS), Bardet-Biedl syndrome 
(BBS) and Meckel-Gruber syndrome (MKS). While less common, these recessive disorders generally 
develop at a much earlier age and involve more severe disease phenotypes (1). 
 
3.1.1 Nephronophthisis 
 
 Nephronophthisis (NPH) is the most common genetic cause of ESRD in children and 
adolescents with an estimated prevalence of 1 in 50,000 (5). NPH is characterized by the histological 
triad of interstitial fibrosis, tubular basement membrane disruption, and tubular atrophy with multiple 
cysts localized primarily to the corticomedullary border of the kidney. The majority of the cysts are 
derived from the distal convoluted and collecting tubules of the nephron (4; Fig 1B). Initial symptoms 
including polyuria and polydipsia begin at an average of 6 years of age, with renal failure occurring by 
an average age of 13 in the most common form of this disease (5, 6). Unlike other forms of cystic 
kidney diseases, kidneys are generally normal or reduced in size. Genetic research has identified 
sixteen causative genes (NPHP1-15 and NPHPL1) although these account for only 30% of cases of 
NPH, indicating that further causative genes will be identified in future (7–10). However, 
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heterozygous mutations in several related disease genes could increase total mutational load and 
account for NPH symptoms in patients without a homozygous mutation, as has been demonstrated for 
BBS proteins (11, 12). Extra-renal symptoms in NPH-related diseases such as Senior-Løken 
Syndrome and JBTS include retinal degeneration, liver fibrosis, or cerebellar vermis aplasia and occur 
in 10-20% of patients (5), the severity of which may depend on the type of mutation (7) or modifier 
genes involved (13). The overlapping extra-renal phenotypes caused by mutation of genes encoding 
different “cystoproteins” may be explained in part by a common localization or function of these 
protein products. Many cystoproteins form interaction complexes, including several of the 
nephrocystin proteins encoded by the NPH genes 1 to 11 (13, 14), therefore similar phenotypes arising 
from different genetic mutations may occur due to the disrupted function of the same interaction 
complex. Protein function overlap or co-dependency is further hinted at by relatively recent 
demonstrations that nephrocystin proteins co-localize to the same subcellular organelle: the primary 
cilium. Accumulating evidence that in fact all cystoproteins analyzed to date localize to the primary 
cilium or basal body generated the “ciliary hypothesis”, which stated that all proteins responsible for 
monitoring the need for renal epithelial cell division localize at least in part to primary cilia, and the 
formation of renal cysts could result from defective proliferation control by these organelles (15). The 
idea that one subcellular organelle could link a broad spectrum of disease phenotypes led to a new 
classification of human genetic diseases, the ciliopathies. 
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Figure 1. Healthy and polycystic kidneys. 
A. One nephron segment in a healthy kidney, illustrating location of nephron tubules and the location 
of primary cilia on tubular epithelial cells. The kidneys contain approximately 600,000 to one million 
nephron segments which filter 180L litres of urine per day. Blood enters the glomerulus which retains 
proteins but expels fluid into the proximal tubule. Fluid continues through the loop of Henle to the 
distal tubule before joining the collecting duct en route to the ureter. The nephron tubule system 
regulates the osmolarity of the urine, re-absorbing salts and water as required. Epithelial cells lining 
the tubules of the nephron each possess a primary cilium projecting into the lumen, which bends in the 
direction of fluid flow. Adapted in part from (16). B. Schematic drawing of a nephron's segments and 
cystic kidney images from ADPKD (left panels) and NPH (right panels). The magnifications of the 
pictures are not equal: both diseased kidneys are shown in comparison to the size of a healthy kidney. 
Kidneys in ADPKD are grossly enlarged with multiple cysts in all nephron segments, while NPH 
kidneys are normal to small in size with cysts primarily derived from the collecting tubules and 
localized at the corticomedullary border. Adapted from (2)(Reproduced with permission from Wilson 
2004 NEJM, Copyright Massachusetts Medical Society) and (17) (Reprinted from “Identification of a 
New Gene Locus for Adolescent Nephronophthisis, on Chromosome 3q22 in a Large Venezuelan 
Pedigree”, Volume 66, Heymut Omran et al, Copyright (2000), with permission from Elsevier), and 
The PKD Foundation. 
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3.1.2 Ciliopathies 
 
 The classification of various distinct genetic diseases associated with renal cysts as 
ciliopathies occurred only recently in medical history. In 1994 mutation of the Tg737 gene in mice 
was reported to cause a cystic kidney phenotype similar to ARPKD (18); however, the function of the 
Tg737 gene was unclear at that time. In 1999, C. elegans protein lov-1 was identified as a homolog to 
human PKD1, and shown to localize to sensory neuronal cilia (19). In 2000, sequencing of the 
Chlamydomonas reinhardtii flagellar protein IFT88 revealed homology to Polaris, the protein product 
of mouse and human Tg737 (20). This work further demonstrated that IFT88 was required for cilia 
assembly and that kidney tubule cells in the Tg737 mutant mouse lacked elongated luminal cilia. Two 
years later, the protein products encoded by two genes mutated in ADPKD, polycystin-1 and 
polycystin-2, were demonstrated to colocalize with Polaris/IFT88 at the mammalian primary cilium 
(21). This prompted intense investigation into the protein products of genes known to cause cystic 
kidney disease when mutated and it transpired that all cystoproteins localize to primary cilium, basal 
body or centrosomes (1, 7, 13, 22, 23). The subsequent association of multiple diverse human genetic 
disorders with ciliary dysfunction thus defined a collective group of “ciliopathies”, where distinct 
clinical entities manifest with a subset of overlapping clinical features, including polycystic kidneys 
(24). 
 The ciliopathy concept creates an explanation for the pleiotropic phenotypes associated with 
this group of diseases, because the cystoproteins included within the ciliary proteome are highly 
conserved throughout evolution and are expressed in many organ systems (13). For example, function 
of the pancreas and liver also depend upon tubular systems with luminal monocilia, which may 
explain the involvement of these organ systems in hereditary renal cystic diseases (25). Additionally,  
NPH-associated retinitis pigmentosa could be due to an interrupted interaction of several NPH 
proteins with key proteins in the connecting cilium of photoreceptor cells in the retina, which is the 
structural equivalent to the transition zone of renal epithelial cells (26–29). Primary cilia or ciliary 
motor proteins are also involved in olfactory function, axonal elongation, and left-right asymmetry, 
which may explain ciliopathy-associated phenotypes such as anosmia, brain malformations, and situs 
inversus (13, 30). Mutations in genes encoding known centrosomal or ciliary proteins have also been 
demonstrated as causative in BBS-associated obesity and NPH-associated skeletal defects (30). 
 Although the ciliopathy concept nicely links symptoms in separate organ systems to the same 
subcellular organelle, the converse challenge for this model will be to explain how the dysfunction of 
a single organelle leads to disparate phenotypes: for example, the predominant total-kidney cyst 
formation seen in ADPKD vs. the more specifically localized cysts of NPH; or the lack of retinitis 
pigmentosa in ADPKD but not NPH. It has been demonstrated that the same ciliary protein can have 
different roles in different tissue types (31), therefore extra-renal phenotypes might depend on which 
protein is affected. Within the kidney, it has been suggested that ciliary dysfunction initiates cyst 
formation but extraciliary cystoprotein functions determine the final phenotypic fate (32). Indeed, 
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many cystoproteins localize to multiple subcellular regions and interact with members of cell-cell or 
cell-matrix adhesion complexes (1, 13).  Examples include the adherens junction localization of 
nephrocystin-1 (33) and polycystin-1 (34) which are the respective protein products of the most 
frequent gene mutations causing NPH and ADPKD, or the nuclear localization of NPHP2 (35) or 
NPHP7 (36). Such multiplicity of potential functional roles call for caution to avoid a simple “guilt by 
association” description of the ciliary proteins in cyst formation (13). That the relationship between 
cysts and cilia is not as straightforward as promised was demonstrated by the Polaris transgene rescue 
in the Tg737 null mouse, where mice developed renal cysts despite a rescued ciliary phenotype (37). 
Additionally, the latest NPH gene identified, NPHP1L/XPNPEP3 isofom 1, is the first gene not 
consistent with the ciliary hypothesis, with the XPNPEP3 protein localizing to mitochondria rather 
than primary cilia (38). However, mice with a Polaris transgene expression displayed unusually 
elongated renal primary cilia, and the zebrafish xpnpep3 morphant phenocopies other known ciliary 
morphants and can be rescued by a human version of XPNPEP3 lacking a mitochondrial localization 
sequence; the implied ciliary involvement is supported by the role of XPNPEP3 in cleavage of known 
ciliary cystoproteins during development. These observations suggest that any disruption in the 
homeostatic function of primary cilia, including cross-talk between the primary cilium and the rest of 
the cell, may be enough to initiate renal cyst formation. In order to tease apart which cellular functions 
are disrupted during cyst formation and whether these require functional primary cilia, it will be 
important to closely study this organelle and elucidate the precise ciliary and extraciliary functional 
roles of cystoproteins involved in ciliopathies.  
 
3.2 The Primary Cilium 
 
 A cilium is an antennae-like structure protruding from the surface of virtually every 
mammalian cell, and protruding from the apical surface of differentiated renal epithelial cells. Much of 
the current knowledge has been gained from studies of the structurally similar flagellae of the green 
algae Chlamydomonas rheinhardtii. After cell division, both the mother and the daughter centriole 
migrate together to the plasma membrane to become the basal body. Both centrioles are barrel-like 
structures but only the mother centriole, which was inherited rather than duplicated during cell 
division, extends subdistal appendages which are required for microtubule enucleation as well as distal 
appendages which anchor to the plasma membrane and delineate a boundary from which the ciliary 
membrane will extend (22, 39). The ciliary membrane extends to surround a central axoneme 
consisting of nine peripheral doublet microtubules assembled on top of the mother centriole template 
(Fig 2A). This “9 + 0” axoneme organization is characteristic of non-motile primary cilia. Motile cilia 
are often expressed in multiple copies on the cell surface, and contain dynein arms as well as an 
additional central microtubule pair allowing for bi-directional movement characteristic of their 
long-recognized roles in cell or fluid propulsion.  Although first reported in 1898 and studied 
INTRODUCTION 8
structurally for the past 45 years (40) a lack of more than circumstantial evidence regarding function 
led to primary cilia being largely overlooked by the biomedical community as vestigial organelles or 
at best, a mechanism to sequester centrioles during interphase (41, 42). However, advances in 
microscopy and biochemical technology during the past 15 years have allowed for a recent explosion 
of research, establishing the primary cilium’s place as a critical functional element in an increasing list 
of human tissues. 
 Early evidence connecting primary cilia to cell function described a link between the presence 
of the cilium and the cell cycle, whereby serum stimulation induced cell cycling coupled with biphasic 
ciliary disassembly, with the second wave occurring at the initiation time of DNA synthesis and 
centriole duplication (43). Ciliation was noted to occur in the late G1 phase of dividing cells, and it 
was proposed that at this point the cell could exit mitosis, and the retained cilium in G0 could remove 
the centriole from the mitotic cycle. That primary cilia are disassembled prior to mitosis and 
reassembled after cytokinesis has since been well established, although the direction of causality 
continues to be unclear (44, 45). The ciliary control of cell-cycle regulation is ambiguous; for 
example, a reduction of the intraflagellar transport protein IFT27 elongates the cell cycle (46), but a 
reduction of IFT88 promotes cell-cycle progression (47). In general, kinase activity within the ciliary 
region seems important in regulating ciliary disassembly and cell-cycle re-entry. For example, 
Aurora A kinase-dependant activation of the tubulin deactylase HDAC is required for disassembly 
(48), as is the  recruitment of phosphorylated Tctex-1 to the transition zone, which accelerates ciliary 
disassembly and cell-cycle reentry (49). Conversely, dysfunction of the JBTS1 gene product, ciliary-
localizing phosphatase INPP5E, results in cilia destabilization (50, 51). However, examples also exist 
describing protein kinase requirement for ciliary assembly (52) as well as for cell-cycle control over 
primary cilia dynamics. For example, ciliary assembly depends on the cell-cycle dependent removal of 
the disassembly-linked phosphoprotein Nde1 from the centrosome (53), while disassembly depends on 
cell-cycle dependent accumulation of Nek2 to the mother centriole at G2 (54). In any case, though the 
hierarchy of command remains uncertain, the importance of this reciprocal relationship between cell 
cycle and the primary cilium is clear, with recent in vivo evidence demonstrating that interrupting the 
ciliary regulation of cell cycle reentry influences whether the cell divides or differentiates in the 
developing brain (49). Teasing apart the roles of the cilium, centrosome, and the cell cycle in 
differentiation and tissue homeostasis will require a deeper understanding of the molecular 
mechanisms governing communication between the primary cilium, the external environment, and the 
cell.  
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3.2.1 Ciliary Communication with the Cell – the “Ciliary Pore Complex” 
 
 Communication between the cilium and the cell requires the cilium to act as a separate 
functional unit, and the cilium is considered an independent subcellular organelle despite a lack of 
membrane boundary between the ciliary lumen and the cytoplasm. However, even though the ciliary 
membrane is continuous with the apical cell membrane, numerous examples describe localization of 
both membrane and axonemal proteins restricted to or specifically concentrated at the primary cilium 
(55–59). Thus, both membrane and cytoplasmic proteins cannot freely diffuse into the ciliary 
compartment. Nearly 200 proteins have been identified within the primary cilium by proteomic and 
computational analysis (59), and including the basal body the complete ciliary proteome could include 
over 1000 different polypeptides, although whether all would be required for function in every cell 
type remains unclear (60, 61). Protein synthesis has not been shown to occur in the ciliary lumen, so to 
maintain this distinct ciliary protein composition the cell must regulate either the entry or retention of 
proteins within the cilium by a functional barrier. The absence of protein synthesis also requires a 
highly efficient mechanism in place to shuttle proteins within the cilium, which is achieved by the 
intraflagellar transport (IFT) system described below. Understanding this composition and action of 
this barrier as well as the molecular mechanisms driving IFT will allow a better understanding of how 
the communication between the cilium and the cell is regulated.  
Positioned in the cytosol at the base of the cilium, the centrosome is a prime candidate to 
regulate protein transport to and from the cilium. The centrosome consists of the mother and daughter 
centrioles whose migration toward the apical membrane after mitosis initiates ciliogenesis, as well as a 
variety of peri-centriolar proteins of as yet unknown functions. Early studies using electron 
microscopy noted satellite arms projecting uniquely from the mother but not daughter centriole during 
early ciliogenesis (62), which have since been further characterized as distal and subdistal appendages. 
Subdistal appendages are thought to play a role in anchoring microtubules (63), whereas distal 
appendages are involved in the recruitment and tethering of the basal body to the plasma membrane 
(64, 65). The ciliary axoneme consists of doublet (A & B) microtubules which are assembled on top of 
the triplet (A, B & C) microtubules of the mother centriole. The distal appendages attach to the mother 
centriole immediately proximal to the doublet axoneme, attaching to the C tubule just prior to its 
termination and in this context are called “transition fibers” (Fig 2 B-D). In contrast, immediately after 
the transition of A & B tubules from the centriole to the axoneme exists the “ciliary necklace”, 
consisting of Y-shaped bridges that connect the outer doublet microtubules of the axoneme to the 
ciliary membrane (64, 66; Fig 2 E-G). Together these structures are termed the “transition zone”, and 
both are independently important for cilia integrity. For example CEP 164, which localizes 
specifically to distal fibers, and CEP290/NPHP6, which localizes to the Y-links of the ciliary 
necklace, are both required for assembly of primary cilia (67, 68).   
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Figure 2. The pimary cilium. 
A. Schematic illustrating ciliary structure and protein transport. The basal body is surrounded by peri-
centriolar material and is comprised of the mother centriole which projects distal/transition fibers that 
adhere to the plasma membrane at the base of the cilium, as well as subdistal fibers which are involved 
in microtubule enucleation. The ciliary axoneme is composed of 9 doublet microtubules assembled on 
top of the mother centriole template. Motile cilia contain a central mircotubule pair and dynein arms 
required for movement, whereas primary cilia do not. Newly synthesized proteins are transported in 
vesicles from the Golgi apparatus to the apical membrane at the base of the cilium where the vesicle is 
exocytosed, leaving the proteins to interact with IFT particles and unidirectional motors. The entire 
IFT train must cross the transition fibres and Y-links of the transition zone to gain access to the ciliary 
lumen. Anterograde transport requires hetero-trimeric Kinesin-2 motor complex while retrograde 
transport uses cytoplasmic dynein1b. Transition zone proteins strictly regulate entry of new proteins 
and exit of old proteins from the cilium as described in the main text. B. Scanning electron microscopy 
(SEM) image of the ciliary necklace component of the transition zone as visualized by freeze-fracture 
(arrow) (66; © Gilula and Satir, 1972. Originally published in Journal of Cell Biology. 
doi:10.1083/jcb.53.2.494.). C-D. Transmission electron microscopy (TEM) image of ciliary 
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necklace Y-links (arrowheads, C), which disappear if NPHP6 expression is interrupted (D) (68; © 
Craige et al., 2010. Originally published in Journal of Cell Biology. doi:  
10.1083/jcb.201006105). E. Model of distal fibers (alar sheets) and microtubule-nucleating subdistal 
fibers attached to mother centriole (69; © Anderson 1972. Originally published in Journal of Cell 
Biology. doi:10.1083/jcb.54.2.246). F. TEM image cross-section of the distal/transition fibers (69; 
© Anderson 1972. Originally published in Journal of Cell Biology. doi:10.1083/jcb.54.2.246). 
G. Schematic of the transition fibers, highlighting 60nm distance between each (70; Nachury et al., 
2010, with permission from Annual Reviews). H-I. Immunofluorescence image of 
glycosylphosphatidylinositol-fluorescent protein (green) is excluded from a specialized periciliary 
membrane domain surrounding the cilium (red, J), while Galectin-3 (red, K) concentrates in this 
region (reproduced from (71), copyright © by the National Academy of Sciences, U.S.A.). J. 
Schematic of the periciliary membrane domain highlighting size of specialized apical membrane 
region (70; Nachury et al., 2010, with permission from Annual Reviews). 
 
 
 The idea that the transition zone could act as an impermeable ciliary barrier was initially 
suggested  by two studies in 1972: the first, using freeze-etching combined with electron microscopy, 
identified the ciliary necklace and proposed it to be involved in the “control of localized membrane 
permeability”(66); whereas the second, using 3D reconstruction techniques to model transition fibers, 
described these structurally as trapezoidal sheets, possibly capable of limiting the size of particles 
entering the cilium (69). Both of these ideas have since found support, and several authors have now 
likened the selective regulation of protein entry to the cilium to that of the nuclear pore, proposing that 
the transition zone acts as a “ciliary pore complex” (CPC; 70, 72–75). Structurally, the sheets formed 
by the transition fibers form a “nine-bladed propeller-like structure jammed at the entrance of the 
ciliary lumen”, with the space between consecutive sheets theoretically large enough to allow free 
diffusion of particles smaller than 60 nm in diameter (70). Diffusion studies in photoreceptor cells 
have provided evidence that small molecules such as the 27 kDa green fluorescent protein (GFP) 
move freely between the ciliary lumen and cytoplasm (76) suggesting that the lumen likely has a 
similar composition to the cytoplasm in terms of ions and small proteins. However, there is a reduction 
of diffusion rate across the connecting cilium for even small particles compared to aqueous solution 
which is not explained by the size obstruction of the axoneme, and suggests that even the ciliary entry 
of smaller sized proteins could be regulated (77). This regulation is reminiscent of that occurring at the 
nuclear pore complex (NPC), which excludes nuclear entry of proteins larger than 60 kDa, slows 
proteins 30-60 kDa, and allows free diffusion of anything under 30 kDa. At the cilium, it was recently 
shown that proteins larger than 40 kDa require the presence of specific nucleoporins at the CPC (78). 
The same group had previously demonstrated that the 170 kDa ciliary motor protein KIF17 required 
importin-β2 as well as a ciliary concentration of the GTP-bound form of the small G-protein Ran (75), 
both of which are similarly required at the NPC to translocate and release nuclear cargo. The ciliary 
protein polycystin-1 also requires Rab and Arf GTPase activity for ciliary localization (79). Such 
parallels between ciliary and nuclear import lead to an important question regarding how ciliary versus 
nuclear cargoes are trafficked to the correct location. One possibility is the recognition of distinct 
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targeting sequences within the cargo proteins. Importins are known to recognize a nuclear localization 
sequence (NLS) on their cargo, and it was shown that a specific lysine-rich C-terminal sequence on 
KIF17 acted as a ciliary localization sequence (CLS; 75). When this target sequence was replaced with 
the NLS from the SV-40 large T antigen, KIF17 was targeted to the nucleus. Ciliary-targeting 
sequences have been identified on a number of ciliary proteins, and some common motifs are 
surfacing (70). For example, the CLS of the photoreceptor rhodopsin contains the amino acid sequence 
Q-V-(S/A)-P-A, while the PKD gene products associated with ADPKD, polycystin-1 and polycystin-
2, contain a conserved motif (K/R)-V-x-P,  suggesting V-x-P as a common sequence important for 
ciliary targeting (70, 79–82). Other CTS sequences include an A-x-(S/A)-x-Q motif identified in 
several G protein–coupled receptors (83), and critical C-C-C and K-T-R-K residues in the cytoplasmic 
tail of fibrocystin, the product of the human ARPKD gene PKHD1 (84).  
 Proteins that are destined for the cilium are thought to be contained within post-Golgi vesicles 
and exocytosed at the apical plasma membrane at point of transition fiber contact (72, 73). Once there, 
proteins must be transported across the transition zone and throughout the cilium. Although it is not 
clear exactly how crossing the transition zone is regulated, the mechanism of protein transport through 
the cilium is well established. IFT was first observed in 1993 using DIC microscopy to visualize the 
flagella of Chlamydomonas reinhardtii where the IFT protein trains were shown to move at a rate of 
~2 µm per second from the ciliary base to tip, and ~3.5µm per second in the reverse direction (85). 
The suggestion that these IFT trains were the same as the  electron dense “rafts” bound periodically to 
both the flagellar membrane and the B tubule of the ciliary axoneme seen by electron microscopy was 
subsequently verified (86). All axonemal microtubules are oriented with their plus end towards the 
distal tip of the cilium (87), so transport of cargo such as membrane receptors or axoneme components 
requires microtubule motors operating in a plus-end direction to reach the distal end of the cilium as 
well as minus-end direction to recycle components back to the ciliary base. These motors are now well 
established as the anterograde heterotrimeric kinesin-II and the retrograde cytoplasmic dynein1b (72, 
88–90), both of which are carried in an inactive state by the other motor when not in use (91–93). 
More recently, a second anterograde motor, homodimeric OSM-3/KIF17, was shown to act 
cooperatively with kinesin-II in the proximal cilium as well as independently along the singlet 
microtubules of the distal cilium (94, 95). Since  KIF17 has been  shown to be important for correct 
ciliary localization of the olfactory channel subunit CNGB1b (96) as well as for cone opsin in the 
photoreceptor outer segment (97), it has been suggested that multiple anterograde motors might be 
important in specific cilia types for correct protein localization and function (98, 99).  
 Chlamydomonas reinhardtii mutants have demonstrated that the function of both anterograde 
and retrograde IFT are required to maintain flagellar length (86, 88). This suggests a constant turnover 
of ciliary proteins must be maintained by transport and entry of proteins to the cilium. In addition to 
motor proteins, the IFT complex consists of at least 15 different polypeptides which sediment in 
density gradients as two complexes, termed A and B (89). Several of these IFT particles have been 
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implicated not only in ciliary protein transport but also for protein entry across the transition zone. 
Despite their most well known function within the cilium proper, most IFT particles including motor 
proteins localize predominantly to the basal body region, outside of the cilium (89, 90, 100). 
Intriguingly, electron microscopy has demonstrated that IFT52 localizes to the transition fibers at the 
point of membrane contact where golgi vesicles are thought to exocytose, leaving their cargo to be 
associated with IFT particles for ciliary transport (72, 101, 102). IFT particles could also be directly 
involved with ciliary targeting of golgi vesicles, as IFT20 localizes to these golgi vesicles as well as 
IFT rafts and is required for the ciliary localization polycystin-2 (102, 103). It is well known that IFT 
particles are recycled as they can continue to maintain the cilium without new protein synthesis for 
several hours (93, 104). Retrograde IFT is required for protein exit from the cilium (88, 105), and it is 
thought that IFT particles are dissociated at the point of ciliary exit, subsequently reforming to carry 
new cargo (93). Distinct apical staining patterns suggest the existence of a diffusion barrier which 
might function as a specialized periciliary membrane domain (PCMD) of condensed lipids which 
maintains a rich concentration of proteins intended as ciliary cargo close to the basal body region (70, 
71, 106; Fig 2H-J). IFT particles share evolutionarily conserved sequence domains with the 
prototypical coat protein I (COPI) and clathrin transport proteins (107), and it has been proposed that 
the IFT particles may polymerize into a flat coat which serves as a focal point for motor proteins to 
propel the unit through this diffusion barrier (70). The location of IFT particles to the transition fibres 
supports this possibility; however, both the IFT proteins and cargo would still need to translocate 
through the Y-links at the ciliary necklace. Evidence exists to suggest that regulating protein transport 
across this region of the transition zone may involve known ciliopathy proteins, including the 
nephrocystins.   
 
3.2.2 Nephrocystin proteins at the ciliary pore complex. 
 
 Many ciliopathy related proteins form complexes at the base of the primary cilium, and several 
MKS, JBTS, and NPH proteins have been shown by immunofluorescence to localize specifically to 
the transition zone (14, 23). Using tandem affinity purification followed by mass spectrometry, 
reciprocal interaction studies identified two nephrocystin complexes: NPHP1-4-8 and NPHP 5-6 (14). 
All three proteins in the first complex localize to the transition zone, while NPHP6 localizes to both 
the basal body and transition zone and NPHP5 to the basal body (14, 68). Although not required for 
ciliary assembly, studies in C. elegans have reported a mild stunted or misshaped ciliary phenotype 
following nphp-1 or nphp-4 knockdown, the penetrance and severity of which is exacerbated 
significantly by combined knockdown with transition zone mks proteins (108, 109), highlighting the 
functional overlap of TZ proteins which may account for the variety of disease phenotypes associated 
with disruption individual protein function in this structure (31). Interestingly, combined mks/nphp-1 
or mks/nphp-4 mutant strains lacked the Y-links which form the ciliary necklace (109). Independently, 
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NPHP6 has been shown by electron microscopy to localize specifically to the Y-links within the 
transition zone and to be required for the formation of these structures (68). When these Y-links are 
disrupted, the ciliary membrane at the transition zone is located further away from the axoneme (68, 
109), suggesting that NPH proteins play a role in the structural integrity of this region. Furthermore, 
disrupted Y-links due to NPHP6 knockdown have led to altered flagellar protein composition and 
reduced retrograde transport velocity (68), and nphp-4 knockdown in C. elegans leads to decreased 
ciliary access or motility of motor proteins such as OSM3/KIF17 and OSM6/IFT52 (108). Together 
these results suggest that NPH proteins at the transition zone are not only important for keeping 
proteins from entering cilia, but also for facilitating entry and exit of required proteins, supporting the 
notion that NPH proteins located at the ciliary necklace Y-links contribute to a functional ciliary gate 
(23, 109, 110). The mechanism of action of NPH proteins at this gate is not clear; however, due to the 
known role of IFT particles in trafficking ciliary proteins it has been suggested that TZ nephrocystins 
may modulate the packaging of ciliary cargo to IFT trains (99), which is supported by observations 
that a murine Nphp1 mutant develops retinal degradation due to inefficient IFT transport to outer 
segments of photoreceptor cells rather than impaired connecting cilium formation (111). Indeed, the 
recently reported novel NPH genes NPHP12 and NPHP13 were identified to respectively encode IFT 
proteins IFT139 and IFT144 (8, 10), further establishing an intimate link between NPH proteins and 
IFT. Other reports that several nephrocystin proteins interact with the TZ guanine exchange factor 
RPGR (26, 27, 112, 113), which in analogy to its function at the nuclear pore may be important for 
GTP-dependent release of G-protein bound cargo, have prompted speculations that the nephrocystin 
proteins may be involved specifically in the release of cargo after transport into the ciliary lumen (73). 
As the importance of the cilium in the cell’s reception of environmental signals is increasingly 
recognized, it becomes apparent that regulating ciliary protein entry or IFT competence would 
influence the availability of signaling components such as transmembrane receptors or downstream 
effector proteins and have a profound effect on the capacity for communicating signals to the rest of 
the cell. 
 
3.3 The role of primary cilia as signaling pathway platforms. 
 
 The importance of primary cilia to act as a mechanism for the cell to receive environmental 
signals was initially obvious only in specialized sensory cells involved in vision and olfaction. The 
high-turnover light-sensitive rhodopsin molecules of retinal photoreceptor cells are produced in the 
cell body and their translocation to the outer segment depends upon IFT-mediated transport through a 
primary “connecting” cilium. The presence of multiple primary cilia projecting from the dendrites of 
olfactory neurons into the mucus membrane of the nasal epithelium was shown long ago to be required 
for odorant perception (114, 115), and many odorant receptors have since been shown to localize to 
these organelles (116, 117). The sensory role for apparently “non-specialized” primary cilia was less 
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obvious, but in recent years they have also been shown to be important for signal reception in a 
number of different tissues, prompting their likening to a “cellular antenna”(114, 118, 119) . For 
example, the inhibitory hormone somatostatin receptor 3 has been shown to exclusively localize to 
neuronal primary cilia in all brain regions except the cerebellum (120), and the serotonin receptor 
5HT6  localizes to primary cilia in the striatum, nucleus accumbens, olfactory tubercle and islands of 
Calleja (121). More recently, the melanin-concentrating hormone receptor1 has also been shown to 
localize to neuronal cilia (83), while the somatostatin receptor 3 has additionally been localized to 
primary cilia of pancreatic islets and the pituitary gland (56). Motile cilia also have been shown to 
have chemo- and mechano-sensory functions. For example, four members of the sensory bitter taste 
receptor (T2R) family are specifically expressed on motile airway epithelial cilia (122), and 
accumulating data suggests that sensory-motor-response circuit controlling beat frequency in 
multiciliated epithelia of the respiratory tract, oviduct and ependymal lining of the ventricles of the 
brain is mediated by the cilia themselves (123). 
 As cilia-specific receptors continue to be identified, the role of these organelles in 
communicating the signal to the rest of the cell is also being elucidated. One of the better understood 
ciliary signaling pathways is the hedgehog (Hh) signaling pathway, which is important for dorsal-
ventral patterning during embryonic development. In 2003 it was reported that two different mouse 
mutants which disrupted mouse homologues of IFT172 and IFT88 had defective Hh signaling, 
suggesting ciliary involvement in the function of this signaling pathway (124). It has since been 
demonstrated that primary cilia are a key component of both the activation and repression of Hh 
signaling: under basal conditions the Hh effector proteins Gli2 and Gli3 are processed to their 
repressor form at the ciliary tip (125), whereas when a Hh ligand binds to its receptor Patched (Ptc), 
the activator Smoothened (Smo) translocates into the cilium (126) where it inhibits the processing of 
Gli2 & Gli3, allowing their nuclear translocation and target gene activation (127). Of interest, 
depletion of the small GTPase Septin 2 at the TZ increased diffusion of several ciliary membrane 
proteins but decreased retention of Smo, reducing the Hh signaling response (128) and supporting an 
argument whereby specificity of ciliary protein entry and exit is critical for signaling pathways. In 
addition to Hh signaling, primary cilia are also required for platelet-derived growth factor-AA (PDGF-
AA) signaling. The PDGF receptor alpha (PDGFRα) localizes to fibroblast primary cilia which are 
required for downstream MEK1/2-ERK1/2 pathway activation (129). The primary cilium has also 
been shown to regulate second messenger cyclic AMP (cAMP) formation. Adenylyl cyclase III, which 
converts ATP to cAMP, is located in olfactory cilia where it is required to transform chemosensory 
information to electrical signals (130). More recently it has also been shown to localize to neuronal 
and astrocyte cilia where it might play a similar role, altering membrane potential through calcium 
influx and possibly regulating neuronal firing rate (131).  
 Interestingly, renal cilia have also been shown to regulate calcium signaling. The bending of 
cilia in response to fluid flow increases calcium influx followed by intracellular calcium release (132, 
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133). This effect is a specific response to laminar fluid flow rather than mechanical pressure (134) and 
is abolished in previously responsive confluent cell monolayers lacking cilia due to chemical removal 
(135), as well as in collecting tubule cell preparations or intact segments lacking cilia due to Tg737 
genetic mutation (136–138). The mechanically sensitive ion channel mediating this effect is thought 
primarily to be the ciliary cystoprotein polycystin-2 (139, 140), which requires co-expression of 
polycystin-1 for correct apical localization and ion channel function (141). Indeed, flow-induced 
calcium response is completely abrogated in human primary cultures of PKD cyst-lining cells lacking 
polycystin-1, despite cells retaining otherwise normal calcium signaling (142). In non-ciliated Tg737 
mutant cells which also do not respond to flow, basal calcium levels are increased, which suggests de-
regulated calcium entry in stimulated and non-stimulated conditions (136, 137). Indeed, Tg737 mutant 
cells show altered polycystin-2 localization throughout the apical membrane rather than concentration 
in the cilium (136), which again highlights the important role of the transition zone in maintaining 
restricted localization of signaling molecules within the cell versus the cilium.  
 Calcium signaling has a number of downstream effects which may contribute to cyst 
formation if de-regulated. For example, cAMP activity in normal cells inhibits MAPK signaling and 
cell proliferation, but stimulates this pathway in cystic cells (143). This switch in cAMP activity is 
mimicked in normal cells by blocking calcium influx, which causes cAMP to activate B-Raf instead of 
Raf-1 and leads to aberrant activity of the MEK/ERK pathway (144). The switch in cAMP activity 
involves a calcium-restriction-dependent decrease in PI3K/AKT activity (144), which is an upstream 
regulator of mTOR. Of interest, AKT/mTOR signaling is upregulated in ARPKD and ADPKD (145, 
146); however, clinical use of an mTOR inhibitor reduced cyst size but did not improve renal function 
(147, 148),  indicating that other causal triggers must exist contributing to cyst expansion. One 
possibility involves abnormal secretion in cyst lining cells. In ADPKD, altered cell polarity in cystic 
epithelia results in an apicobasal reversal of the Na+/K+-ATPase sodium pump localization and 
aberrant apical secretion of sodium ions into the cystic lumen, providing a gradient that causes further 
fluid secretion and cyst expansion (4). That this might be a major causal trigger is supported by results 
of a recent 3 year double blind clinical trial demonstrating that Tolvaptan, a vasopressin V2-receptor 
antagonist which suppresses proliferation and luminal fluid secretion, slowed kidney growth (149). Of 
interest, the apicobasal reversal of the Na+/K+-ATPase sodium pump localization mirrors the normal 
developmental status of the kidney, where apical location of sodium pumps is thought to be required 
for dilation of the newly formed lumen of kidney tubules (4). Unlike in ADPKD, kidneys in 
nephronophthisis are generally reduced in size, with an increase in apoptosis rather than 
hyperproliferation allowing for cyst expansion at the expense of native tissue (1, 13). The 
“developmental state” of cyst-lining epithelia may also reflect causal triggers more applicable to NPH 
such as defects in cell polarity, cell-matrix or cell-cell interactions, which have also been identified in 
cyst lining epithelia (4). These defects could result from de-regulated TZ control of ciliary-mediated 
signaling pathways. In particular, de-regulated calcium signaling in response to flow may lead to 
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changes in the polarity of the cell due to interrupted balance of the three major Wnt signaling 
pathways as further described in the following section: Wnt/Ca2+, Wnt/PCP, and canonical Wnt (150). 
The canonical Wnt signaling pathway is known to play a crucial role in kidney development, while 
Wnt/PCP signaling is important in cell polarity, and both of these Wnt pathways could be mediated 
via the Wnt/Ca2+ pathway (150). A failure for Wnt signaling to progress from canonical Wnt in early 
development to polarity-directed pathway activation could result in aberrant protein localization and 
be influenced by incorrect interpretation of calcium influx by the cilium. Thus, Wnt signaling 
represents a prime candidate for investigation as a de-regulated signaling pathway in the formation of 
kidney cysts. 
 
3.3.1 The Wnt signaling pathway and kidney cyst formation 
 
 Inter-cellular communication by secreted Wnt ligands is required to establish signaling 
gradients needed for dorsoventral and anteroposterior axes specification during vertebrate 
development (151, 152), but Wnt signaling also plays key roles in regulating cell fate decisions and 
migration (153), cell cycle progression and stem cell maintenance (154). In adults, Wnt signaling 
drives tissue renewal in rapidly self-renewing organs such as the intestine and skin, where Wnt 
pathway activation is required not only to maintain stem cell populations but also to drive expansion 
of new epithelial cell precursors (153, 155, 156). Deregulation of Wnt signaling can therefore lead to 
disastrous consequences both for the developing embryo and for the adult organism, where de-
regulated Wnt signaling is a major contributor to cancer (156, 157). De-regulated canonical Wnt 
signaling in mouse models also leads to kidney cyst formation, possibly due to aberrant proliferation, 
although discerning the sequence of events is complicated by findings that renal cysts develop in both 
gain- and loss-of-function mutants (158–161). As with ciliary dysfunction, it appears that any 
deviation from normal Wnt function is sufficient to induce renal cyst formation. Maintaining a delicate 
balance of canonical Wnt activation may also be critical for appropriate regulation of other intimately 
linked noncanonical Wnt signaling pathways, such as the Wnt/Planar Cell Polarity (PCP) pathway. 
Wnt/PCP signaling regulates developmental processes including convergent extension (CE) and 
oriented cell division (OCD). CE is a process required for the intercalation of tubule cells and resultant 
tubule extension rather than expansion, while OCD ensures that the mitotic spindle axis is oriented so 
the cell divides along the length of the tubule. Both of these events are required for normal kidney 
tubule development and are abnormal in cells lining kidney cysts, perhaps contributing to tubule 
expansion rather than elongation (162, 163). Wnt ligands have been shown to compete for receptor 
binding and use several of the same downstream mediators, suggesting that activation of one Wnt 
pathway may be at the expense of another (164, 165). This crosstalk between Wnt pathways also 
means that dysfunction in one pathway could disrupt the regulation of another. As an example, 
transgenic mice overexpressing the canonical Wnt ligand Wnt9b develop renal cysts (166), whereas 
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mice lacking Wnt9b expression have defects in PCP-regulated convergent extension and oriented cell 
division, but this also leads to the development of renal cysts (167), rendering it difficult to determine 
the causative event leading to cyst formation in either scenario. Evidence that defects in orientation of 
dividing cells does not precede cyst initiation suggests that PCP defects may be a secondary effect in 
renal cystic pathogenesis (163); however, it has also been pointed out that the low incidence of cancer 
in ciliopathy patients suggests that PCP defects rather than aberrant β-catenin signaling features more 
predominantly (168). 
Canonical Wnts are classified as those that mimic the  β-catenin overexpression effects of 
neural tube malformation or secondary body axis induction, although many of these act in a context 
dependent manner (169). Put in simplistic terms, activation of canonical Wnt target genes occurs when 
the major effector of this pathway, cytosolic β-catenin, escapes degradation by the constitutively 
active “destruction complex” and is allowed to enter the nucleus where it interacts with T cell factor 
(TCF) or lymphoid enhancer-binding factor (LEF) transcription factors (Fig 3A). When the canonical 
Wnt pathway is inactive, kinase members of the destruction complex, glycogen synthase kinase-3β 
(GSK3β) and casein kinase 1 (CK1), sequentially phosphorylate β-catenin, targeting it for β-
transducin repeat containing E3 ubiquitin protein ligase (β-TrCP) mediated ubiquitylation and 
subsequent degradation by the proteasome. Binding of a Wnt ligand to a Frizzled (Fz) receptor in the 
presence of low-density lipo-protein receptor-related protein-5 or -6 (LRP-5/6) coreceptors recruits the 
entire destruction complex to the membrane where it can no longer interact with β-TrCP and instead 
binds and phosphorylates LRP-5 or -6, enhancing the Wnt response (156, 170, 171). The switch in 
destruction complex function is mediated by the Wnt-induced activation of the protein Dishevelled 
(Dsh or Dvl), which aids in the clustering of Fz and LRP receptors and relocation of the destruction 
complex to the plasma membrane (172–174). In contrast to its cytosolic/nuclear role in enhancing 
canonical Wnt response, membrane-bound Dsh is important in mediating the non-canonical Wnt/PCP 
signaling, which functions independently of β-catenin. Although Wnt/PCP signaling is not as well 
defined, it requires Dsh to localize asymmetrically at the cell membrane where it is involved in 
downstream activation of small GTPases Rho and Rac, as well as activation of c-Jun N-terminal 
kinase (JNK) and inhibition of GSK3β, both of which influence microtubule dynamics (172; Fig 3B). 
The mechanisms controlling the switch in Dsh activation are also not yet clear; however, evidence 
exists to suggest that calcium signaling may play a key role in antagonizing the canonical Wnt 
pathway (150, 165, 175). As noted above, calcium influx due to ciliary bending releases a pool of 
intracellular calcium leading to various downstream effects that could contribute to cyst formation if 
de-regulated. Expression of a Dsh mutant able to activate Wnt/PCP but not canonical Wnt signaling 
also leads to an increase of intracellular calcium release (176). The switch to Dsh-dependent Wnt/PCP 
activation may depend on the expression of ciliary proteins including the nephrocystins, and may 
require ciliary-dependent restraint of Dsh-dependent canonical Wnt signaling.  
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Figure 3. Wnt signaling pathways. 
A. Canonical Wnt signaling in an inactive “off” state (left), where β-catenin is constitutively degraded 
by the destruction complex, and its active “on” state (right), where the destruction complex binds LRP 
at the plasma membrane and can no longer ubiquitinate β-catenin, leading to its accumulation and 
nuclear translocation (171; Reprinted from Cell, Vol 149, Vivian Li et al., Wnt signaling through 
inhibition of β-catenin degradation in an intact Axin1 complex, 1245-1256, Copyright 2012, with 
permission from Elsevier). B. Simplified schematic illustrating the relationship between three major 
Wnt signaling pathways. A Wnt ligand binds to a Fz receptor and activates either the Wnt/β-catenin 
(left), Wnt/PCP (middle), or Wnt/calcium signaling pathways depending on context (see main text). 
Dsh activates β-catenin signaling by inhibiting destruction complex member GSK3β, which promotes 
signaling cascades involved in cell proliferation. Dsh can also activate PCP signaling via downstream 
GTPases Rac and RhoA, leading to activation of JNK and Rho-kinase, which play an important role in 
cytoskeletal reorganization. Activation of Wnt/calcium signaling involves G protein-coupled receptors 
and Phospholipase C (PLC) mediated PIP2 cleavage into Diacylglycerol (DAG) and IP3, promoting 
intracellular calcium release leading to Protein Kinase C (PKC) and Cam Kinase II (CamKII) 
activation. In addition to its role in PCP signaling, Dsh can directly activate of PKC and CamKII. 
Calcium influx due to ciliary bending may have a role in the degradation or membrane sequestration 
of Dsh. Figure based on (176–178), see main text for more detail. 
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3.3.2 The Wnt signaling pathway and the role of cilia & NPH proteins 
 
The involvement of primary cilia in Wnt regulation is a highly debated topic, but several lines 
of evidence support a functional link. One of the first examples describing primary cilia as important 
in Wnt regulation was demonstrated in 2005 where the inversin (INVS) gene product NPHP2 
interacted with Dsh and abrogated the ability of Dsh to stimulate canonical Wnt signaling (178). 
Furthermore, NPHP2 over-expression reduced cytosolic but not membrane-bound Dsh protein levels, 
and was required for convergent-extension movements in Xenopus laevis embryos. Morpholino 
knockdown of inversin caused renal cysts in developing zebrafish embryos that could be rescued by 
expression of diversin, a protein known to be important in Wnt/PCP signaling. As application of flow 
on cultured cells increased the protein levels of NPHP2, it was speculated that the initiation of urine 
flow in the developing kidney leads to an NPHP2-mediated switch from canonical Wnt signaling that 
is required in early development to β-catenin-independent Wnt signaling pathways that might be 
necessary to further develop or maintain tubular geometry, reflecting the developmental decrease in 
canonical Wnt activity post-nephrogenesis (179). It has since been reported that Invs mutant mice do 
not show abnormalities in canonical Wnt reporter activity or β-catenin localization during late kidney 
development (180), although human nephronophthisis patients with INVS nonsense mutations do 
display intensely upregulated diffuse β-catenin in non-dilated, dilated and cystic tubules, as well as 
nuclear β-catenin and Dsh in a subset of patient tubular cells (181).  
The discrepancy of in vivo data pertaining to the requirement of NPHP2 in canonical Wnt 
regulation extends to the requirement of the cilium itself. Homozygous deletion of the axonemal 
kinesin subunit KIF3a, which is required for ciliogenesis, leads to upregulated canonical Wnt reporter 
activity in the developing mouse and increased nuclear β-catenin response to Wnt3a stimulation in 
Kifa-/- embryonic fibroblasts (182). The same study replicated these results using cells derived from 
two other knockouts that blocked ciliogenesis, Ofd1 and Ift88. These findings however, have since 
been contradicted in vivo and in vitro in embryonic mice lacking primary cilia due to the loss of Ift88, 
Ift172, Kif3a, or the retrograde motor protein Dync2h1 (183) although a kidney-specific knockout of 
Kif3a led both to renal cysts and to upregulated β-catenin and canonical Wnt target gene c-myc (184). 
In the developing zebrafish embryo, ift88 morpholino knockdown also led to loss of primary cilia and 
interrupted Hh signaling but did not display any of the common phenotypic readouts for canonical or 
non-canonical Wnt signaling, prompting the authors to suggest that cilia were required for Hh 
signaling but the basal body may be more important in Wnt regulation (185). Indeed, knockdown of 
any one of the centrosomal proteins bbs1, bbs4, or bbs6 leads to upregulated canonical Wnt response 
as well as convergent extension defects in zebrafish (186); furthermore, the accompanying loss of 
basal body function interrupted the antagonism of canonical Wnt3a signaling by non-canonical Wnt5, 
which supports a role for the basal body in altering the behaviour of downstream Wnt effector 
molecules such as Dsh. However, the cilium itself is likely not completely irrelevant to canonical Wnt 
regulation, as loss of either of  the ADPKD gene products polycystin-1 and polycystin-2, which 
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localize to primary cilia, leads to upregulated canonical Wnt target gene expression in cystic kidney 
epithelia (187, 188), and many of the canonical Wnt proteins localize to the cilium as well as the basal 
body (182, 189, 190). Although the relationship between cilia, the centrosome, and the Wnt signaling 
pathways leaves much to be discovered, it is largely believed that the ciliary/centrosome complex may 
influence the cellular response to canonical and non-canonical Wnt signaling in a reciprocal, if not 
proportionate, manner (60, 191). 
In line with this, many of the nephrocystin proteins have also been shown to negatively 
regulate canonical Wnt signaling or to promote PCP, although whether this is due to their function at 
the centrosome or cilium is unclear. In addition to NPHP2/INVS, both NPHP3 and NPHP4 have 
independently been shown to negatively regulate Dsh-stimulated canonical Wnt reporter activity and 
to result in PCP defects if protein expression is reduced (192, 193). NPHP2 and NPHP4 have both 
been linked to degradation of cytosolic Dsh (178, 193), whereas NPHP8 homolog rpgrip1l, which is 
required for several PCP processes in zebrafish development, protects Dsh from degradation (194). 
Meanwhile, NPHP7 was shown to negatively regulate β-catenin-stimulated reporter activity, despite 
increasing nuclear β-catenin accumulation (195). Many of the nephrocystin proteins interact with each 
other, but the mechanisms by which these nephrocystin complexes are regulated or contribute to Wnt 
regulation are largely unknown. Recently, a novel mechanism linking canonical Wnt regulation with 
primary cilia was introduced. The ciliary Von-Hippel-Lindau protein (pVHL) was shown to stabilize 
protein levels of the short isoform of the gene for apoptosis and differentiation in epithelia (Jade-1; 
alias plant homeo-domain finger protein (PHF)17 isoform 1S), which can act as a transcription factor 
and regulator of apoptosis (196, 197). Jade-1 was recently also identified as a novel E3-ubiquitin 
ligase targeting cytosolic as well as nuclear β-catenin for proteasomal degradation (198) and may 
therefore be able to “fine-tune” β-catenin levels, contributing to the ciliary regulation of the Wnt 
response. Indeed, loss of pVHL disrupts ciliogenesis and leads to cystic kidneys in patients with VHL 
disease (199–201), which fits into a model where cyst formation involves derepressed canonical Wnt 
signaling due to decreased Jade-1 stabilization. It was previously reported that pVHL localizes to the 
primary cilium (200), although whether Jade-1 also localizes to the primary cilium is unknown. If the 
primary cilium is a connection point between Jade-1 and pVHL, it stands to reason that other ciliary 
Wnt regulators may likewise interact with Jade-1. In particular, Jade-1 could be a means by which 
nephrocystin proteins are able to influence Wnt regulation, thus contributing to the critical balance 
required for this signaling pathway in the kidney. 
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4 THESIS AIMS 
 
The biological factors leading to kidney cyst formation are largely unknown; however, 
progress toward understanding cystic kidney pathology has recently been propelled by the recognition 
that all proteins mutated in genetic forms of cystic kidney disease localize to primary cilia or the 
centrosomal region. In the past decade the primary cilium has been shown to be involved in several 
cellular signaling pathways, including canonical Wnt signaling. Specifically, the centrosome appears 
to be involved in targeting beta-catenin, the main effector of canonical Wnt signaling, for proteasomal 
destruction. De-regulated Wnt signaling in mice causes kidney cysts, and therefore may be a critical 
pathway regulated by the ciliary cystoproteins. In particular, several nephrocystin proteins have been 
reported to negatively regulate canonical Wnt signaling although mechanisms remain unclear. 
Recently, Jade-1 was identified to be an E3 ubiquitin ligase for β-catenin. Jade-1 was shown to be 
stabilized by the cystoprotein pVHL although it is unknown how this stabilization occurs, or whether 
ability to influence canonical Wnt signaling via the stabilization of Jade-1 might extend to other ciliary 
cystoproteins, such as the nephrocystins. 
The specific hypothesis of this PhD project is that NPH proteins will stabilize Jade-1, leading 
to decreased canonical Wnt signaling. Loss of Jade-1 stabilization may therefore be a critical factor in 
the pathogenesis of the cystic kidney phenotype in Nephronopthisis. 
The major aims of this PhD work are to: 
1.   Identify whether Jade-1 is a ciliary protein. 
2.  Characterize a potential connection between Jade-1 and the NPH proteins and their 
role in modulating Wnt signaling. 
3. Determine the mechanisms underlying regulation of Jade-1 by the cilium and by 
nephrocystin proteins. 
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5 MATERIALS AND METHODS 
 
5.1 Materials 
 
5.1.1 Chemical Reagents  
Table 1. List of Chemicals, Reagents and Solutions 
Chemical/Reagent/Solution Product  Number Provider 
Acetic Acid 7332.1 Carl Roth 
Acrylamide 7906.2 Carl Roth 
Agarose A9539-500G Sigma 
Ammonium persulfate (APS) A0834 Applichem 
Ampicillin Sodium Salt K029.2 Carl Roth 
Aqua dest. Injectabile (PCR grade water) PZN-1087335 Berlin-Chemie AG 
Bovine Serum Albumin (BSA) 1066 Gerbu 
Bromphenol Blue A512 Carl Roth 
Calcium chloride dihydrate HN04.2 Carl Roth 
Collagen A L7220 Biochrom 
Complete Protease Inhibitor Tablets (EDTA-free) 11873580001 Roche  
Coumeric Acid C-9008 Sigma 
Dimethyl sulfoxide (DMSO) Hybri-Max D2650 Sigma 
Dithiothreitol (DTT) 6908.1 Carl Roth 
Dulbecco’s Modified Eagle Medium (DMEM) D6429 Sigma 
DMEM-F12 D6421 Sigma 
Deoxyribonucleotide triphosphate (dNTP)-mix 200415 Stratagene 
Ethidiumbromide solution (1%) 2218.2 Carl Roth 
Ethylenediaminetetraacetic acid (EDTA) E-5134 Sigma 
Ethanol 96% + 1% Methyl ethyl ketone WAL641.5000 Geyer 
Ethanol 99.8% 9065.3 Carl Roth 
Fetal Bovine Serum (FBS) S 0115 Biochrom AG 
Fetal kidney cDNA library (human) 780608  Stratagene 
GeneRuler 1kb DNA Ladder SM0311 Fermentas 
Glucose (D+)-Monohydrate 1.04074.1000 Merck 
Glycerol 3783 Carl Roth 
Glycine    3908.2 Carl Roth 
HEPES Buffer 1M H0887 Sigma 
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Chemical/Reagent/Solution Product  Number Provider 
Hydrogen Peroxide 30% 107209 Merck 
Incidin Plus 3011520 Ecolab 
Isopropanol 5752.3 Carl Roth 
LB-Agar X965.1 Carl Roth 
LB-Medium X964.2 Carl Roth 
L-Glutamine 200mM Conc. 25030-024 Invitrogen 
Lipofectamine-2000 11668-027 Invitrogen 
Loading Dye Solution (6X) R0611 Thermo Scientific 
Luminol 9253 Fluka 
Magnesim acetate tetrahydrate 275.1 Carl Roth 
Magnesium chloride heptahydrate 1.05833.0250 Merck 
Methanol  4627.5 Carl Roth 
MG132 Insolution 474791 Merck/Calbiochem 
Normal Donkey Serum 017-000-121 Dianova 
Okadaic Acid Sodium Salt 459620-20 Merck/Calbiochem 
Oligofectamine 12252011 Invitrogen 
Opti-MEM 31985-047 Invitrogen 
PageRuler Plus Prestained Protein Ladder 26620 Fermentas 
Passive Lysis Buffer 5x E1941 Promega 
Paraformaldehyde (PFA) P6148 Sigma 
Phenylmethylsulfonyl fluoride (PMSF) P7626-25G Sigma 
Polyacrylamide T802.1 Carl Roth 
Potassium acetate 4820.1000 Merck 
Potassium chloride 6781 Carl Roth 
Potassium dihydrogen phosphate  P-018.2 Carl Roth 
Power SYBR Green 4367669 Applied Biosystems 
ProLong Gold antifade reagent with DAPI P-36931 Invitrogen 
Protein G Sepharose  GEHE17-0618-01 VWR 
Qiazol 79306 Qiagen 
RNase-free water Ultra Pure 10977-035 Invitrogen 
Sepharose CL-4B CL4B200 Sigma 
Sodium-Bicarbonate Solution 7,5% S8761 Sigma 
Sodium chloride 3957.1 Carl Roth 
Sodium dodecyl sulfate (SDS) pellets CN30.3 Carl Roth 
Sodium fluoride S-1504 Sigma 
Sodium(di-) hydrogen phosphate heptahydrate 1.06574.1000 Merck 
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Chemical/Reagent/Solution Product  Number Provider 
Sodium(tetra-) diphosphate decahydrate 1.06591.0500 Merck 
Sodium orthovanadate S6508-50G Sigma 
N,N,N´,N´-tetramethylethylenediamine (TEMED) 2367.3 Carl  Roth 
Tris Hydrochlorid (HCl) 9090.3 Carl  Roth 
Trizma Base T1503 Sigma 
Triton X-100 1.08603.1000 Merck 
Trypsin-EDTA Solution (1x) T3924 Sigma 
Tween20 3472 Caesar&Lorentz 
 
5.1.2 Assays/Kits 
Table 2. List of Assays/Kits 
Assay/Kit Product Number Provider 
Big Dye Terminator version 3.1 Sequencing kit 4337455 Applied Biosystems 
Turbo DNA-freeTM AM1907 Ambion 
Dual Luciferase Assay System E1910 Promega 
GeneJet PCR Purification Kit K0702 Fermentas 
GeneJet Gel Extraction Kit K0692 Fermentas 
GeneJet Plasmid Miniprep Kit K0503 Fermentas 
High Capacity cDNA Reverse Transcription  4368814 Applied Biosystems 
KOD Hot Start DNA polymerase kit 71086 Merck/Novagen 
NucleoBond® Xtra Midi prep kit  740410 Machury-Nagel 
T4 DNA Ligase EL0011 Fermentas 
Venor® GeM Mycoplasma Detection Kit 11-1050 Minerva Biolabs 
Zenon® Tricolor Mouse IgG2b Labeling Kit Z25260 Molecular Probes 
Zenon® Tricolor Rabbit IgG Labeling Kit Z25360 Molecular Probes 
 
5.1.3 Antibodies 
All antibodies react specifically against human. 
 
Table 3. List of primary antibodies and their providers 
Antigen (epitope) Clone Source IF WB Provider 
14-3-3 β (N-term) (polyclonal) Rabbit - 1:1000 Santa Cruz 
cMYC (N-term) (polyclonal) Rabbit - 1:500 Cell Signaling 
Fibrillarin (aa. 1-100) (polyclonal) Rabbit - 1:500 Abcam 
Flag (DYKDDDDK) M2 (monoclonal) Mouse 1:1000 1:10000 Sigma 
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Antigen (epitope) Clone Source IF WB Provider 
Flag (DYKDDDDK) (polyclonal) Rabbit 1:1000 1:1000 Sigma 
Jade-1 (a.a. 5.201) (polyclonal) Rabbit 1:100 - Genetex 
Jade-1 (a.a. 1-301) (polyclonal) Rabbit 1:100 - Proteintech 
Jade-1 (Ab1: a.a. 450-509) (polyclonal) Rabbit 1:100 - Sigma 
NPHP1 62 (monoclonal) Mouse 1:100 - Zentgraf Lab 
NPHP4 (a.a. 673–1032) 12H6-2B12 
(monoclonal) 
Mouse 1:100 - Saunier Lab 
Tubulin, acetylated-        
 (acetylated Lys40 ± 4) 
6-11B-1 
(monoclonal) 
Mouse 1:1000 - Sigma 
Tubulin, β- E7 (monoclonal) Mouse - 1:5000 DSHB 
Tubulin, gamma- (a.a. 437-
451+ Nterm CG) 
(polyclonal) Rabbit 1:250 - Sigma 
V5 (GKPIPNPLLGLDST) SV5-Pk1  
(monoclonal) 
Mouse  1:1000 1:5000 Serotec 
V5 (GKPIPNPLLGLDST) (polyclonal) Rabbit  1:1000 1:1000 Millipore 
 
Table 4. List of secondary antibodies and their providers 
Antibody Product Number Provider 
Cy3-AffiniPure Donkey α-Rabbit IgG (H+L) 711-165-152 Jackson ImmunoResearch
DyLight-488 AffiniPure Donkey α-Mouse IgG(H+L) 715-485-150 Jackson ImmunoResearch
DyLight-488 AffiniPure Donkey α-Rabbit IgG(H+L) 711-485-152 Jackson ImmunoResearch
DyLight-549 AffiniPure Donkey α-Mouse IgG(H+L) 715-505-150 Jackson ImmunoResearch
Polyclonal goat anti-rabbit immunoglobulins/HRP P0448 Dako  
Polyclonal goat anti-mouse immunoglobulins/HRP P0447 Dako  
 
5.1.4 Enzymes 
 
Table 5. List of enzymes and their providers 
Enzyme Product Number Provider 
Dpn1  5000U R0176L New England Biolabs 
Hind III restriction enzyme R0104L  New England Biolabs 
KpnI restriction enzyme R0142L  New England Biolabs 
Mlu1 restriction enzyme R0198L New England Biolabs 
NarI restriction enzyme R0191L   New England Biolabs 
NotI restriction enzyme R0189L New England Biolabs 
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5.1.5 Genes of Interest 
 
Table 6. Genes and isoforms investigated 
Gene (Human) Gene ID (NCBI) Isoform 
β-catenin  1499 NM_001904 
CK1α2 1452 NM_001892.4 
EPS  58513 NM_021235.2 
GSK3β 2932 NM_002093.3 
Jade-1 short isoform  79960 NM_024900.3 
NPHP1 AF023674 NM_001128178.1 
NPHP2/INVS BC111761 GenBank: BC006370.2 
NPHP3 27031 NM_153240 
NPHP4 261734 NM_015102 
NPHP5 9657 NM_001023570.2 
NPHP7 84662 NM_032575 
NPHP8 23322 NM_015272 
NPHP9 284086 NM_178170 
PLK1 5347 NM_005030.3 
 
5.1.6 Plasmids and their providers 
 
Table 7. List of plasmids used and their providers 
Vectors used Provider 
pcDNATM6/V5-His B Invitrogen (V220-20) 
M50 Super 8x TOPFlash Addgene plasmid 12456 (Moon Lab) 
M51 Super 8x FOPFlash Addgene plasmid 12457 (Moon Lab) 
Renilla luciferase pGL4.74 Promega (E6921) 
F.EPS1-225 pcDNA6 Nephrolab Cologne 
V5.EPS1-225 pcDNA6 Nephrolab Cologne 
F.NPHP1 WT FL pcDNA6 Nephrolab Cologne 
F.NPHP2/INVS WT FL pcDNA6 Open Biosystems clone ID 40012263 
F.NPHP3 WT FL pcDNA6 Nephrolab Cologne 
F.NPHP4 WT FL pcDNA6 Nephrolab Cologne 
V5.NPHP4 WT FL pcDNA6 Nephrolab Cologne 
F.NPHP5 WT FL pcDNA6 Nephrolab Cologne 
F.NPHP7 WT FL pcDNA6 Nephrolab Cologne 
F.NPHP8 WT FL pcDNA6 AG Walz, ZKF, University Hospital Freiburg 
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Vectors used Provider 
F:NPHP9 WT FL pcDNA6 Nephrolab Cologne 
F:PLK1 Nephrolab Cologne 
 
 
5.1.7 Oligonucleotides 
 
 All oligonucleotides were purchased from Biomers (Konstanz, Germany).  
  
 All inserts were designed for human genes. 
 
 
Table 8. List of oligonucleotides used 
CLONING PRIMERS  
Insert Name/Primer Name Sequence (5’ 3’) 
β-catenin FL WT 
FP: hbcat 1 mlu  
RP: h.beta catenin 782 not  
 
CGCGGGACGCGTATGGCTACTCAAGCTGATTTG 
CGCGGGGCGGCCGCCTTACAGGTCAGTATCAAACCA 
CK1α1 WT FL 
FP: hCK1alpha 1 mlu 
RP: hCK1 alpha 305 not 
 
CGCGGGACGCGTATGGCGAGTAGCAGCGGCTCC 
CGCGGGGCGGCCGCCTTATGCTTTCTGCTTTAACATTGT 
GSK3β WT FL 
FP: hGSK3β 1 mlu 
RP: hGSK3β 433 not 
 
CGCGGGACGCGTATGTCAGGGCGGCCCAGAACC 
CGCGGGGCGGCCGCCTCAGGTGGAGTTGGAAGCTGA 
Jade1 WT FL 
FP: hJade-1 1 mlu  
RP: hJade-1 509 not  
 
CGCGGGACGCGTATGAAACGAGGTCGCCTTCCC 
CGCGGGGCGGCCGCCCTATAAGGTGTCAGTGTCAAT 
Jade1 1-149 
FP: hJade-1 1 mlu 
RP: hJade-1 149 not 
 
CGCGGGACGCGTATGAAACGAGGTCGCCTTCCC 
CGCGGGGCGGCCGCCCTATGCAGCATCCATGTC 
Jade1 150-299 
FP: hJade-1 150 mlu 
RP: hJade-1 299 not 
 
CGCGGGACGCGTTGGCTGGAACTGACCAATGAA 
CGCGGGGCGGCCGCCCTAGGGCTCCATCTTCTCTGG 
Jade1 300-509 
FP: hJade-1 300 mlu 
RP: hJade-1 509 not 
 
CGCGGGACGCGTATCACCAAGGTGTCACACATT 
CGCGGGGCGGCCGCCCTATAAGGTGTCAGTGTCAAT 
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MUTAGENESIS PRIMERS  
Insert Name/Primer Name Sequence (5’ 3’) 
Jade1 S13A  
FP: hJade1 S13A fp 
RP: hJade1 S13A rp 
 
AGCAGCAGTGAGGATGCTGACGACAATGGCAGCCTGTCA 
GCTGCCATTGTCGTCAGCATCCTCACTGCTGCTGGGAAG 
Jade1 S18A  
FP: hJade1 S18A fp Nar1 
RP: hJade1 S18A rp Nar1 
 
TCTGACGACAATGGCGCCCTGTCAACTACTTGGTCCCAG 
CCAAGTAGTTGACAGGGCGCCATTGTCGTCAGAATCCTC 
Jade1 S20A  
FP: hJade1 S20A fp HindIII 
 
RP: hJade1 S20A rp HindIII 
 
GATTCTGACGACAATGGAAGCTTGGCAACTACTTGGTCCCA
GAATTCC 
CTGGGACCAAGTAGTTGCCAAGCTTCCATTGTCGTCAGAAT
CCTC 
Jade1 S89A  
FP: hJade1 S89A fp KpnI 
RP: hJade1 S89A rp KpnI  
 
GTCCAGGTGCCTGTGGCCCCGGGTACCATCCCTCAGCCT 
CTGAGGGATGGTACCCGGGGCCACAGGCACCTGGACCCC 
Jade1 T92A  
FP: hJade1 T92A fp NarI 
RP: hJade1 T92A rp NarI 
 
CCTGTGAGCCCGGGCGCCATCCCTCAGCCTGTGGCCAGG 
CACAGGCTGAGGGATGGCGCCCGGGCTCACAGGCACCTG 
Jade1 S121A  
FP: hJade1 S121A fp NarI 
RP: hJade1 S121A rp NarI 
 
CAACTCGGGAGGCTCGGCGCCTGATGACACGATGTACTT 
CAACTCGGGAGGCTCGGCGCCTGATGACACGATGTACTT 
Jade1 S377A  
FP: hJade1 S377A fp NarI 
 
RP: hJade1 S377A rp NarI 
 
AGGAAACCCGAGGAGGCTCTTGGCAAGGGCGCCGCACAGG
AGAATGGGGCC 
GGCCCCATTCTCCTGTGCGGCGCCCTTGCCAAGAGCCTCCTC
GGGTTTCCT 
 
qPCR Primer Pairs   
Gene Name/Primer Pair Sequence (5’ 3’) 
Jade1 (human) 
FP: qPCR Jade1 exon 7 fp 
RP: qPCR Jade1 exon 9 rp 
 
TGAAGCCCACCCGTAGCGGA 
CTCCTGTGCAGCCCCCTTGC 
HPRT (human) 
FP: hHPRT1 fp 
RP: hHPRT1 rp 
 
TGACACTGGCAAAACAATGCA 
GGTCCTTTTCACCAGCAAGCT 
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Sequencing Primers  
Gene /Primer Name Sequence (5’ 3’) 
pcDNA6 (-mlu) fsp1 CGTGTACGGTGGGAGGTCTA 
pcDNA6 (-mlu) rsp 1 AGGAAAGGACAGTGGGAGTG 
hJade1 bp.426-446 fsp CCTCAATGACATGGATGCTGC 
h. Jade1 bp.516-537 fsp GAGGGTCCTAGAGGAATTTGA 
h.beta catenin bp.1213-1232 fsp CTTGTTCAGCTTCTGGGTTC 
h.beta catenin bp.1425-1405 rsp GTGTCGGCTGGTCAGATGACG 
 
siRNA Oligonucleotides  
Gene Name/Oligo Name Sequence (5’ 3’) 
Jade1/HsPHF17_7 (Qiagen catolog no. SIO3077718) GAAGACCATCTTAGCAGAGAA 
Jade1/HsPHF17_1 (Qiagen catolog no. SIO0137627) AAGCGGGAGCAGGATGTCTTA 
Jade1/HsPHF17_5 (Qiagen catolog no. SIO3042669) AGCAGCGATGCTACGACAATA 
NPHP4 AAGCAACGAGATGGTGCTACA 
Scrambled (control) AAATGTACTGCGCGTGGAGAC 
 
5.1.8 Buffers & Solutions 
 
Table 9. Composition of buffers & solutions 
Buffer / Solution Composition 
Annealing buffer (2x) 60 mM HEPES pH 7.4  
4 mM Mg(CH3COO)2 
200 mM CH3CO2K 
 
Cell Culture Medium (293 T) 10% (v/v) FBS  
in DMEM 
 
Cell Culture Medium (RPE-1) 10% FBS (v/v)  
2 mM L-Glutamine 
1.2 g/L Sodium bicarbonate 
in DMEM-F12 
 
Cell Fraction Buffer A 10mM HEPES 
1.5mM MgCl2 
10 mM KCl 
pH 7.9 
 
Cell Freezeing Solution 70 % (v/v) FBS 
20 % (v/v) DMEM 
10 % (v/v) DMSO 
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Buffer / Solution Composition 
Dulbecco’s PBS (DPBS) 1 mM CaCl2 
0,5 mM MgCl2 
in 1xPBS  
 
ECL Detection Solution 100 mM Tris  
1,25 mM Luminol  
0,2 mM Coumaric acid  
0,75% (v/v) H2O2  
pH 8.5 
 
HEBS (2X)  50 mM HEPES  
280 mM NaCl  
10 mM KCl  
1.5 mM Na2HPO4  
pH 7.08 
 
IP Lysis Buffer 20 mM Tris  
1% (v/v) TritonX-100  
50mM NaCl  
15 mM Na4P2O7 
50 mM NaF 
pH 7.5 
 
Laemmli Sample Buffer (1X) 50 mM Tris  
2% (w/v) SDS 
10% (v/v) Glycerol  
Bromphenol Blue  
50 mM DTT  
pH 6.8 
 
Laemmli Sample Buffer (2X) 100 mM Tris 
4% (w/v) SDS 
20% (v/v) Glycerol 
Bromphenol Blue 
100 mM DTT 
pH 6.8 
 
Laemmli Sample Buffer (3X) 150 mM Tris 
6% (w/v) SDS 
30% (v/v) Glycerol 
Bromphenol Blue 
150 mM DTT 
pH 6.8 
 
Ligation Buffer (10X)  400 mM Tris 
100 mM MgCl2 
100 mM DTT 
5 mM ATP 
pH 7.8 
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Buffer / Solution Composition 
Phosphate Buffered Saline (PBS) 137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 
2 mM KH2PO4 
 
Resolving Gel 750 mM Tris 
10% (v/v) PAA 
0.2% (w/v) SDS 
pH 8.8 
 
Running Buffer 25 mM Tris 
192 mM Glycine 
0.1% (w/v) SDS 
 
Stacking Gel 250 mM Tris 
5% (v/v) PAA 
0.2% (w/v) SDS 
pH 6.8 
 
SOC Medium 2% (w/v) Tryptone 
0.5% (w/v) Yeast Extract 
8.6 mM NaCl 
2.5 mM KCl  
20 mM MgSO4 
20 mM Glucose 
 
TAE (1X) 40 mM Tris 
20 mM Acetic Acid 
1mM EDTA 
pH 8.5 
 
Transfer Buffer 25 mM Tris 
188 mM Glycine 
0.1% (w/v) SDS 
 
Wash Buffer 30 mM Tris 
300 mM NaCl 
0.3% Tween20 
pH 7.5 
 
 
 
5.1.9 Materials 
 
Table 10. List of materials and their providers 
Material Product Number Provider 
10 cm dish for Agar Plates 82.1473 Sarstedt 
Blotting paper (Type BF4, 580 x 580) FT-2-521-580580G VWR 
Cell culture dishes (12-well) 3513 Corning 
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Material Product Number Provider 
Cell culture dishes (6-well) 3516 Corning 
Cell culture dishes (10-cm) 430167 Corning 
Cell culture dish (96-well F-Form) 655180 Greiner BioOne 
Cell culture dish (96-well U-Form) 650180 Greiner BioOne 
Combs (10 well, 1 mm) for acrylamide gels NC3010 Invitrogen 
Coverslips (round 18 mm Nr. 1.5) 631-0153 VWR 
Eppendorf tubes (1.5 ml) 72.690.001 Sarstedt 
Fast Optical 96-well plates 4346907 Applied Biosystems 
Gel cassette (1 mm) NC2010 Invitrogen 
Hemacytometer (Neubauer Improved) - BlauBrand 
Polypropylene conical tube (15 ml) 188271 Greiner BioOne 
Polypropylene conical tube (50 ml) 227261 Greiner BioOne 
MicroAmp Optical Adhesive Film 4311971 Applied Biosystem 
Millipore Immobilon-P Transfer Membranes  T831.1 Carl  Roth 
Needle (20G) MicrolanceTM3 (1½”)  301300 BD 
Nunc CryotubeTM 368632 Thermo Scientific 
PCR Soft-tubes 0.2 ml assorted colours 711088 Biozym 
PCR Soft-tubes 0.2 ml clear 710920 Biozym 
PCR Soft-tubes 0.2 ml 8 Tubes/Flat Caps, clear 710970 Biozym 
Pipette tips (200 µl yellow) 70.762 Sarstedt 
Pipette tips (1000 µl blue) 70.760.002 Sarstedt 
Safe Lock 1,5 ml Eppendorf tubes 211-2130 VWR 
Stripettes (5 ml) 4051 Corning 
Stripettes (10 ml) 4101 Corning 
Stripettes (25 ml) 4251 Corning 
SuperFrost®/Plus microscope slides 7695002 Th.Geyer Group 
Syringe (PlastipakTM 1 ml) 7392/2007 BD 
TipOne (0.1-10 µl XL), sterile  S1110-3810-c Starlab 
TipOne (1-200 µl beveled), sterile S1111-1816-c Starlab 
TipOne (101-1000 µl graduated), sterile S1111-2831-c Starlab 
Ultra-Clear Tubes (UZ Tubes) 344062 Beckman Coulter 
Weighing tray 140 x 140 mm 2159.1 Carl  Roth 
Weighing tray 89 x 89 mm 2150.1 Carl  Roth 
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5.1.10 Equipment 
 
Table 11. List of equipment and their providers 
Equipment Model Provider 
Analogue tube rolloer SRT6 Stuart 
Autoclave V-150 Systec 
Avanti centrifuge J-301 Beckman 
Axiovert microscope and apotome system 200M Carl Zeiss MicroImaging 
Centrifuge (refrigerated) 5810 R Eppendorf 
Eppendorf Research® Multipipette (10-100 µl) 3122000043 Eppendorf 
Fast Real-Time PCR System 7900HT ABI 
Fusion Solo chemiluminometer 60-FU-SOLO PeqLab 
Hamilton syringe (50 µl Type 705) 549-1155 VWR 
HERAcell Incubator  240 Heraeus 
HERAcell Incubator  150 Heraeus 
Heraeus B12 Function Line incubator 50042307 Kendro Laboratory Products 
Horizontal electrophoresis system 1582 - 030305 Dan-Kar 
Incubator (Agarose) T 6030 Heraeus 
Innova Incubator Shaker 4400 New Brunswick Scientific 
Inverted microscope CK2 Olympus 
JuLiTM Smart Fluorescence Cell Imager DBJ01B Bulldog Bio 
Laminar Flow Cabinet HS12 Heraeus 
MacsMix Tube Rotator MX100 Miltenyi Biotech 
Microcentrifuge   5424 Eppendorf 
Microcentrifuge (refrigerated)  5415 R Eppendorf 
Microcentrifuge (refrigerated) 5417R Eppendorf 
Mithras multimode microplate reader LB 940 Berthold Technologies 
Multifuge 4KR Heraues 
Nanodrop Spectrophotometer 1000 PeqLab 
Pipetboy acu 155 015 Integra Biosciences AG 
Pipetman Pipette set (P2, P10, P100) F167500 Gilson 
Pipetman Pipette set (P20, P200, P1000) F167300 Gilson 
Power supply (for Dan-Kar system) EPS200 Pharmacia Biotech 
Powerpac 200 Power supply 1655052 Bio-Rad 
Powerpac 3000 Power supply 1655057 Bio-Rad 
Shaker  KS 260 IKA 
Suction Pump  MD 4C Vacuubrand 
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Thermal cycler (MJ mini) PTC-1148 Bio-Rad 
Thermomixer Comfort 1.5 ml Thermoblock 5360 000.011 Eppendorf 
Thermomixer Comfort shaker & heating plate 5355 000.011 Eppendorf 
Ultra-centrifuge (Optima) TLX-120 Beckman 
Ultra-centrifuge rotor TLA-55 Beckman 
UV Transilluminator system MW312 Intas 
Vortex Mixer MS525-20 Heidolph (Reax) 
Water bath  WNB 22 Memmert 
Water bath (digital heating bath) HBR4 IKA 
XCell SureLockTM Mini-Cell electrophoresis 
system 
100601-1408 Invitrogen 
 
5.1.11 Software  
 
Table 12. List of software used and their providers 
Software Version Provider 
Axiovision 4.8 Carl Zeiss MicroImaging 
Edit-Seq 5.06 DNASTAR 
FinchTV 1.4.0 Geospiza Inc. 
Fusion-CAPT 15.16 Vilber Lourmat 
GDS  3.10 Intas Science Imaging Instruments GmbH 
Graphpad Prism 5 for Windows 5.2 GraphPad Software Inc. 
Macromedia Freehand MX 2003 Adobe 
Microsoft Office Suite 2003 Microsoft 
MikroWin  2000 Berthold Technologies 
Nanodrop 1000  3.7 Thermo Scientific 
SeqManII 5.06 DNASTAR 
SDS Software 2.4 Applied Biosystems 
 
Software (online) Website 
Ensemble.org http://www.ensembl.org/ 
NCBI Primerblast software http://www.ncbi.nlm.nih.gov/tools/primer-blast/ 
NCBI Pubmed  http://www.ncbi.nlm.nih.gov/pubmed/ 
NEB Double Digest Finder http://www.neb.com/nebecomm/doubledigestcalculator.asp 
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5.2 Methods 
 
5.2.1 Plasmids & siRNA  
 
5.2.1.1 Cloning PCR  
 
 All Flag- and V5-tagged constructs were generated by PCR from a fetal human kidney cDNA 
library (Stratagene) using KOD Hot Start polymerase kit using a modified version of the 
manufacturer’s instructions (per 50 µl reaction: 30 µl PCR grade water; 4.5 µl MgSO4 (25 mM); 2.5 µl 
DMSO; 5 µl dNTPs (2 mM); 0.5 µl forward primer (100 µM); 0.5 µl reverse primer (100 µM); 1 µl 
cDNA library (10 ng); 5 µl KOD Buffer (10x); 1 µl KOD Hot Start DNA polymerase (1 U/µl)). 
Cloning primers were used as indicated in Table 8. Reaction ingredients were assembled in 0.2 ml 
PCR soft-tubes on ice. The reaction was run using an MJ mini thermal cycler. The PCR Polymerase 
was activated at 95°C for 2 minutes, followed immediately by a 40 repetitions of a three-step cycle 
consisting of: 1) Denaturing for 20 seconds at 95°C; 2) Annealing for 20 seconds at [Primer Tm – (5-
10) °C]; 3) Extension for 1 minute/kbp at 70°C. The PCR cycle was optimized by adding a final 
incubation step of 10 minutes at 70°C to allow for re-annealing of double stranded DNA. PCR 
products were purified using the GeneJet PCR Purification kit according to the manufacturer’s 
instructions. 
 
5.2.1.2  siRNA Annealing 
 
 Annealing of siRNA was based on the published protocol (202). All siRNA oligonucleotides 
were resuspended in 10 mM Tris (pH 8.0) using an appropriate volume to produce a final 
concentration of 100 pmol/µl. Equal volumes of each strand were combined in a 1:1 ratio on ice, and 
diluted with RNase-free water to a concentration of 40 µM. An equal volume of 2x Annealing buffer 
was added to yield a final concentration of 20 µM. The mixture was heat-shocked for 1 minute at 95°C 
and subsequently incubated for 1 hour at 37°C.  Annealing success was evaluated by running samples 
on a 3% agarose gel (section 3.2.1.5) and comparing product size to a single stranded oligonucleotide 
sample. 
 
5.2.1.3  Mutagenesis PCR 
 
 All mutagenesis reactions used the plasmid templates and primers as indicated in Table 8 and 
were based on the QuikChange protocol (203). Primers were designed to alter the amino acid of 
interest to alanine by changing the minimum number of bases required. A silent mutation was added to 
yeild a novel restriction site for diagnostic digest as indicated in Table 8. Primers were designed to 
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have a Tm not less than 78°C and a GC content over 40%, with the mutation site flanked by 15 bases 
upstream and 21 bases downstream. The following components were assembled per 50 µl reaction in a 
0.2 ml PCR soft-tube on ice: 32 µl PCR grade water, 5 µl DMSO, 4.5 µl MgSO4 (25 mM), 0.5 µl 
dNTP-mix (25 mM each), 5 µl KOD Buffer (10x); 1 µl KOD Hot Start DNA polymerase (1 U/µl); 1 
µl DNA plasmid template (10 ng/µl); 0.2 µl forward mutagenesis primer (50 µM); 0.2 µl reverse 
mutagenesis primer (50 µM). Using an MJ mini thermal cycler, the polymerase was activated at 95°C 
for 2 minutes, followed immediately by 16 repetitions of a three-step cycle consisting of: 1) 
Denaturing for 45 seconds at 95°C; 2) Annealing for 1 minute at 55°C; 3) Extension for 2 
minute/kilobase-pair at 68°C. The PCR cycle was optimized by adding a final incubation step of 10 
minutes at 68°C to allow for re-annealing of double stranded DNA. Reaction efficiency was assessed 
using a 1% agarose gel to check for amplification of the vector in comparison to a control run without 
enzyme. For successful reactions the remainder of the sample was incubated with 1 µl of Dpn1 for 2 
hours at 37°C followed by heat inactivation at 70°C for 10 minutes, in order to digest methylated 
template DNA. 
 
5.2.1.4  Enzymatic Digest 
 
Enzymatic digests were performed using enzymes and buffers from New England BioLabs 
(NEB) according to a modified version of the manufacturer’s protocol. All cloning PCR products 
intended to be used for novel plasmid generation contained an N-terminal mlu1 restriction site and a 
C-terminal not1 restriction site.  Cloning PCR products digested using these enzymes could therefore 
be ligated to the vector pcDNA6 backbone of an existing plasmid which had been digested in a similar 
fashion. A digest intended for subsequent gel extraction (section 3.2.1.6) was performed as a 30 µl 
reaction using PCR grade water plus the following components: 500ng DNA, 3 µl BSA (15 µM), 3 µl 
NEB buffer #3, 0.5 µl Mlu1 (5 U/µl), and 0.5 µl Not1 (5 U/µl)). Reactions were incubated at 37°C for 
2 hours and analysed using a 1% agarose gel (section 3.2.1.5). 
After bacterial transformation (section 3.2.2) all clones were screened in a diagnostic digest. 
For newly cloned plasmids Mlu1 and Not1 enzymes were used, and for mutated plasmids either Mlu1 
or Not1 was used together with the enzyme corresponding to the inserted novel restriction site (as 
indicated in Table 8). Diagnostic digests were performed in a 15 µl reaction using PCR grade water 
plus the following components: 400ng DNA, 1.5 µl BSA (15 µM), 1.5 µl NEB buffer (as appropriate 
for enzymes used and selected usng NEB Double Digest Finder software), 0.4 µl each enzyme (at 
5 U/µl). Reactions were incubated at 37°C for 30 minutes and analysed using a 1% agarose gel 
(section 3.2.1.5). 
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5.2.1.5  Agarose Gel Electrophoresis 
 
 DNA electrophoresis was performed according to standard protocols (204). Gels were made 
by pouring 11 ml of warm 1% Agarose in 1 x TAE buffer on a glass plate measuring 5 x 7.5 cm and 
fixing a Plexiglas comb (3 mm teeth) at one end. For general use, a stock of 1% Agarose solution was 
kept warm in a Heraeus T 6030 incubator. For siRNA, freshly prepared 3% Agarose in 1 x TAE buffer 
was used. After cooling, the comb was removed and the entire gel was placed in the Dan-Kar 
horizontal electrophoresis system filled with 1 x TAE buffer. DNA samples were mixed with an 
appropriate volume of 6X loading dye solution and 15 µl of this solution was loaded per well using a 
100 µl pipette, with one well per gel reserved for 3 µl of a 1kb DNA ladder to enable sample size 
estimation. Gels were run at 90V for 30 minutes using an EPS200 power supply. DNA was visualized 
using an Intas UV Transilluminator system and photographed using Intas GDS Windows software. 
DNA sample size was assessed in comparison to the 1kb DNA ladder. 
 
5.2.1.6  Gel Extraction 
 
 Plasmid inserts and vectors (section 3.2.2) intended for ligation (section 3.2.1.7) were digested 
with Mlu1 and Not1 restriction enzymes (section 3.2.1.4) and separated using a 1% agarose gel 
(section 3.2.1.5). Required DNA bands were excised from the gel using a scalpel under UV-light. 
Protective clothing and face mask were worn at all times. The excised gel slice was melted at 60°C 
and DNA was extracted using the GeneJet Gel Extraction Kit as per the manufacturer’s instructions, 
with a final elution volume of 30 µl. 
 
5.2.1.7  Ligation 
 
 Appropriate pairs of insert DNA and vector DNA were ligated after extraction from agarose 
gel (section 3.2.1.6). Ligations were performed using the T4 ligase kit with a modified protocol of the 
manufacturer’s instructions: in a 20 µl reaction in PCR grade water the following components were 
added: 2 µl T4 ligase buffer (10x), 2 µl vector DNA, 8 µl insert DNA, and 0.4 µl T4 ligase (5 U/µl). 
Reactions were incubated 1 hour at room temperature. A control reaction substituting water in place of 
insert DNA was included. 
 
5.2.2 Clone Selection and Plasmid Amplification 
  
 Ligated plasmids were prepared as described in 3.2.1. In all cloning conditions a modified 
pcDNATM6/V5-His B vector purchased from Invitrogen was used. To modify for standard cloning 
using an Mlu1/Not1 digest insert (section 3.2.1), an internal Mlu1 site was removed by standard 
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mutagensis PCR (section 3.2.1.3). A cloning cassette was then inserted using the HindIII and Not1 
sites after the CMV promtor. The cloning cassette contained the following sites: HindIII restriction 
site; Kozak sequence; Flag-tag sequence; 9 x HIS-tag sequence; BamH1 restriction site; glycine 
spacer; ecoR1 restriction site; Mlu1 restriction site; Not1 restriction site. The purchased 
pcDNATM6/V5-His B vector included an ampicillin resistance gene. 
 
5.2.2.1  Bacteria 
  
 ElectroMAX™ DH10B™ T1 Phage-Resistant electrocompetent E. coli cells were purchased 
from Invitrogen (Product number 12033-015) and stored in 50 µl aliquots at -80°C until use.  
 
5.2.2.2 Transformation  
 
Bacterial transformation was performed using standard techniques (205). DH10 bacteria were 
thawed on ice. 5 µl of ligation or control ligation (section 3.2.1.7) was added to 25 µl bacteria and 
incubated on ice for 10 minutes. Bacteria were heat shocked for 45 seconds at 42°C using an IKA 
digital heating water bath. After heat-shock, bacteria were incubated on ice for 2 minutes prior to 
adding 175 µl of warmed SOC medium. Bacteria were then incubated at 37°C for 1 hour using an 
Eppendorf Thermomixer shaker with 1.5 ml Thermoblock at 800-1200 rpm, and subsequently 50 µl 
was pipetted onto a pre-warmed selective agar plate. Bacteria were streaked over the plate using a 
glass spatula sterilized by ethanol and fire. After drying, plates were incubated in a Heraeus B12 
Function Line incubator at 37°C overnight. Selective agar plates were made by dissolving 4g of LB-
Agar in water and adding 100 µg/ml of ampicillin antibiotic. The solution was autoclaved and poured 
into 92 x 16 cm Sarstedt petri dishes under laminar flow. After cooling plates were stored at 4°C until 
use.  
 
5.2.2.3  Bacterial culture  
 
 Bacteria grown on agar plates were incubated overnight at 37°C. Surviving colonies that had 
been transformed with the experimental ligation product were compared to surviving colonies that had 
been transformed with the control ligation product and an appropriate number of colonies were picked 
using a 200 µl pipette tip and dropped into a 15 ml conical tube containing 3 ml of LB Medium (206). 
This bacterial mini culture was incubated at 37°C in the Thermoshake incubator for at least 8 hours or 
until cloudy at which time 1 ml was used for amini-prep (section 3.2.2.4). After diagnostic digest 
(section 3.2.1.4) and analysis following agarose gel separation (section 3.2.1.5), the remaining 2 ml 
from a positive clone was used to start a midi culture consisting of 200 ml LB medium. Midi preps 
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were incubated overnight at 37°C in the Innova 4400 shaker incubator. LB medium was freshly 
prepared using 20g/L of LB-Medium in water and adding 100 µg/ml ampicillin antibiotic.  
 
5.2.2.4  Plasmid preparation 
 
 Plasmids were purified from 1 ml mini cultures by SDS/alkaline lysis and silica membrane 
purification using the GeneJet Plasmid Miniprep Kit according to the manufacturer’s instructions and 
using an Eppendorf 5424 microcentrifuge. Plasmids were purified from a 200 ml midi culture by 
modified alkaline/SDS lysis and charged silica bead column purification using the NucleoBond Xtra 
midi prep kit according to the manufacturer’s instructions. Bacterial pellets were acquired using the 
Heraues multifuge and DNA pellets were acquired using the Beckman Avanti centrifuge. Pellets were 
washed twice with 75% (v/v) Ethanol and left to dry in an open 50 ml conical tube. When clear, 200-
400 µl of 10 mM Tris buffer (pH 7.5) was added on top of the pellet and incubated overnight. The 
resultant DNA solution was vortexed, briefly centrifuged using the Eppendorf 5810R centrifuge, and 
transferred to a 1.5 ml Eppendorf tube. The solution was then centrifuged at 20,000 x g using the 
Eppendorf 5424 microcentrifuge and transferred to a sterile 1.5 ml safe-lock Eppendorf tube. Plasmid 
concentration was determined using the Nanodrop 1000 spectrophotometer according to 
manufacturer’s instructions. 
 
5.2.2.5  Sequence verification 
 
 Insert DNA sequences of newly cloned or mutated plasmids were verified by purchasing 
automated DNA sequencing service from the Cologne Centre for Genomics. Samples were prepared 
for sequencing using the Big Dye Terminator version 3.1 sequencing kit according to the 
manufacturer’s intructions with a modified reaction protocol. Samples were prepared as a 10 µl 
reaction in PCR grade water plus the following components: 2.25 µl Big Dye Terminator sequencing 
buffer, 0.25 µl Big Dye Terminator version 3.1, and 0.25 µl sequencing primer (100µM). Using an MJ 
mini thermal cycler, the following cycle was repeated 32 times: 1) Denaturing for 10 seconds at 96°C; 
2) Annealing for 5 seconds minute at 55°C; 3) Extension for 4 minutes at 60°C. In every case, the 
foward and reverse pcDNA6 sequencing primers were used (Table 3.1.7). Longer inserts required 
additional sequencing reactions using the primers indicated in Table 3.1.7.  Sequence readings were 
assessed using EditSeq and SeqManII (DNASTAR) software as well as FinchTV software. 
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5.2.3 Cell Culture  
 
5.2.3.1 Cell lines: HEK 293T and RPE-1 
 
Immortalized Human Embryonic Kidney (HEK) 293T cells were provided by Dr. Brian Seed 
(Harvard Medical School, Boston). Retinal pigmented epithelial (RPE)-1 cells were purchased from 
ATCC (human telomerase reverse transcriptase (hTERT) immortalised cell RPE-1 cell line; Product 
number CRL-4000™). Although this is a telomerase-immortalized cell line it was important not to 
exceed 35 passages or 80% confluency as doing so interfered with the uniformity of cell profile. HEK 
293T cells were incubated in 293T medium and stored in the HERAcell 240 incubator which 
maintained 37°C with 5% carbon dioxide. RPE-1 cells were incubated in RPE-1 medium and stored in 
the HERAcell 150 incubator which maintained 37°C with 5% carbon dioxide. When experimentally 
required, cilia growth was stimulated in RPE-1 cells by growing cells to 70-80% confluency and then 
serum-starving for 24-48 hours in RPE-1 medium lacking FBS supplement.  
All cell culture techniques were performed according to standard protocols (207). All cells 
were maintained in 10 cm culture dishes and handled until harvesting exclusively under laminar flow. 
Cells were passaged upon reaching 80% confluency. To passage the cells, the cell media was aspirated 
using the Vacuubrand suction pump and cells were washed with sterile PBS. After PBS aspiration, 1 
ml trypsin was added prior to incubation at 37°C until cells were no longer adherent. A single cell 
suspension was achieved after addition of 9 ml warm medium by gentle trituration using a 10 ml 
stripette, avoiding air bubbles.  The resultant 10 ml cell suspension was divided into 2 ml portions and 
added to new cell culture dishes each containing 8 ml of warm medium. Dishes were gently rocked 
from side to side to evenly disperse cells and centripetal force was avoided when returning dishes to 
the incubator. When experiments required use of a 6-well or 12-well culture dish, 2 ml of the re-
suspended cells was added to 10 ml of medium and mixed using a 10 ml stripette. The resultant 12 ml 
solution was then evenly distributed over the 6-well or 12-well culture dish. When experiments 
required the use of a 96-well cell culture plate, re-suspended cells were counted using a Neubauer 
Improved hemacytometer and appropriate amount of medium was added to achieve 400,000 cells per 
ml. The cell suspension was transferred to a V-bottom dish and 100 µl of the cell suspension was 
added per well using an Eppendorf Research® Multipipette multipipette. 
When necessary, cells were frozen to maintain a stock at a lower passage number. To freeze, a 
confluent 10 cm dish of cells was trypsinized and resuspended in appropriate cell culture medium. 
Cells were gently pelleted at room temperature using the Eppendorf 5810R centrifuge at 86 x g and 
the supernatant was removed. The cell pellet was resuspended in 1 ml of Cell Freezing Medium and 
transferred to a 1.8 ml Nunc Cryotube, which was placed in a thick Styrofoam box and frozen at -20°C 
for 2 hours before transferring to -80°C. To thaw, cell vials were hand-warmed and resuspended in 9 
ml of warm medium in a 15 ml conical tube. Cells were gently centrifuged at room temperature using 
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the Eppendorf 5810R centrifuge at 86 x g and the supernatant was removed. Cells were again 
resuspended in 9 ml of warm medium and transferred to a 10 cm culture dish and incubated at 37°C 
overnight in a quarantined incubator. The following day cells were washed with warm medium or split 
1:1 depending on growth, and afterward were split as described above upon reaching 80% confluency. 
One dish was reserved for two days without changing the medium in order to complete a mycoplasm 
test using the Venor® Mycoplasma Detection kit according to the manufacturer’s instructions. 
 
5.2.3.2 Transfection: CaCl2 Method 
 
HEK 293T cells were transfected using the CaCl2 method for all standard plasmid 
transfections (208, 209). For experiments requiring a larger amount of protein, 10 cm dishes were 
used. Appropriate amounts of plasmids were added to a 1.5 ml Eppendorf tube containing 400 µl 
CaCl2 for each experimental data point. When required, DNA amounts between experimental data 
points were balanced by adding an appropriate amount of pcDNA6 vector not containing a coding 
insert (empty vector). Under laminar flow, 400 µl of 2 x HEBS solution was added to the CaCl2 
solution dropwise while vortexing. The complete solution was then added drop-wise to a 10 cm dish 
of HEK 293T cells at 60% confluency. For experiments requiring transfection of a 6-well culture dish, 
DNA was pipetted into 100 µl of CaCl2, and 100 µl of 2 x HEBS was added drop-wise while 
vortexing under laminar flow. For experiments requiring transfection of a 12-well culture dish, DNA 
was pipette into 50 µl of CaCl2, and 50 µl of 2 x HEBS was added drop-wise while vortexing under 
laminar flow. In all cases, the medium was replaced 6-8 hours after transfection and cells were 
harvested the following day. 
 
5.2.3.3 Transfection: Lipofectamine Method 
 
For experiments in a 96-well format and for experiments require siRNA knockdown, cells 
were grown to 80% confluency and transfected using Lipofectamine 2000 according to a modified 
version of the manufacturers instructions. Under laminar flow, the required amount of DNA with or 
without siRNA was added to 90 µl of Opti-MEM in a 1.5 ml Eppendorf tube or a V-bottom 96-well 
cell culture dish. In a separate 1.5 ml Eppendorf tube, 2.5 µl of Lipofectamine per µg of DNA 
transfected was incubated in 90 µl of Opti-MEM at room temperature for 5 minutes. After 5 minutes, 
the lipofectamine solution was added to the DNA solution and incubated for 20 minutes at room 
temperature. After this time, the mixed solution was added to an appropriate amount of warm cell 
culture medium and the cell media was exchanged. In the case of a 96-well transfection, 50 µl of the 
mixed solution was added directly to each of 3 separate wells using a multipipette. 
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5.2.3.4 Reagent incubation 
 
 When required, cells were incubated with 1 µM okadaic acid in DMEM for 45 minutes, or 
with 1 µM MG132 in DMEM for 4 hours. Control cells were incubated with an equal concentration of 
the appropriate solvent in DMEM. In all cases, solutions were prepared using pre-warmed medium in 
a conical tube under laminar flow, and the cell media was exchanged. 
 
 
5.2.4 Biochemistry/ Molecular Biology 
 
All basic biochemistry and molecular biology was performed according to standard techniques 
(210) with modifications as indicated. All experiments were validated by a minimum of three 
biological replicates. 
 
5.2.4.1  Whole cell lysate 
 
 To prepare whole cell lysates (WCL), cells were harvested on ice 24 hours after transfection in 
1 ml cold PBS and transferred to a 1.5 ml Eppendorf tube. Cells were pelleted at 20,000 x g using the 
Eppendorf 5415 R microcentrifuge for 30 seconds at 4°C. The supernatant was aspirated and cells 
were resuspended in 80 µl Laemmli sample buffer (1X). During resuspension it was ensured that the 
entire pellet was lifted and suspended in the sample buffer.  Samples were boiled for 10 minutes using 
an Eppendorf Thermomixer shaker with 1.5 ml Thermoblock set to 0 rpm and 95°C, and then re-
pelleted for 5 minutes at 20,000 x g using the Eppendorf 5424 microcentrifuge. 30 µl of the 
supernatant was analyzed by Western Blot (section 3.2.4.4). 
 
5.2.4.2  Immunoprecipitation 
 
 Immunoprecipitation (IP) experiments were performed as described previously. HEK 293T 
cells were harvested on ice 24 hours after transfection in 6 ml cold PBS and transferred to a 15 ml 
conical tube. When required, 1 ml of the resultant cell suspension was removed to a 1.5 ml Eppendorf 
tube for processing as a whole cell lysate (section 3.2.4.1). The remaining cell suspension was pelleted 
using the Eppendorf 5810 R centrifuge for 5 minutes at 4°C and 86 x g. The supernatant was 
discarded, and the pellet was resuspended in 1 ml IP Lysis Buffer plus 2 mM Na3VO4 and 250 µM 
PMSF. Cells suspensions were incubated on ice for 15 minutes, and then centrifuged at 20,000 x g for 
15 minutes at 4°C using the Eppendorf 5415 R microcentrifuge. The supernatant was transferred to an 
Ultra-Clear ultracentrifuge tube and ultracentrifuged at 100,000 x g for 30 minutes at 4°C using the 
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Optima ultracentrifuge and TLA-55 rotor. 50 µl of the post-ultracentrifugation supernatant was kept as 
the “IP lysate” and boiled for 5 minutes at 95°C after adding 50 µl of Laemmli sample buffer (2X). 
The remaining post-ultracentrifugation supernatant was transferred to a 1.5 ml Eppendorf tube and 
incubated using the MacsMix tube rotator for 1 hour at 4°C with 30 µl of prepared anti-Flag-agarose 
beads (M2). When required, supernatants were instead incubated for 1 hour at 4°C with 1 µg anti-V5-
antibody (monoclonal) followed by a second 1 hour incubation at 4°C with 30 µl Protein G sepharose. 
After incubation, the sepharose or agarose was pelleted using the Eppendorf 5415 R microcentrifuge at 
800 x g for 3 minutes at 4°C,  and the supernatant was discarded. Pellets were washed 3 times by 
resuspending in 1 ml IP lysis buffer and centrifuging at 800 x g for 3 minutes at 4°C using the 
Eppendorf 5415 R microcentrifuge. After the last wash and supernatant removal, 30 µl of Laemmli 
sample buffer (2X) was added to the pellet and gently mixed by flicking. Samples were boiled at 95°C 
for 5 minutes, and then re-pelleted for 5 minutes at 20,000 x g using the Eppendorf 5424 
microcentrifuge. 30 µl of the supernatant was analyzed by Western Blot (section 3.2.4.4). 
 
5.2.4.3  Subcellular Fractionation 
 
 HEK 293T cells were harvested on ice 24 hours after transfection in 6 ml cold PBS and 
transferred to a 15 ml conical tube. When required, 1 ml of the resultant cell suspension was removed 
to a 1.5 ml Eppendorf tube for processing as a whole cell lysate (section 3.2.4.1). The remaining cell 
suspension was pelleted using the Eppendorf 5810 R centrifuge for 5 minutes at 4°C and 48 x g. The 
supernatant was discarded and the cell pellet was resuspended in 100 µl of the hypotonic Cell Fraction 
Buffer A plus 4.0 µl Complete Protease Inhibitor Cocktail (25X stock solution as per the 
manufacturer’s instructions). Cells were incubated on ice for 10 minutes, and then disrupted 14 times 
using a 21-gauge needle and 1 ml syringe. The mixture was gently centrifuged at 100 x g for 30 
minutes at 4°C using the Eppendorf 5415 R microcentrifuge in order to pellet the nuclear fraction. The 
supernatant was transferred to an Ultra-clear ultracentrifuge tube and ultracentrifuged at 100,000 x g 
for 60 minutes at 4°C using the Optima ultracentrifuge and TLA-55 rotor. 40 µl of the resultant 
supernatant was transferred to a new 1.5 Eppendorf tube and mixed with 20 µl of Laemmli sample 
buffer (3X), boiled for 5 minutes at 95°C, and centrifuged for 1 minute at 20,000 x g using the 
Eppendorf 5424 microcentrifuge to yield the cytosolic fraction. Meanwhile, the nuclear pellet was 
resuspended in 1 ml cold PBS and centrifuged at 9200 x g for 10 minutes at 4°C using the Eppendorf 
5415 R microcentrifuge. The supernatant was discarded, and the remaining pellet was resuspended in 
140 µl of Laemmli sample buffer (1X), boiled for 10 minutes at 95°C and centrifuged for 5 minutes at 
20,000 x g using the Eppendorf 5424 microcentrifuge to yield the nuclear fraction. 30 µl of the 
supernatant was analyzed by Western Blot (section 3.2.4.4). 
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5.2.4.4  Western Blot and Protein Detection 
 
 Proteins were separated by SDS-PAGE electrophoresis and visualized by HRP 
chemiluminescence. Each gel cassette was prepared by mixing 6 ml of Resolving Buffer with 0.15% 
TEMED and 0.1% APS and adding a top layer of Isopropanol. After hardening, all isopropanol was 
removed and replaced with 1.7 ml Stacking Buffer was mixed with 0.15% TEMED and 0.1% APS. A 
10-well comb was inserted and the stacking gel was allowed to dry. Gels were assembled into the 
XCell SureLockTM Mini-Cell electrophoresis system as per manufacturer’s instructions and the 
chamber was filled with Running Buffer so that the interior space between the gels was completely 
full and the exterior part was filled to a depth of 2 cm. Samples were loaded using a 50 µl Hamilton 
syringe which was cleaned 5 times with running buffer between each sample. One well was reserved 
to load 3 µl of Page-ruler Plus protein ladder. After all samples were loaded, gels were run using a 
Powerpac 3000 using the following program: 70 V for 30 minutes, then 25 milliamps per gel for 
approximately 2 hours, or until the ladder used had extended the entire length of the gel.  
 Separated proteins were transferred from the gel to a Millipore Immobilon-P polyvinylidene 
difluoride membrane using a Powerpac 200 power supply set to 12 V for one hour. To prepare the 
membrane for transfer, it was soaked first in methanol and then in Transfer Buffer, and placed onto a 
square of blotting paper which had been cut to size and also soaked in Transfer Buffer. The resolving 
gel was cut to the length of the ladder, soaked in Transfer Buffer, and placed on top of the membrane. 
A second square of blotting paper soaked in Transfer Buffer was placed on top, and air bubbles were 
rolled out using the length of a stripette. After transfer was complete, the protein ladder was traced in 
pen and the membrane was incubated in Washing Buffer plus 5% BSA for a minimum of 30 minutes 
at room temperature. Membranes were then washed 3 x 5 minutes with Washing Buffer, and incubated 
with the appropriate primary antibody as indicated in figure legends at a concentration indicated in 
Table 3.1.3. Primary antibodies were diluted in Washing Buffer and re-used. After primary antibody 
incubation, membranes were washed 3 x 5 minutes in Washing Buffer, and then incubated for 
30 minutes with the appropriate HRP-conjugated secondary antibody (Table 3.1.4) diluted 1:15000 in 
Washing Buffer. After this time, membranes were once more washed 3 x 5 minutes in Washing 
Buffer. Excess buffer was then shaken off and membranes were transferred to a plastic tray. 1 ml of 
ECL Detection Solution was then applied per membrane and proteins were visualized using a PeqLab 
Fusion Solo chemiluminometer and Fusion-CAPT software.  
 
5.2.4.5  Immunofluorescence 
 
Immunofluorescence experiments were performed according to standard techniques (211). 
Cells were grown in 12-well culture dishes on glass coverslips placed into wells using tweezers 
sterilized by fire under laminar flow. For experiments using HEK 293T cells, coverslips were coated 
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with Collagen A by incubating for 1 hour at 37°C. Excess Collagen A was removed and cover-slips 
were allowed to dry before passaging cells into the dish (section 3.2.3.2). After required experimental 
treatment, cells were fixed with 4% PFA or ice-cold methanol as indicated in figure legends. Cells 
were then washed once with Dulbecco’s PBS, permeabilized for 8 minutes with 0.05% Triton X-100 
in Dulbecco’s PBS, and then blocked for 1 hour with 5% normal donkey serum in Dulbecco’s PBS. 
Primary antibodies were incubated sequentially with for 1 hour using concentrations indicated in 
Table 3. For all endogenous staining, anti-Jade-1 was incubated first, except when combined with 
endogenous NPHP4 staining, in which case anti-NPHP4 was used first. Secondary antibodies (Table 
4) were diluted 1:500 and used according to figure legends. Cover-slips were washed for a minimum 
of 4 x 5 minutes with Dulbecco’s PBS between all antibody steps. When required as indicated by 
figure legends, Zenon® Tricolor Labeling Kits were used according to the manufacturer’s instructions. 
Cover-slips were washed extensively with Dulbecco’s PBS prior to mounting onto glass slides using 
Prolong Gold antifade reagent with DAPI as a mounting medium. Cells were visualized using an 
Axiovert 200 microscope (objective EC Plan Neofluar x 40/1.3 Oil) equipped with an Axiocam MRm 
and apotome system. Images were captured using Axiovision 4.8 software. 
 
5.2.4.6  Luciferase Assay 
 
 Luciferase reporter assays were performed according to standard procedure (212) using a 96-
well transfection format. HEK 293T cells were passaged as described in section 3.2.3.2 and the 
resultant cell suspension was counted using a Neubauer Improved cell counting chamber. Cells were 
diluted to 400,000 cells /ml, and plated using an Eppendorf Research® Multipipette multipipette. 
When cells had reached 80% confluency a total amount of 140 ng of DNA per well was transfected 
using Lipofectamine 2000 (section 3.2.3.4) as follows and according to figure legends:  50 ng 
TOPFlash or FOPFlash firefly luciferase; 25 ng constitutively active Renilla luciferase pGL4.74; 5 ng 
Flag.β-catenin WT/mutant; 50 ng V5.Jade1 WT/mutant or empty vector; 10 ng V5.NPH 
protein/F.NPH protein/F.CK1α or empty vector. In all cases, experimental plasmids were added to a 
prepared master mix containing Flag-tagged β-catenin (F.β-catenin) and the reporter plasmids. Non-
stimulated cells received only the reporter plasmids balanced with empty vector. For knockdown 
experiments, 20 nM of siRNA was incubated in Lipofectamine together with plasmids, as indicated in 
figure legends. Each transfection was performed in triplicate, and each experiment was repeated at 
least three times. After 24 hours, cells were lysed for 15 minutes at room temperature using the 
Promega passive lysis 5X buffer and analysis according to the manufacturer’s instructions. Firefly and 
Renilla luciferase activities were analyzed using the Promega dual-luciferase reporter assay system 
and the Mithras LB940 luminometer according to the manufacturer’s instructions. Wnt reporter 
activity was quantified as relative luciferase units (RLU) by scoring the Firefly reporter activation as 
measured per transfection efficiency as quantified by the Renilla luciferase activity. Data were 
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normalized by setting the “β-catenin plus empty vector” treatment group to 100%, and significance 
was assessed for all β-catenin stimulated treatment groups using a one-way analysis of variance 
(ANOVA) with Tukey's post-hoc test (section 3.2.7). To assess the effect of Jade-1 siRNA, data were 
normalized to set β-catenin stimulation to 100% separately for each Jade-1 siRNA condition. The 
amount that NPHP4 reduced the signal was then analyzed by normalizing so that the reduction by 
NPHP4 in the negative siRNA condition was set to 100%.  
 
5.2.4.7  RNA Extraction  
 
 HEK 293T cells were seeded in a 6-well format (section 3.2.3.2) and transiently transfected 
for 24 hours using the CaCl2 method (section 3.2.3.3) according to the figure legend. RNA was 
extracted based on a modified version of the guanidinium thiocyanate-phenol-chloroform extraction 
method (213). After transfection, cells were washed with PBS, harvested in 700 µl of Qiazol and 
transferred to a 1.5 ml RNAse-free Eppendorf tube. Cells were incubated for 5 minutes at room 
temperature prior to the addition of 120 µl of Chloroform. The mixture was shaken vigorously  and 
incubated for 2 minutes at room temperature, then centrifuged at 12000 x g for 15 minutes at 4°C 
using the Eppendorf 5417R microcentrifuge. 300 µl of the aqueous phase was then transferred to a 
new 1.5 ml RNase-free Eppendorf tube and an equal volume of isopropanol was added. The mixture 
was again vigourously shaken and incubated for 15 minutes at room temperature. The RNA was 
pelleted by centrifugation at 12000 x g for 15 minutes at 4°C using the Eppendorf 5417R 
microcentrifuge. The supernatant was discarded using a 1 ml pipette tip, then briefly re-spun and any 
remaining supernatant was removed using a 10 µl pipette tip. The RNA pellet was then washed by 
adding 1 ml of 75% (v/v) Ethanol and vortexing, and re-pelleted by centrifugation at 7000 x g for 5 
minutes at 4°C using the Eppendorf 5417R microcentrifuge. The supernatant was again discarded 
using a 1 ml pipette tip, briefly re-spun, and any remaining supernatant was removed using a 10 µl 
pipette tip. The RNA pellet was then dried by leaving the open Eppendorf tube on a clean surface for 
2-5 minutes until the pellet was clear. The pellet was resuspended in 30 µl of RNase-free water and the 
yield was measured using the using the Nanodrop 1000 spectrophotometer according to 
manufacturer’s instructions. 
 
5.2.4.8  Real-Time quantitative qPCR 
 
 Extracted RNA (section 3.2.4.7) was brought to a concentration of 0.2 µg /µl in RNAse-free 
water and treated with the Turbo DNAse kit according to the manufacturers instructions. Reverse 
transcription was performed using the High Capacity cDNA Reverse Transcription kit according to the 
manufacturers instructions. Jade-1 mRNA was assessed by SYBR Green qPCR and normalized by 
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using human HPRT1 mRNA as an endogenous control. Primers used are described in Table 3.1.7. 
Primers were designed using NCBI Primerblast software to produce an amplicon size of 50-150 base 
pairs with a CG content of 40-70%, and were checked for intron inclusion using Ensemble.org. 
Primers were resuspended in RNAse-free water and appropriate pairs were combined in a 1:1 ratio to 
yield a concentration of 50 µM each. Primer pairs were validated in a separate experiment by running 
a standard curve PCR with 4 cDNA dilutions (50 ng; 5 ng; 0.5 ng; 0.05 ng) and a genomic DNA 
control. Only primer pairs with a demonstrated efficiency between 90 and 110% and R2 value close to 
0.99 were used. For all experiments, Power SYBR Green was diluted to 54.7% (v/v) in RNAse-free 
water and added to 50 ng of cDNA plus 300 nM primer mix. Experiments were run using Fast Optical 
96-well plates covered with adhesive film. Experimental data points were assessed in triplicate 
reaction volumes of 25 µl each, and internal controls consisted of an RNA sample from each 
experimental triplicate as well as non-template control run with each primer mixture. All qPCR 
experiments were performed on a real-time PCR system (7900HT, Applied Biosystems) according to 
the following protocol: 95°C for 10 minutes followed by 40 repeats of 95°C for 15 seconds plus 60°C 
for 1 minute. A dissociation curve was run after every experiment. Experiments were run as Absolute 
Quantification and data was converted to Relative Quantification prior to analysis using SDS software. 
At least three biological repititions were performed and data were analyzed by Student's t test 
(section 3.2.7). 
 
 
5.2.5 Zebrafish  
 
All zebrafish work was performed in collaboration with Dr. Sandra Habbig and 
Dr. Julia Hatzold in the lab of Prof. Dr. Matthias Hammerschmidt. Morpholinos were obtained 
from Gene Tools (Philomath, OR) with sequences as follows:  
ATG-targeting  nphp4:   5′ - GCGCTTCTCCACTCAGACATCAGAG - 3′  
ATG-targeting  jade-1:  5′ - TCGGGACACGGCTTCGCTTCATCCT - 3′ 
5′UTR-targeting  jade-1: 5′ - CGTGGCCTTCAAGTGATGCGGAAAT - 3′  
Morpholinos were diluted in Danieau's buffer (58 mM NaCl; 0.7 mM KCl; 0.4 mM MgSO4; 
0.6 mM Ca(NO3)2 ;5 mM HEPES; pH 7.6) and injected into wild-type zebrafish embryos at the 1- to 
2-cell stage (214) using a PV 820 Pneumatic PicoPump (World Precision Instruments). Injection doses 
consisted of 1.5 nl of the morpholino solution at 20 μM (low dose) or 100 μM (high dose). Embryos 
were kept in E3 buffer (5 mm NaCl, 0.17 mm KCl, 0.33 mm CaCl2, 0.33 mm MgSO4, 0.00001% 
methylene blue) at 28 °C and were analyzed after 72 h for body curvature using a Leica 
stereomicroscope (M165FC) equipped with Leica camera (DFC425C). Over 150 fish were counted for 
each data point and only embryos displaying a distinct curvature of the tail angled more than 45° from 
the head-neck axis were scored as positive. Data for low-dose comparisons were collected from three 
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independent experiments per condition, and average phenotype frequencies were calculated a 
percentage of wild-type fish using a one-way ANOVA with Tukey's post-hoc test (section 3.2.7). 
Cystic morphants used for sectioning were PFA-fixed and embedded in paraffin. Samples were 
sectioned using a Leica microtome (RM2235) and stained using standard Hemotoxylin and Eosin 
staining protocol (215) and visualized using a Zeiss Axiophot with Zeiss Axiocam. 
 
5.2.6 Mass Spectrometry 
 
 All experiments involving mass spectrometry were performed in collaboration with Dr. 
Markus Rinschen in the CECAD Proteomics Facility run by Dr. Tobias Lamkemeyer. Experiments 
were performed as previously described with slight modifications (216). HEK 293T cells were 
passaged into 10 cm cell culture dishes (section 3.2.3.2) and transfected using the CaCl2 method 
(section 3.2.3.3). After 24 hours, cells were lysed in a buffer containing 8M Urea and 50mM 
ammonium bicarbonate with added Pierce protease and phosphatase inhibitor cocktail (Thermo 
Scientific). Protein concentration was determined using by bicinchoninic acid (BCA) Protein Assay 
(Thermo Scientific). 400µg of proteins were reduced using DTT and alkylated using Iodoacetamide as 
previously described (216). Peptides were digested using trypsin at a w:w ratio of 1:50 at 37°C for 16 
hours. After desalting procedure, phosphopeptides were enriched using Fe-NTA immobilized metal 
affinity chromatography columns (Thermo Scientific). After final clean-up (ZipTip columns, 
Milipore), samples were analyzed using an LTQ Orbitrap Discovery mass spectrometer (Thermo 
Scientific) coupled to a Proxeon EASY-nLC II nano-LC system (Proxeon/Thermo Scientific). Intact 
peptides were detected at a resolution of 30,000 in the mass-to-charge (m/z) range 200–2000 (MS). 
Internal calibration was performed using the ion signal of (Si(CH3)2O)6H at m/z 445.120025 as a lock 
mass. For LC-MS/MS analysis, up to five CID spectra (MS2) were acquired following each full MS 
scan. Sample aliquots were separated on a 15 cm, 75 µm reverse phase column (Proxeon/Thermo 
Scientific). Gradient elution was performed from 10 to 40% acetonitrile within 90 minutes at a flow 
rate of 250 nl/min. Generated raw data were searched using the SEQUEST algorithm against the most 
recent version of the Uniprot human database (released 2012-06-01).The false discovery rate was 
adjusted to be lower than 0.01. This analysis and visualization of spectra was performed using the 
ProteomeDiscoverer software (Thermo Scientific). Identified phosphorylation sites were compared 
with previously discovered phosphorylation sites in the latest version of the database PhosphoSitePlus 
(2012-06-01; www.phosphosite.org). 
 
5.2.7 Statistics 
 
 All data are presented as mean average plus standard error of the mean (SE), calculated using 
Microsoft Excel software. Data was normalized as indicated by figure legends and in the respective 
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methods sections. Statistical analysis was performed using Prism software and differences between 
means were assessed by one-way ANOVA or Student’s t test as appropriate. Tukey's post-hoc test was 
used with or without Bonferroni correction as required.  
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6 RESULTS 
 
6.1 Jade-1 is a dynamic protein that co-localizes with neprocystins at the transition zone. 
 
In order to investigate whether Jade-1 could be a candidate protein for a mediator of ciliary 
signaling regulation by nephrocystin proteins, it was necessary to determine whether these proteins 
localize together at the cilium, centrosome, or pericentrosomal region. Immunofluorescence staining 
using a ciliated Retinal Pigmented Epithelial (RPE-1hTERT) cell line demonstrated Jade-1 to be a 
highly dynamic protein. Nuclear and cytoplasmic staining patterns confirmed earlier reports (197, 
198), but it was apparent that cells in close proximity to one another did not share uniform nuclear vs. 
cytoplasmic fluorescence intensities (Fig 4A). Furthermore, a distinct perinuclear staining pattern was 
observed in some cells, as was intense ciliary staining as confirmed by co-localization with the ciliary 
marker acetylated-tubulin The variation of ciliary and nuclear fluorescence intensities between cells 
was confirmed using a second anti-Jade-1 antibody (Fig 4B), and this variation did not appear to 
correlate with any apparent state of cell division or confluency. Centrosomal localization of Jade-1 
appeared consistent between cells as did mitotic spindle labeling in dividing cells. The centrosomal 
localization of Jade-1 was confirmed using a third commercial antibody to demonstrate colocalization 
with centriole-marker gamma-tubulin in Human Embryonic Kidney (HEK) 293T cells (Fig 5A), and 
localization at the base of the cilium as labeled by acetylated-tubulin in RPE-1 cells (Fig 5B). The 
localization of Jade-1 at the base of the cilium in RPE-1 cells despite dissociation of the microtubule 
network (Fig 6) confirmed Jade-1 to be a bona fide centriole-associated protein (217). In addition, 
Jade-1 was demonstrated to co-localize with NPHP1 at the transition zone (Fig 7), supporting the 
possibility of an interaction between Jade-1 and the nephrocystin complex at this location. 
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Figure 4. Jade-1 is a dynamic protein that localizes to the nucleus, cytoplasm, and centrosome in 
ciliated RPE-1 cells. 
RPE-1 cells were grown to 60% confluency on glass coverslips prior to serum starvation for 24 hours 
to induce cilia formation. Cells were then fixed using PFA and immunostained using two separate 
anti-Jade-1 antibodies (magenta; Genetex, A; Proteintech, B) in combination with anti-acetylated-
tubulin used to identify primary cilia (green) A. Within the same field of view, most cells 
demonstrated a nuclear accumulation of Jade-1, but some cells demonstrated an additional perinuclear 
staining pattern (dashed arrow), while others lacked nuclear Jade-1 accumulation (N). Furthermore, in 
only some cells Jade-1 showed an intense ciliary staining pattern (C), but regardless of ciliary status in 
all cells an accumulation of Jade-1 was seen at the ciliary base. B. Despite weaker overall labeling, 
weak ciliary and centrosomal labeling could still be identified in all cells (e.g. arrowheads), and 
sporadically cells were labeled with an intense signal in the nucleus or primary cilium. Jade-1 also 
intensely labeled the mitotic spindle in dividing cells (*). Merged images include DAPI. Scale bar = 
10 µm. Data from figure A has been previously published in Borgal et al., 2012 (218). 
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Figure 5. Confirmation of centrosomal Jade-1 localization 
A. HEK 293T cells grown on collagen A-coated coverslips were PFA-fixed and immunostained using 
an anti-Jade-1 antibody (green) as well as anti-gamma-tubulin antibody (magenta) as a marker of the 
centrosome. Jade-1 localized to the cytosol and nucleus and an accumulation at the centrosome co-
localized with gamma-tubulin (arrows). Jade-1 was also visualized at mitotic spindle and centrosome 
dividing cells (*). B. RPE-1 cells grown on glass coverslips to 60% confluency and serum starved for 
24 hours were immunostained using an anti-Jade-1 antibody (green) and anti-acetylated-tubulin 
antibody (magenta) to identify primary cilia. The Jade-1 immunofluorescence signal was 
concentratred in the nucleus and at the base of the cilium (arrow-heads). All stainings were done 
sequentially with anti-Jade-1 used prior to centrosomal or ciliary markers. Specificity of the antibody 
was confirmed by immunofluoresence staining of over-expressed V5.Jade-1 protein and by 
immunostainings using secondary antibody only (not shown). Merged images with DAPI. Scale bar = 
10 µm. Data has been previously published in Borgal et al., 2012 (218). 
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Figure 6. Jade-1 localizes to the ciliary base independently of the microtubule network. 
Immunofluorescence images of RPE-1 cells which were serum starved for 48 hours and then PFA-
fixed immediately (-) or after 30 minutes on ice (+), which is sufficient to dissociate the microtubule 
network. Cells were immunostained with anti-alpha tubulin (green) or anti-Jade-1 (magenta) 
antibodies. In both cases, endogenous Jade-1 localizes to the ciliary base (arrows). Merge with DAPI; 
Scale bar = 10 µm. Dissociation of the microtubuli network was performed by Claudia Dafinger. Data 
has been previously published in Borgal et al., 2012 (218). 
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Figure 7. Jade-1 co-localizes with NPHP1 at the transition zone of primary cilia 
RPE-1 cells were grown on glass coverslips and serum starved for 24 hours prior to PFA fixation and 
immunostaining with anti-NPHP1 (green), anti-Jade-1 (magenta), and anti-acetylated-tubulin (cyan) 
antibodies. A. Jade-1 was visualized at the basal body and co-localized with NPHP1 at the transition 
zone (arrows). B. At times, Jade-1 could also be visualized within the cilium (arrowheads). Merge 
with DAPI; Scale bar = 2 µm. Data has been previously published in Borgal et al., 2012 (218). 
 
 
6.2 Jade-1 interacts with the nephrocystin protein complex. 
 
The co-localization of Jade-1 and NPHP1 at the transition zone indicated that Jade-1 might 
interact with members of the nephrocystin complex. Immunoprecipitation experiments demonstrated 
that V5-tagged Jade-1 (V5.Jade-1) co-precipitated with Flag-tagged NPHP1 (F.NPHP1), as well as 
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with all of the other members of the nephrocystin protein complex tested: F.NPHP2, F.NPHP3, 
F.NPHP4, F.NPHP5, F.NPHP7, F.NPHP8, and NPHP9 (Fig 8A).  In order to determine an optimal 
candidate to study in terms of influencing Wnt regulation by Jade-1, a TOPflash TCF/LEF reporter 
assay was used to screen for negative Wnt reporter activation by NPH proteins. All NPHP proteins 
tested restrained canonical Wnt reporter activity at high expression levels. When protein expression 
was decreased, only F.NPHP4 and F.NPHP9 retained a robust ability to negatively regulate reporter 
activity (Fig 8B). F.NPHP4 consistently interacted with V5.Jade-1. The contribution of this interaction 
to the negative Wnt regulator role for NPHP4 was therefore further investigated. 
 
 
Figure 8. Jade-1 interacts with the canonical Wnt negative regulating NPH protein complex. 
A. HEK 293T cells were transiently transfected with V5.Jade-1 and one of eight Flag-tagged NPH 
proteins or a control protein (F.EPS1-225). After 24 hours, immunoprecipitation was performed using an 
anti-Flag antibody. V5.Jade-1 co-precipitated with all nephrocystin proteins but not the control 
protein. B. HEK 293T cells were transiently transfected for 24 hours with TOPflash TCF/LEF reporter 
plasmid plus a constitutively active Renilla luciferase reporter plasmid used as a transfection control. 
Flag-tagged beta-catenin and NPHP plasmids or F.EPS1-225 were transfected as indicated; where 
required DNA amount was balanced with empty vector. Very low transfected plasmid amounts of 
F.NPHP4, F.NPHP7 and F.NPHP9 were still able to significantly reduce TOPflash reporter activity. 
Reporter activation in the presence of each F.NPH protein was evaluated in comparison to β-catenin 
alone, using paired t-test with Bonferroni correction (F.β-catenin alone in comparison to: F.NPHP4 
(t(4) = 24.14, p<0.0001); F.NPHP7 (t(4) = 8.835, p = 0.0009); F.NPHP9(t(4) = 9.174, p < 0.0008); 
error bars indicate mean ± SE). 
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6.3 Overexpressed NPHP4 facilitates nuclear translocation of Jade-1 in a 
phosphorylation-dependent manner 
 
 The interaction between NPHP4 and Jade-1 was confirmed by immuno-precipitation 
experiments. V5.Jade-1 co-precipitated with F.NPHP4 but not a control protein (F.EPS1-225), while in 
the reverse experiment, V5.NPHP4 co-precipitated with F.Jade-1 but not a control protein (Fig 9A-B). 
Furthermore, endogenous Jade-1 co-precipitated with F.NPHP4 but not a control protein (Fig 9C). 
Endogenous Jade-1 was also demonstrated to co-localize with endogenous NPHP4 by 
immunofluorescence. NPHP4 and Jade-1 could both be visualized at the centrosome of ciliated RPE-1 
cells (Fig 10A). NPHP4 was also visualized in a distinct peri-nuclear staining pattern, and in cells 
where endogenous Jade-1 was also localized to the peri-nuclear region there was a striking overlap 
between these two proteins (Fig 10B).  
 
Figure 9. Confirmation of the interaction between Jade-1 and NPHP4. 
A. HEK 293T cells were transiently transfected with V5.Jade-1 and F.NPHP4 or a control protein 
(F.EPS1-225) and after 24 hours immunoprecipitation was performed using an anti-Flag antibody. 
V5.Jade-1 co-precipitated with F.NPHP4 but not the control protein. Interestingly, overexpression of 
F.NPHP4 led to a decrease of V5.Jade-1 protein expression in the cytosolic IP lysate but an increase of 
V5.Jade-1 in the whole cell lysate, which was taken from the same culture dish prior to the IP 
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procedure. Endogenous tubulin staining from the whole cell lysates showed equal protein amounts. B. 
In the reverse experiment, HEK 293T cells were transiently transfected with V5.NPHP4 and either 
F.Jade-1 or F.EPS1-225 and immunoprecipitation was performed 24 hours later using an anti-FLAG 
antibody. V5.NPHP4 was co-immunoprecipitated by F.Jade-1 but not F. EPS1-225 C. HEK 293T cells 
were transiently transfected with F.NPHP4 or a control protein, and 24 hours later 
immunoprecipitation was performed using an anti-Flag antibody. Endogenous Jade-1 was present in 
both cell lysates, but was detected only in the precipitates of F.NPHP4 and not the control protein. IB, 
immunoblot; HC, heavy chain. Blots are representative of three independent experiments. Data has 
been previously published in Borgal et al., 2012 (218). 
 
 
 
Figure 10. Endogenous Jade-1 co-localizes with endogenous NPHP4. 
RPE-1 cells were serum starved for 24 hours then fixed with methanol (A) or PFA (B) and 
immunostained using anti-NPHP4 (green) and anti-Jade-1 (magenta) antibodies. A. NPHP4 
(arrowheads) could be observed at the cilium together with Jade-1 (arrow). B. In all cells, endogenous 
NPHP4 was concentrated in the peri-nuclear region (green). In cells in which Jade-1 (magenta) was 
also localized to the peri-nuclear region, there was a striking co-localization between these two 
proteins. Scale bar = 10 µm. Data has been previously published in Borgal et al., 2012 (218). 
 
 
 
 Upon closer examination of the immunoprecipitation experiments, it was observed that while 
overexpression of F.NPHP4 decreased the amount of V5.Jade-1 protein in the mostly cytosolic IP 
lysate, overexpression of F.NPHP4 led to a consistent increase of V5.Jade-1 protein in the nuclei-
containing whole cell lysate taken from the same experiment at the time of cell harvesting (Fig 9A). 
Together with the observed perinuclear localization of endogenous NPHP4 (Fig 10B, left panel) and 
RESULTS 59
striking co-localization with endogenous Jade-1 in this region (Fig 10B, right panel), it was proposed 
that over-expression of NPHP4 might stabilize the overall protein level of Jade-1, and lead to its 
translocation from the cytosol to the nucleus. To confirm this stabilization, V5.NPHP4 was expressed 
together with V5.Jade-1 or V5.EPS, using V5.GFP as a transfection control. The overexpression of 
V5.NPHP4 led to the stabilization of V5.Jade-1 but did not alter the protein level of V5.GFP 
(Fig 11A). Overexpression of NPHP4 did not alter translation of Jade-1 as determined by qPCR 
experiments (Fig 11B); instead, results indicated that NPHP4 protected Jade-1 from proteasomal 
degradation, since the stabilization of V5.Jade-1 by the proteasome inhibitor MG132 provided no 
further effect compared to the stabilization of V5.Jade-1 by V5.NPHP4 (Fig 11C). 
 
Figure 11.  NPHP4 stabilizes Jade-1 by protecting the protein from degradation 
A. HEK 293T cells were transiently transfected with a plasmid master mix of V5.Jade-1 plus V5.GFP 
together with either V5.NPHP4 or a control protein (V5.EPS1-225) and harvested 24 hours later as a 
whole cell lysate. Overexpression of V5.NPHP4 but not expression of a control protein (V5.EPS1-225) 
led to increased protein expression of V5.Jade-1 but did not alter expression of V5.GFP, confirming a 
specific effect of NPHP4 on Jade-1. B. Overexpression of V5.NPHP4 did not alter mRNA levels of 
V5.Jade-1 as determined by qPCR. HEK 293T cells were transiently transfected with V5.NPHP4 or a 
control protein (V5.EPS1-225) and harvested after 24 hours (n=3; error bars indicate mean ± SE). C. 
The proteasome inhibitor MG132 (1µM in DMEM, 4 hours) led to the stabilization of V5.Jade-1, but 
did not enhance the protein stabilization of V5.Jade-1 by V5.NPHP4. HEK 293T cells were transiently 
transfected with V5.Jade-1 plus V5.NPHP4 or empty vector for 24 hours prior to 4 hour incubation 
with fresh medium containing 1µM MG132 or DMSO. Cells were processed as a whole cell lysate. 
All blots are representative of at least three independent experiments. Data has been previously 
published in Borgal et al., 2012 (218). 
 
 
 Cell fractionation was then used to determine whether the overexpressing NPHP4 led to a 
nuclear translocation of Jade-1 (Fig 12A). Overexpression of V5.NPHP4 but not a control protein 
(V5.EPS1-225) led to a reduction of cytoplasmic protein expression of V5.Jade-1 but an increase in 
nuclear V5.Jade-1 protein expression. Interestingly, V5.NPHP4 associated with the nuclear fraction in 
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contrast to V5.EPS1-225. Immunofluorescence analyses confirmed that nuclear V5.Jade-1 was increased 
in cells which co-expressed F.NPHP4 (Fig 12B), and in agreement with the observed endogenous 
NPHP4 staining pattern (Fig 10) further demonstrated that over-expressed NPHP4 did not localize 
within the nucleus, despite the close association indicated by cell fraction. Upon closer inspection of 
cell fraction experiments it was observed that when overexpressed together with a control protein, 
V5.Jade-1 fractioned as a smaller cytosolic band plus a larger nuclear band. When expressed together 
with V5.NPHP4, both the smaller and larger bands of V5.Jade-1 were associated with the nuclear 
fraction (Fig 12A). In all overexpression experiments, V5.Jade-1 was visualized as a double band, and 
it was noted that the addition of NPHP4 almost always led to an increase in the smaller of these two 
bands (Fig 11A; Fig 9A WCL). The question was therefore raised as to whether NPHP4 altered the 
phosphorylation status of Jade-1, and whether this contributed to nuclear translocation.  
To answer this, two experiments using the phosphatase inhibitor okadaic acid were performed.  
In the first, V5.Jade-1 was co-expressed with V5.NPHP4 or empty vector in the presence or absence 
of okadaic acid (Fig 12C).  Under standard conditions, V5.NPHP4 stabilized the smaller band of 
V5.Jade-1; however, in the presence of okadaic acid V5.NPHP4 was unable to do so. Cell 
fractionation was also performed in the presence or absence of okadaic acid (Fig 12D). Under standard 
conditions, over-expressed V5.Jade-1 predominantly associated with the nuclear fraction, in agreement 
with over-expression data visualized by immunofluorescence (Fig 12B). However, in the presence of 
okadaic acid over-expressed V5.Jade-1 associated predominantly with the cytosolic fraction, 
suggesting a reduced ability to translocate to the nucleus when phosphatase activity was disrupted. 
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Figure 12. NPHP4 increases nuclear translocation of Jade-1 in a phosphorylation-dependent 
manner. 
A. Subcellular fractionation was performed 24 hours after transient transfection of V5.Jade-1 together 
with either V5.NPHP4 or a control protein (V5.EPS1-225) in HEK 293T cells.  V5.NPHP4 decreased 
the amount of V5.Jade-1 associating with the cytosolic fraction (Cyt), but increased the amount of 
V5.Jade-1 associating with the nuclear fraction (Nuc). Over-expressed V5.NPHP4 predominantly 
associated with the nuclear fraction, in contrast to the control protein V5.EPS1-225.  Note that when 
expressed with the control protein, V5.Jade-1 was visualized as a smaller cytosolic band plus a larger 
nuclear band. In the presence of V5.NPHP4, the smaller band was instead associated with the nuclear 
fraction. Endogenous tubulin and endogenous fibrillarin marked the cytosolic and nuclear fractions, 
respectively. The cytosolic fraction was concentrated three times more than the nuclear fraction in 
order to visualize cytosolic V5.Jade-1. B. Immunofluorescence image of HEK 293T cells transiently 
transfected with low amounts of V5.Jade-1 and F.NPHP4. Cells were fixed in PFA after 24 hours and 
immunostained with anti-Flag antibody (magenta) or anti-V5 antibody (green). Cells positive for both 
expressed proteins showed an increased amount of V5.Jade-1 in the nucleus (arrows) compared to 
cells that only expressed V5.Jade-1 (arrowheads). Note that overexpressed F.NPHP4 does not localize 
within the nucleus. Flag and V5 staining in nontransfected cells confirmed that nuclear Jade-1 staining 
was specific (not shown). Scale bar = 10 µm. C. HEK 293T cells were transiently transfected with 
V5.Jade-1 plus either V5.NPHP4 or empty vector. After 24 hours, cells were incubated for 45 minutes 
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in fresh medium containing 1 µM water as control (Co.) or okadaic acid (O.A.) and then harvested as a 
whole cell lysate. V5.NPHP4 stabilized the smaller band of V5.Jade-1 under control conditions but not 
in the presence of okadaic acid. D. HEK 293 cells were transiently transfected with V5.Jade-1. After 
24 hours, cells were incubated in fresh medium containing 1 µM okadaic acid or water for 45 minutes, 
and then harvested for cell fractionation. V5.Jade-1 accumulated in the nucleus under control 
conditions but in the cytosol when incubated with okadaic acid. All western blots are representative of 
3 independent experiments. Data has been previously published in Borgal et al., 2012 (218). 
 
 
6.4 NPHP4 and Jade-1 additively reduce canonical Wnt signaling 
 
 Both NPHP4 and Jade-1 have previously been published to negatively regulate the canonical 
Wnt signaling pathway (193, 198). Furthermore, Jade-1 was demonstrated to ubiquitylate the major 
canonical Wnt effector β-catenin in the nucleus as well as in the cytosol (198). Since NPHP4 enhances 
Jade-1 specifically in the nucleus, it was questioned whether NPHP4 could enhance the negative 
regulation of the canonical Wnt pathway by Jade-1. To test this, V5.NPHP4 and V5.Jade-1 were 
expressed either separately or together in combination and assessed for their ability to reduce β-
catenin-stimulated TOPFlash TCF/LEF reporter activity in a dual-luciferase assay (Fig 13A). In 
agreement with previous reports, both V5.NPHP4 and V5.Jade-1 were able to reduce the TOPFlash 
reporter activity in a dose dependent manner. When the transfected amounts of V5.NPHP4 and 
V5.Jade-1 were titrated so that each individually reduced TOPFlash reporter activity by 50%, the 
combination of the titrated amounts of these two plasmids additively reduced Wnt reporter activity by 
a further 50%. Corroborating these results, transfection of the same plasmid ratios additively reduced 
endogenous protein expression of the canonical Wnt target gene c-myc (Fig 13B). Addition of a 
control protein to either V5.NPHP4 or V5.Jade-1 did not further reduce Wnt reporter activity by either 
of these proteins (Fig 13C), and neither V5.NPHP4 nor V5.Jade-1 were able to reduce the heightened 
reporter activaty induced by the non-phosphorylatable S33A mutant β-catenin (Fig 13D). 
 In order to determine whether there existed a hierarchy of dependence in the ability of Jade-1 
and NPHP4 to negatively regulate the canonical Wnt pathway, siRNA knockdown experiments were 
performed. Knocking down endogenous NPHP4 significantly enhanced the ability of β-catenin to 
stimulate canonical Wnt reporter activity compared to scrambled siRNA. Furthermore, in the presence 
of NPHP4 siRNA, the ability of over-expressed V5.Jade-1 to negatively regulate Wnt reporter activity 
was significantly reduced (Fig 13E). Similarly, knocking down endogenous Jade-1 reduced the ability 
of V5.NPHP4 to negatively regulate canonical Wnt reporter activity (Fig 13F). However, this effect 
did not reach significance, indicating that the requirement of NPHP4 by Jade-1 is more potent than the 
requirement for Jade-1 by NPHP4. 
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Figure 13. NPHP4 and Jade-1 additively reduce canonical Wnt activity in a mutually dependent 
fashion. 
For all canonical Wnt reporter assays, the constitutively active Renilla luciferase reporter was used to 
control transfection efficiency and was mixed with either the TOPflash TCF/LEF reporter plasmid or 
non-responsive control reporter FOPFlash as indicated. Prior to adding experimental plasmids, F.β-
catenin or empty vector were added to this reporter mixture to ensure equal plasmid amounts. In all 
cases HEK 293T cells were transiently transfected for 24 hours prior to lysis, and Wnt reporter activity 
was quantified as relative luciferase units (RLU). A. Expression of either V5.NPHP4 or V5.Jade-1 
plus empty vector was able to reduce β-catenin stimulated TOPflash reporter activity. When the effect 
by each plasmid was titrated to a 50% reduction of reporter activity, the combination of V5.NPHP4 
and V5.Jade-1 together further reduced reporter activity significantly (F(3,31) = 66.79, p<0.0001; 
Tukey’s post hoc test as indicated, **= p<0.01, ***=p<0.001). Error bars indicate mean ± SE. 
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Experiments were each done in triplicate for TOPFlash. FOPFlash levels consistently showed no 
activation (one triplicate was done for each treatment group). B. HEK 293T cells were transiently 
transfected with F.β-catenin and experimental plasmids as indicated, using the same ratios as used for 
the luciferase experiments. Cells were processed 24 hours later as a whole cell lysates. Expression of 
V5.NPHP4 and V5.Jade-1 reduced the protein level of Wnt gene target c-myc. C. Transient 
transfection of a control plasmid (V5.EPS1-225) in addition to either V5.NPHP4 or V5.Jade-1 did not 
further reduce Wnt reporter activity. N.S. = not significant as determined by one-way ANOVA 
between the four experimental conditions (F(3,11) = 1.841; p = 0.24; error bars indicate mean ± SE). 
D. Neither V5.Jade-1 nor V5.NPHP4, alone or in combination, were able to reduce the heightened 
reporter activity stimulated by the non-phosphorylatabe S33A β.catenin mutant (error bars indicate 
mean ± SE). E. Transient transfection with F.β-catenin and reporter plasmids, together with either 
NPHP4 siRNA or control siRNA and either V5.Jade-1 or empty vector. Wnt reporter activity was 
significantly increased in the presence of NPHP4 siRNA compared to cells receiving control siRNA. 
This effect was reversed by the addition of V5.Jade-1, although V5.Jade-1 combined with NPHP4 
siRNA did not reduce Wnt reporter activity to the extent that V5.Jade-1 combined with control siRNA 
could (F(3,15) = 13.88, p<0.001; Tukey’s post hoc test as indicated, * = p<0.05, *** = p<0.001; error 
bars indicate mean ± SE). F. The amount that V5.NPHP4 in the presence of control siRNA was able to 
reduce F.β-catenin-stimulated TOPFlash reporter activity was normalized to 100% (see “Materials & 
Methods”), and this value was compared with the reduction in reporter activity due to V5.NPHP4 in 
the presence of three separate Jade siRNAs. Jade siRNA showed a non-significant trend toward 
reduced NPHP4 efficacy (error bars indicate mean ± SE). Data has been previously published in 
Borgal et al., 2012 (218). 
 
 
6.5 Genetic interaction of NPHP4 and Jade-1 in zebrafish embryos.  
 
 To test whether the biochemical relationship between NPHP4 and Jade-1 had functional 
relevance in vivo, the developing zebrafish embryo was used as a model system. This can be 
considered an appropriate model to study the function of genes related to human cystic kidney disease 
because the zebrafish homologs of human cystoproteins localize to primary cilia and morpholino 
knockdown of these results in pronephric cyst formation in the zebrafish embryo (219, 220). In vivo 
morpholino knockdown of nphp4 expression has previously been reported to lead to a curved body 
phenotype in zebrafish (193, 221). This phenotype has been associated with defects in canonical Wnt 
signaling, ciliary defects, and pronephric cysts  (178, 193, 221–224). Injection of an nphp4 ATG-
targeting morpholino confirmed a body curvature phenotype in 92% of injected embryos at 72 hours 
post fertilization. Injection of either a jade-1 ATG- or jade-1 5’UTR-targeting morpholino also 
resulted in a curved body phenotype 72 hours post-fertilization, although the prevalence of this 
phenotype was weaker (56.5% of embryos) using the same ATG-targeting morpholino dose (Fig 
14A). When morpholino injection doses were individually titrated so that knockdown of either gene 
alone yielded almost no body curvature, the combined injection of nphp4 and jade-1 morpholinos at 
this dosage resulted in a body curvature phenotype in 31.5% of injected embryos. This genetic 
interaction indicates that Jade-1 and NPHP4 are involved in the same functional pathway in vivo (Fig 
14B).  
Furthermore, pronephric cysts were identified in developing embryos 72 hours after jade-1 
5’UTR morpholino injection (Fig 14C). Taken together these data support a model whereby reduced 
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expression of the canonical Wnt regulator Jade-1 contributes to kidney cyst formation, and this is 
exacerbated by reduced expression of the Jade-1 stabilizing protein NPHP4. 
 
Figure 14. Genetic interaction of Jade-1 and NPHP4 in the developing zebrafish embryo. 
Morpholinos targeting jade-1 or nphp4 were injected into zebrafish embryos at the 1-2 cell stage. 
Developing embryos were assessed 72 hours post fertilization (hpf) for body curvature, and were 
scored as positive only if the tail was angled more than 45° from the head-neck axis. This abnormal 
body curvature phenotype has previously been associated with mutations in cystic kidney causing 
disease genes, ciliary abnormalities, pronephric cysts, and defective Wnt signaling (see text). 
A. Representative images of 72 hpf embryos injected with nphp4 or jade-1 morpholinos as indicated. 
B. Injection doses of nphp4 and jade-1 ATG-targeting morpholinos were individually titrated to a 
concentration low enough to yield almost no obvious phenotype. The combination of these two 
morpholinos at this low concentration resulted in a dramatic increase in the occurrence of abnormal 
body curvature (F(2,8) = 25.35; p<0.001, Tukey’s post hoc test describes difference between 
combination and each individual condition, ** = p< 0.01; error bars indicate mean ± SE). C. Injection 
of the jade-1 5’UTR-targeting morpholino resulted in the development of pronephric cysts 
(arrowhead, upper panel; PT, pronephric tubule; PD, pronephric duct; G, glomerulum). All zebrafish 
experiments were performed in collaboration with Dr. Sandra Habbig and Dr. Julia Hatzold in the lab 
of Prof. Matthias Hammerschmidt. Data has been previously published in Borgal et al., 2012 (218). 
 
6.6 Classical β-catenin kinase CK1α phosphorylates Jade-1, abolishing negative Wnt 
regulation 
 
The ability of NPHP4 to stabilize Jade-1 protein levels and augment repression of canonical 
Wnt activity appears to be dependent on the ability of NPHP4 to alter the phosphorylation status of 
Jade-1: if phosphatase activity is inhibited by okadaic acid, NPHP4 can no longer stabilize Jade-1 (Fig 
12C). To determine whether phosphorylation of Jade-1 also contributes to regulation of canonical Wnt 
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activity, two candidate kinases were evaluated regarding their impact on Jade-1 phosphorylation 
status. CK1α and GSK3β are both integral kinase members of the constitutively active β-catenin 
destruction complex. When the canonical Wnt pathway is inactive, both of these kinases 
phosphorylate β-catenin to repress the Wnt signal, but when this Wnt pathway is active these kinases 
instead phosphorylate membrane-bound LRP5/6, augmenting the Wnt response (170). It was 
demonstrated that while both F.GSK3β and F.CK1 interact with V5.Jade-1, only F.CK1α altered the 
protein expression of V5.Jade-1 (Fig 15A). Specifically, F.CK1α increased the protein amount of, and 
interacting predominantly with, a V5.Jade-1 species of increased size suggestive of phosphorylation 
(Fig 15A). Whole cell lysate experiments confirmed that co-expression of F.NPHP4 stabilized the 
smaller species of V5.Jade-1 while co-expression of F.CK1α stabilized the larger species of V5.Jade-1 
(Fig 15B). Of interest, co-expression of F.NPHP4 with V5.Jade-1 further repressed the TOPflash Wnt 
reporter activity as was expected; however, the co-expression of F.CK1α completely abolished 
repression of the Wnt reporter by V5.Jade-1 (Fig 15C). Nevertheless V5.Jade-1 was still able to reduce 
the heightened Wnt reporter activity stimulated by F.CK1α, although the ability of V5.Jade-1 to do so 
was significantly reduced (Fig 15D). 
 
Figure 15. F.CK1α increases the expression size of V5.Jade-1 and abolishes repression of 
canonical Wnt reporter. 
A. HEK 293T cells were transiently transfected with V5.Jade-1 and either F.CK1α, F.GSK3β, 
F.NPHP4 as a positive control, or F.EPS1-225 as a negative control. After 24 hours cells the Flag tag 
was immunoprecipitated and all but the negative control protein were found to interact. Of note, only 
co-expression with F.CK1α led to an increase in V5.Jade-1 protein expression size. B. HEK 293T cells 
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were transiently transfected with V5.Jade-1 plus F.NPHP4 or F.CK1α and processed 24 hours later as 
a whole cell lysate. Co-expression of F.NPHP4 stabilized the smaller species of V5.Jade-1, while co-
expression of F.CK1α stabilized the larger species of V5.Jade-1. C. HEK 293T cells were transiently 
transfected with TOPflash and Renilla luciferase reporter plasmids, as well as F.β-catenin and 
experimental plasmids as indicated. Repression of Wnt reporter activity by V5.Jade-1 was augmented 
by F.NPHP4 but completely reversed in the presence of F.CK1α (error bars indicate mean ± SE) D. 
Data pairs from each experiment contributing to Figure 12C were analyzed in terms of the percentage 
that V5.Jade was able to reduce Wnt reporter activity in the presence of co-expressed empty vector, 
F.NPHP4, or F.CK1α. In the presence of empty vector or F.NPHP4, V5.Jade-1 reduced Wnt reporter 
activity by a further 50%; however, in the presence of F.CK1α, the ability of V5.Jade-1 to reduce Wnt 
reporter activity was significantly decreased. F(2,11)=78.72, p<0.0001; Tukey’s post hoc test indicates 
significance from both other conditions: ***=p<0.001; error bars indicate mean ± SE). 
 
 The consensus CK1 phosphorylation motif is (pS/pT)-x-x-(S/T), where a serine or threonine 
residue three positions downstream from a previously phosphorylated serine or threonine residue will 
be recognized and phosphorylated by CK1 (225). CK1 can also phosphorylate an unprimed consensus 
sequence of (D/E)-x-x-(S/T), but this must be preceded by multiple acidic residues to reach the same 
efficiency of a primed substrate (226). Jade-1 has previously been identified in mass spectrometry 
screens to be phosphorylated on several sites which could correspond to classical CK1 
phosphorylation motifs (227, 228; also see Fig 16A). To determine whether the increased size of over-
expressed Jade-1 in the presence of F.CK1α was due to phosphorylation on any of these motifs, mass 
spectrometry was performed on lysates prepared from HEK 293T cells expressing V5.Jade-1 alone or 
in combination with F.CK1. In both conditions, several published sites corresponding to the last serine 
or threonine of a potential CK1α phosphorylation motif were confirmed to be phosphorylated. 
Furthermore, one novel site corresponding to a CK1 motif was identified to be phosphorylated only in 
the presence of F.CK1α (Fig 16B). However, mutation of any of these sites to a nonpolar alanine did 
not reduce the ability of over-expressed F.CK1α to increase the expression size of V5.Jade-1 or alter 
the repression of β-catenin-stimulated TOPflash reporter activity (data not shown; Fig 16A). To 
narrow down the possible sites of action, truncation mutants were sub-cloned from V5.Jade-1 and 
expressed together with either F.CK1α or F.NPHP4. As suggested by the multitude of CK1 
phosphorylation motifs in this region, the Jade-1 N-terminus displayed profound size shifts when co-
expressed with F.CK1α, while the Jade-1 C-terminus was not affected (Fig16C). Of interest, F.NPHP4 
also did not affect the C-terminus of V5.Jade-1, but substantially stabilized both the middle and the N-
terminal segments (Fig 16D). However, in contrast to F.CK1 co-expression which specifically 
enhanced the larger band of the N-terminal V5.Jade-1 truncation, co-expression of F.NPHP4 
predominantly led to stabilization of the lower sized N-terminal fragment. It is furthermore noteworthy 
that in the latter case the larger band in the N-terminal truncation was also mildly stabilized, and in the 
middle segment of V5.Jade-1 the larger band was exclusively stabilized. This is could be due to 
secondary post-translational modifications acting on the partial protein, and indicates that the N-
terminal fragment is required for F.NPHP4 to stabilize the smaller form of full length V5.Jade-1.   
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Figure 16.  The Jade-1 N-terminus is regulated by both CK1α and NPHP4. 
A. Amino acid sequence of Jade-1 with all target serines of classical CK1 phosphorylation motifs 
underlined. Previously published phosphorylation sites identified by mass spectrometry screens are 
shown in red (227, 228). Novel phosphorylated serines identified by mass spectrometry are shown in 
blue. The presence of the letter “A” above a given amino acid indicates a point mutation to alanine. 
All point mutations except serines 18 and 20 had no effect on full-length Jade-1 phosphorylation by 
CK1α. B. HEK 293T cells were transiently transfected with V5.Jade-1 plus either F.CK1α or empty 
vector and were lysed 24 hours later in a buffer containining 8 M Urea and 50 mM ammonium 
bicarbonate. Peptides were digested using trypsin and phosphopeptides were enriched Fe-NTA 
immobilized metal affinity chromatography columns before analysis with LTQ Orbitrap XL mass 
spectrometer. A peak in V5.Jade-1 fragment 114-133 was detected only in lysates containing F.CK1α. 
The phosphorylated residue was identified as S121. C-D. HEK 293T cells were transiently transfected 
with truncations of V5.Jade-1 as indicated plus either empty vector or F.CK1α (C) / F.NPHP4 (D). 
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Cells were processed 24 hours later as a whole cell lysate. In both cases, the C-term truncation was not 
affected, but the N-terminal truncation showed stabilization of the larger band when co-expressed with 
F.CK1α (C), or the smaller band when co-expressed with F.NPHP4 (D). All mass spectrometry was 
performed in collaboration with Dr. Markus Rinschen in the CECAD Proteomics Facility run by 
Dr. Tobias Lamkemeyer. 
 
 The high concentration of serines in an N-terminal fragment of Jade-1 renders it difficult to 
identify by mass spectrometry which single residues might be phosphorylated in the presence of 
CK1α. Point mutation of CK1-target serines for all canonical sites attempted, including the newly 
identified site consisting of a CK1 motif where the target serine was phosphorylated only in the 
presence of F.CK1α, did not alter the ability of CK1α to phosphorylate V5.Jade-1. Therefore, point 
mutation of a putative unprimed CK1 phosphorylation site at S18 was attempted. This site, 
E-D-S-D-D-N-G-S, fulfills the unprimed CK1 motif requirement that a serine be preceded by multiple 
acidic residues immediately prior to the -3 position. Of note, the amino acid sequence continued from 
S18 to S20 is S-L-S, and this sequence is identical to the noncanonical motif reported at the only 
phosphorylation site that CK1 targets on β-catenin, S45 (225). In the case of β-catenin, CK1 
phosphorylates the first serine in this motif and does not require a previous priming event. Of interest, 
if this site on Jade-1 were to be recognized by CK1α, it would create an opportunity for sequential 
phosphorylation by CK1 of canonical motifs T21, S24, and S27. Point mutation of the serine at 
positions 18 to alanine reduced the size shifting effect of F.CK1 on V5.Jade-1. This effect was most 
pronounced when both serine 18 and serine 20 were changed to alanines (Fig 17A). Wnt reporter 
activity modification by the Jade-1 S18AS20A mutant was consistent with predictions based on 
previous data, although it was less dramatic than suggested by the biochemistry. The 
F.CK1α-mediated enhancement β-catenin-stimulated TOPflash reporter activity was significantly 
reduced in the presence of V5.Jade-1 S18AS20A, but not by wild-type V5.Jade-1 (Fig 17B). 
Conversely, the F.NPHP4-mediated decrease in TOPflash reporter activity was augmented in the 
presence of both V5.Jade-1 species (Fig 17C).   
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Figure 17. Point mutations of V5.Jade-1 alter the influence of CK1α but not NPHP4. 
HEK 293T cells were transiently transfected with the indicated expression vectors and were processed 
as whole cell lysates after 24 hours. A. Co-expression with F.CK1α increased protein expression size 
of wild-type V5.Jade-1 but this effect was reduced for the V5.Jade-1 S18AS20A mutant. B. Co-
expression with F.NPHP4 reduced protein expression size of V5.Jade-1 and stabilizes V5.Jade-1 
S18AS20A. Note that in both experiments under basal conditions V5.Jade-1 S18AS20A is reduced in 
size compared to wild-type V5.Jade-1, indicating a lack of endogenous phosphorylation by CK1. C & 
D. HEK 293T cells were transiently transfected with F.β-catenin and TOPflash reporter plasmid, 
constitutively active Renilla luciferase, and experimental plasmids together with either F.CK1α (C) or 
F.NPHP4 (D). Cells were lysed after 24 hours and luciferase activity stimulated by F.β-catenin alone 
was set to 100% for each experiment. Data were then normalized for each experiment so that the 
increase in signal by F.CK1α in the presence of empty vector (C), or the decrease in signal by 
F.NPHP4 in the presence of empty vector (D) was set to 100%. C. The V5.Jade-1 S18AS20A mutant 
significantly reduced the ability of F.CK1α to increase reporter activation, while wild-type V5.Jade-1 
expression did not (F(2,11)=13.52, p=0.006; Tukey’s post hoc test as indicated: **=p<0.01; error bars 
indicate mean ± SE). D. Both V5.Jade-1 species significantly augmented the decrease in reporter 
activity by F.NPHP4 (F(2,11)=52.30, p=0.0002; Tukey’s post hoc test as indicated: ***=p<0.001; 
error bars indicate mean ± SE).  
 
 The increased Wnt reporter activity in the presence of F.CK1α was not predicted. CK1α is a 
well established member of the β-catenin destruction complex and would be expected to contribute to 
the phosphorylation and degradation of endogenous or over-expressed β-catenin. However, CK1 
induces secondary body axis in Xenopus embryos (229) and inhibiting CK1 generates a loss-of-Wnt 
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mom (more mesoderm) phenotype in C. elegans (230), therefore CK1 was originally identified as a 
transducer of Wnt signaling. More recently CK1α has been shown to phosphorylate LRP, contributing 
to the Wnt response (170), therefore the action of CK1α could be context dependent. However, when 
the relationship between over-expressed F.CK1α and F.β-catenin was investigated, it was found that 
protein expression of F.CK1α was reduced in the presence of F.β-catenin (Fig 18A). In contrast, 
expression of the same level of F.β-catenin did not reduce protein expression of V5.Jade-1 (Fig 18B). 
However, when plasmid transfection amount of F.β-catenin was increased by a factor of five, 
V5.Jade-1 protein expression was reduced in a similar fashion to that of F.CK1α (Fig 18B). In line 
with this, over-expression of V5.Jade-1 in a TOPflash reporter assay when F.β-catenin plasmid 
transfection was increased by a factor of five resulted in increased stimulation rather than abrogation 
of the TOPflash reporter luciferase expression (Fig 18C). These data indicate that over-expressed 
β-catenin is able to stimulate degradation of negative canonical Wnt regulating proteins, although it 
does so at different thresholds. 
 
Figure 18. Increased expression of F.β-catenin reduces protein levels of V5.Jade and F.CK1α at 
different thresholds. 
A. HEK 293T cells were transiently transfected with a master mix of F.CK1α plus indicated plasmids 
and processed 24 hours later as a whole cells lysate. Both low and high amounts of transfected F.β-
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catenin were able to reduce protein expression of F.CK1α. B. HEK 293T cells were transiently 
transfected with a master mix of V5.Jade-1 plus indicated plasmids and processed 24 later as a whole 
cells lysate. Only a high amount of transfected F.β-catenin was able to reduce protein expression of 
V5.Jade-1. C. HEK 293T cells were transiently transfected with TOPflash reporter plasmid plus 
constitutively active Renilla luciferase, together with experimental plasmids as indicated. A high 
transfection dose of F.β-catenin increased reporter activity substantially (left panel). When reporter 
activaty was set to 100% independently for the high- and low-dose conditions, TOPflash stimulation 
by low levels of F.β-catenin was signifantly reduced by V5.Jade-1 expression (t(3) = 4.978, 
* = p = 0.01; error bars indicate mean ± SE), whereas reporter activity stimulated by high levels of 
F.β-catenin was increased by V5.Jade-1 expression, although this did not reach significance 
(t(3) = 2.309, p = 0.1; error bars indicate mean ± SE).   
 
6.7 Perspectives: CK1-mediated phosphorylation of Jade-1 by PLK1. 
 
 Altered Wnt regulation due to Jade-1 phosphorylation by CK1α could impact a multitude of 
downstream events. One clue regarding possible biological effects can be derived from the second 
novel phosphorylation site identified on V5.Jade-1 by mass spectrometry (Fig 16A). Serine 377 of 
V5.Jade-1 was phosphorylated only in the presence of over-expressed F.CK1α (Fig 19A), but this site 
does not correspond to either a primed or unprimed CK1 phosphorylation motif. Instead, the 
phosphorylation site surrounding serine 377 on V5.Jade-1 was a close match to the consensus 
phosphorylation motif of Polo-like kinase 1 (PLK1) which is D/E-X-S/T-φ-X-D/E where φ = any 
hydrophobic residue. The putative phosphorylation motif recognized on V5.Jade-1 was E-E-S-L-G-K, 
which fulfilled the criteria with the exception that the last residue was basic rather than acidic 
(Fig 19B).  
 Of interest, the minimum requirement for a Polobox-domain (PBD) binding motif is a serine 
immediately preceding a phosphorylated serine or threonine (231). An S-pT motif exists in the N-
terminus of Jade-1, where the phosphorylated threonine at T21 could be the target of a CK1α motif 
providing the unprimed CK1α target S18 had previously been phosphorylated (Fig 16B, Fig13A). To 
determine whether CK1α-mediated phoshorylation at this site by PLK1 was a possibility, F.PLK1 or a 
control protein were co-expressed with V5.Jade-1 and the Flag protein was immune-precipitated.  
V5.Jade-1 co-precipitated with F.PLK1 but not with a control protein (Fig 19C). The Flag-tagged 
smear corresponding to F.PLK is suggestive of post-translational modification in the presence of 
V5.Jade-1. 
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Figure 19.Jade-1 is phosphorylated in the presence of CK1 on a PLK1-like motif. 
A. HEK 293T cells were lysed 24 hours after being transiently tranfected with V5.Jade-1 plus either 
F.CK1α or empty vector in an 8M Urea buffer with 50mM ammonium bicarbonate. Peptides were 
digested in trypsin and phosphopeptides were enriched using Fe-NTA immobilized metal affinity 
chromatography columns before analysis with LTQ Orbitrap XL mass spectrometer. A peak in 
V5.Jade-1 fragment 373-394 was detected only in lysates containing F.CK1α. The phosphorylated 
residue was identified as S377. B. The motif containing S377 did not resemble a CK1 phosphorylation 
motif and instead was similar to a PLK1 consensus motif. The minimum requirement for a polobox-
domain binding motif is located at Jade-1 residues 20-21, and the required phosphorylation at T21 
matches the target of a canonical CK1 phosphorylation motif. C. HEK 293T cells were transiently 
transfected with V5.Jade-1 and either F.PLK1 or a control protein (F.EPS1-225) for 24 hours. 
Immunoprecipitation was performed using an anti-Flag antibody and V5.Jade-1 co-precipitated with 
F.PLK1 but not the control protein. All mass spectrometry was performed in collaboration with 
Dr. Markus Rinschen in the CECAD Proteomics Facility run by Dr. Tobias Lamkemeyer. 
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7 DISCUSSION 
 
 A growing body of evidence links renal cyst formation to the dysfunction of cell signaling 
pathways mediated by the primary cilium, including the canonical Wnt signaling pathway. The current 
work further links ciliary proteins to canonical Wnt regulation by providing evidence that the 
canonical Wnt regulator Jade-1 is a part of the nephrocystin protein complex. It has recently been 
demonstrated that the single-subunit E3 ubiquitin ligase Jade-1 targets cytosolic and nuclear β-catenin, 
the main effector of canonical Wnt target gene activation, for proteasomal degradation and in doing so 
negatively regulates canonical Wnt signaling (198). The current work demonstrates that Jade-1 
localizes to the centrosome and primary cilium where it interacts with members of the NPH protein 
complex. Jade-1 protein levels are stabilized by NPHP4, which facilitates Jade-1 nuclear translocation 
in a phosphatase-dependent manner. Jade-1 and NPHP4 cooperatively restrain β-catenin signaling, and 
this cooperation is maintained in vivo. The classical β-catenin kinase CK1α phosphorylates Jade-1, 
which abrogates negative Wnt regulation. A novel Jade-1 phosphorylation site identified in the 
presence of CK1α closely resembles a PLK1 phosphorylation motif. PLK1 interacts with Jade-1 and 
may represent a link between Jade-1, NPH proteins, and the cell cycle. Parts of this work pertaining to 
nuclear translocation of Jade-1 by NPHP4 have been previously published in Borgal et al., 2012 (218), 
as indicated in the figure legends. 
  
7.1 Jade-1 is a novel member of the nephrocystin protein complex at the ciliary region. 
  
 In agreement with previous reports, endogenous Jade-1 localized to both the cytosol and 
nucleus, excluding nucleoli (196–198).  The current work has additionally identified endogenous Jade-
1 at the centrosome and within the primary cilium using three independent commercial antibodies. 
Although Jade-1 was most often visualized as a concentration in the nucleus and at the centrosome, 
the dynamic nature of this protein was apparent when comparing neighbouring cells from the same 
experiment.  A minority of cells consistently displayed exceptionally intense nuclear or ciliary 
staining, while other cells were void of nuclear Jade-1 and many cells displayed a peri-nuclear staining 
pattern. The factors influencing Jade-1 localization are not known, and the variation reported here was 
not readily explained by any obvious change in cell cycle status or ciliary length. 
 Despite inter-cellular variation in nuclear or ciliary staining intensities, Jade-1 was 
consistently observed to be present at the centrosome of interphase cells and mitotic spindle of 
dividing cells. Jade-1 was verified to be a component of the centrosome complex independent of 
microtubule transport, and was found to co-localize with transition zone marker NPHP1. Several NPH 
proteins co-localize at the basal-body or transition zone (14, 23), and are therefore well positioned to 
interact with Jade-1. To determine whether any of the NPH proteins were candidates to influence the 
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ability of Jade-1 to negatively regulate canonical Wnt signaling, NPH proteins were screened by co-
precipitation for an interaction with V5.Jade-1, and were assessed for their ability to restrain canonical 
Wnt signaling. V5.Jade-1 was co-precipitated by all NPH proteins tested: F.NPHP1, F.NPHP2, 
F.NPHP3, F.NPHP4, F.NPHP5, F.NPHP7, F.NPHP8, and F.NPHP9. However, the strength of 
interaction was variable between proteins as well as between experiments, and analysis of IP lysates 
indicated that the effect of the different overexpressed NPH proteins could differentially regulate 
V5.Jade-1. Through the last decade several studies have suggested that NPHP proteins form a 
common protein complex in which NPHP1 serves as a scaffolding protein (232–234).  A recent study 
based on tandem affinity purification and mass spectrometry confirmed this and reported NPHP1, 4, 
and 8 to complex separately from NPHP5 and NPHP6 (14). This study also reported that NPHP1, 
NPHP4, and NPHP8 localize specifically to the transition zone while NPHP2, NPHP3, and NPHP9 
localize to the “inversin compartment” at the proximal cilium, and NPHP2, NPHP5, and NPHP6 
localize to the basal body. The differential regulation of over-expressed V5.Jade-1 by various over-
expressed NPH proteins could reflect a role for each of the NPH proteins in the dynamic expression 
pattern of endogenous Jade-1.  NPHP2, NPHP3, NPHP4 and NPHP7 have previously been identified 
as negative canonical Wnt regulators (178, 192, 193, 195). Confirming and extending this, all tested 
NPH proteins restrained rather than amplified canonical Wnt reporter activity. Strikingly, at very low 
doses NPHP4 and NPHP9 maintained a profound effect. The interaction between V5.Jade-1 and 
F.NPHP4 was more robust than that observed for V5.Jade-1 and F.NPHP9, which suggested NPHP4 
may be an optimal candidate to continue to investigate in terms of Wnt regulation via Jade-1. Since all 
NPH proteins complex together in vivo and are therefore likely to interact in vitro, further 
confirmation of endogenous interaction was also sought by co-localization studies described in the 
next section.  
 
7.2 NPHP4 increases nuclear translocation of Jade-1 in a phosphorylation dependent 
manner. 
 
 The interaction between F.NPHP4 and V5.Jade-1 was confirmed by reciprocal co-
immunoprecipitation experiments, and endogenous Jade-1 was further demonstrated to co-precipitate 
with over-expressed F.NPHP4. Endogenous NPHP4 and Jade-1 were also visualized by 
immunofluorescence to localize in close proximity at the primary cilium of serum-starved RPE-1 cells. 
Endogenous NPHP4 immunofluorescence was consistently observed in a peri-nuclear pattern, which 
demonstrated a striking co-localization with endogenous Jade-1 in cells where Jade-1 was 
predominantly non-nuclear. Closer examination of lysates from co-precipitation experiments revealed 
that co-expression of F.NPHP4 decreased V5.Jade-1 in the mostly cytosolic IP lysate but increased 
V5.Jade-1 protein levels in a whole cell lysate taken from the same experiment. Taken together with 
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their peri-nuclear co-localization, these data suggested that NPHP4 was in a prime position to stabilize 
and enhance nuclear translocation of Jade-1.  
To validate this, stabilization of V5.Jade-1 by V5.NPHP4 was first confirmed and 
demonstrated to be specific, as over-expressed V5.NPHP4 did not stabilize the co-expressed control 
protein V5.GFP.  Analysis by qPCR revealed that V5.NPHP4 overexpression did not alter 
transcription rates of endogenous Jade-1. Instead, over-expression of V5.NPHP4 stabilizes V5.Jade-1 
by protecting it from proteasomal degradation, as the stabilization of V5.Jade-1 by the proteasome 
inhibitor MG132 was not further enhanced in the presence of V5.NPHP4. Over-expressed V5.Jade-1 
was consistently visualized in western blot experiments as a double band, and it was the smaller of 
these two bands that was predominantly stabilized by V5.NPHP4, indicating that NPHP4 might 
influence the phosphorylation status of Jade-1. Co-expression of V5.NPHP4 and V5.Jade-1 in the 
presence of the phosphatase inhibitor okadaic acid abrogated the ability of V5.NPHP4 to stabilize 
V5.Jade-1. Cell fractionation revealed that under standard conditions the smaller V5.Jade-1 species 
localizes within the cytosol, whereas the larger species is nuclear. Over-expression of V5.NPHP4 
causes a shift of the smaller Jade-1 species from the cytosol to the nucleus. Under basal conditions 
V5.Jade-1 was observed in immunofluorescence and in western blot to localize primarily to the 
nucleus; however, in the presence of okadaic acid V5.Jade-1 accumulated in the cytosol. Taken 
together, these data support a scenario whereby NPHP4 leads to the protein stabilization of Jade-1 
either by increasing phosphatase activity or by blocking kinase access to phosphorylation sites on 
Jade-1. The non-phosphorylated form of Jade-1 could then escape proteasomal degradation and 
instead be able to enter the nucleus where it is again phosphorylated by nuclear kinases.  
The perinuclear localization of endogenous NPHP4 renders it optimally localized to influence 
nuclear trafficking. In cell fraction experiments over-expressed V5.NPHP4 associated with the nuclear 
fraction in contrast to the cytosolic fractionation of control protein V5.EPS1-225. However, like 
endogenous NPHP4, over-expressed F.NPHP4 was not observed to be nuclear by 
immunofluorescence staining. These data support a close physical relationship between NPHP4 and 
the nuclear envelope. Recent parallels have been drawn between the function of the nuclear pore and 
ciliary/flagellar pore complexes (75, 78), and several classical proteins required for nuclear import and 
export are described as a part of the ciliary proteome (59). Furthermore, NPH and other ciliopathy 
proteins have been demonstrated to provide a specific role in the ciliary pore complex at the transition 
zone (109). The presence of NPHP4 at both the cilium and the perinuclear compartment may reflect 
similar functions involving the regulation of protein import and/or export at each of these locations. 
NPHP4 may therefore represent a novel example in a growing list of proteins that function at both the 
CPC and NPC. The question regarding whether NPC and CPC proteins simply serve the same role at 
separate locations or whether these proteins represent a specific communication link between the 
cilium and the nucleus remains to be addressed. 
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7.3 NPHP4 and Jade-1 additively regulate canonical Wnt signaling. 
 
 NPHP4 and Jade-1 have previously been independently shown to restrain canonical Wnt 
signaling (193, 198). The current data demonstrate that these two proteins act cooperatively to do so: 
the additive reduction in F.β-catenin-stimulated TOPflash TCF/LEF reporter activity by V5.NPHP4 
and V5.Jade-1 would not have been observed if these proteins influenced β-catenin in a mutually 
exclusive fashion. To emphasize this, expression of a control protein was not able to augment the 
effect of either V5.Jade-1 or V5.NPHP4. In addition to reduction of reporter activity, the combined 
over-expression of V5.Jade-1 and V5.NPHP4 were able to reduce protein expression of the canonical 
Wnt target gene cMYC. Neither V5.Jade-1 nor V5.NPHP4 were able to reduce reporter activity 
stimulated by an S33A mutant version of F.β-catenin which cannot be phosphorylated, indicating the 
effect of both proteins depended on their ability to influence the recognition of β-catenin by the 
proteasome. Of interest, phosphorylated β-catenin accumulates at the basal body while the S33A β-
catenin mutant does not (235), which may hint that the regulation of β-catenin by Jade-1 and NPHP4 
requires events occurring at this location. Knockdown of endogenous NPHP4 led to significantly 
enhanced Wnt reporter activity, which could be rescued by over-expression of V5.Jade-1. However, in 
these conditions V5.Jade-1 was significantly less effective than when co-transfected with scrambled 
siRNA. This suggests that the ability of Jade-1 to ubiquitinate β-catenin reaches maximum efficiency 
only in the presence of NPHP4, likely due to protein stabilization and the enhanced opportunity for 
Jade-1 to ubiquitinate nuclear β-catenin. Knockdown of endogenous Jade-1 reduced the efficiency of 
V5.NPHP4 in restraining Wnt reporter activity, but there was substantial variability in this effect 
which indicates that Jade-1 is not the only route through which NPHP4 acts. Indeed, it was recently 
demonstrated that NPHP4 can also regulate canonical Wnt signaling by decreasing the protein level of 
the canonical Wnt activator Dsh upstream of β-catenin (193). It is relevant to note that low amounts of 
Wnt3a can induce a rapid increase in β-catenin without Dsh involvement (236), which opens up the 
intruiging possibility that NPHP4 moderates Wnt signaling via Jade-1 in situations of low level β-
catenin activation but can influence Dsh when β-catenin levels increase. Indeed, the interaction 
between Jade-1 and β-catenin is reduced when Wnt3a is present (198). 
Cooperation between Jade-1 and NPHP4 was supported by the in vivo demonstration of a 
genetic interaction using the developing zebrafish embryo. Morpholino knockdown of each of these 
proteins led to a curved body phenotype which was similar to that reported after morpholino 
knockdown of the known Wnt regulator and cystic kidney causing gene nphp2/inversin (178). This 
phenotype was also recently reported by two independent groups after nphp4 knockdown (193, 221), 
where nphp4 morphants were further demonstrated to have ciliary defects and develop pronephric 
cysts. In accordance with an established link between body curvature, pronephric cysts and ciliary 
defects (222, 223), pronephric cysts were identified in jade-1 morphants displaying body axis 
curvature. The similarity of these phenotypes strongly suggests Wnt deregulation and/or ciliary 
dysfunction in both the nphp4 and jade-1 morphants. Of note, zebrafish body curvature in nphp4 
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morphant embryos was much more frequent than in jade-1 morphants, mirroring the difference in 
potency observed in the regulation of Wnt gene activity by NPHP4 versus Jade-1 in the reporter assays 
described above. This difference may be due either to multiple roles in Wnt regulation for NPHP4 or 
to mechanisms in place to compensate for a loss of Jade-1; either scenario would mean that a loss of 
NPHP4 would have more dramatic consequences. Taken together, these data support a model whereby 
NPHP4 acts through multiple mechanisms to regulate canonical Wnt signaling, one of these being the 
stabilization of the β-catenin ubiquitin ligase Jade-1. 
  
7.4 Phosphorylation of Jade-1 by CK1α abrogates negative Wnt regulation. 
  
 Stabilization of the smaller of the two V5.Jade-1 species by V5.NPHP4 was consistently 
observed by western blot, and this stabilization was dependent on phosphatase activity. To determine 
whether the larger version of V5.Jade-1 could be a result of phosphorylation and whether this 
phosphorylation played a specific role in Wnt regulation, it was first evaluated whether Jade-1 
interacted with any of the classical kinases within the canonical Wnt signaling pathway. Within the 
destruction complex, CK1α primes β-catenin for sequential phosphorylation by GSK3β, leading to 
ubiquitination of cytosolic β-catenin by β-TrCP which targets β-catenin for proteasomal degradation 
(156, 157). Although V5.Jade-1 co-precipitated with F.GSK3β and F.CK1α, only co-expression of 
F.CK1α resulted in an increase in V5.Jade-1 protein expression size. Indeed, F.CK1α appeared to 
stably interact only with this larger version of V5.Jade-1. While the phosphatase-dependent 
stabilization of Jade-1 by NPHP4 further repressed Wnt gene activation, expression of F.CK1α 
increased Wnt reporter activity. Co-expression of V5.Jade-1 in this condition was still able to restrain 
the F.CK1α-mediated enhancement of Wnt reporter activity; however, the ability of V5.Jade-1 to do 
so was markedly reduced. F.CK1α did not reduce protein expression of V5.Jade-1, indicating instead 
that phosphorylation of Jade-1 by CK1α abrogates the ability of Jade-1 to ubiquitinate β-catenin. 
 
7.4.1 CK1α phosphorylates Jade-1 and β-catenin using the same motif 
 
 Mass spectrometry confirmed the presence of several previously published phosphorylated 
serines and identified two novel Jade-1 phosphorylation sites which were only detected when Jade-1 
was co-expressed with CK1α. However, point mutation of any of these serines to alanine did not alter 
the ability of F.CK1α to phosphorylate V5.Jade-1. Truncations of V5.Jade-1 expressed in the presence 
or absence of F.CK1α or F.NPHP4 revealed that in both cases the N-terminus was modified while the 
C-terminus was completely unaltered. The N-terminus of Jade-1 contains many classical CK1 
phosphorylation motifs, several of which are positioned so that the phosphorylation of the target serine 
by CK1 creates the subsequent CK1 phosphorylation motif. CK1 has previously been demonstrated to 
be a kinase capable of sequential phosphorylation of target proteins (237); however, the initial serine 
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in such a cascade must be previously phosphorylated. In the case of Jade-1, the initial serine in a 
cascade of three sequential CK1α phosphorylation motifs corresponds to an unprimed CK1α 
consensus motif, meaning that CK1α would be capable of priming its own sequential phosphorylation 
of Jade-1. The serine in this unprimed CK1α motif, S18, follows a congregation of acidic residues 
which are required for unprimed CK1α phosphorylation (226). Of note, the sequence following S18 is 
S - L - S, which is identical to the noncanonical unprimed motif that CK1α phosphorylates on β-
catenin to prime sequential phosphorylation by GSK3β within the destruction complex (225). This 
sequence is also contained within the adenomatous polyposis coli (APC) protein, which is a member 
of the β-catenin destruction complex. Unprimed phosphorylation of S1505 on APC by CK1 initiates a 
cascade of phosphorylation by CK1 and GSK3β that releases β-catenin from binding within the 
destruction complex (238). Point mutation of the S18 and S20 residues on Jade-1 abolished the CK1α-
induced size shift of Jade-1. Co-expression of the S18AS20A mutant also impaired the ability of 
CK1α over-expression to increase canonical Wnt reporter activity more than co-expression of wild-
type Jade-1 was able to. However, CK1α was still able to increase Wnt reporter activity in these 
conditions, indicating that the action of phosphorylating Jade-1 is not the only contributor to this effect 
or that endogenous Jade-1 can still play a major role.  
 It is interesting to note that the same motif that is phosphorylated by CK1α on β-catenin is also 
phosphorylated by CK1α on Jade-1, with opposing effects: phosphorylation of S45 on β-catenin 
negatively regulates canonical Wnt signaling by priming cytosolic β-catenin for ubiquitination and 
subsequent degradation, whereas phosphorylation of the S18-S20 sequence on Jade-1 abrogates the 
ability of Jade-1 to contribute to β-catenin ubiquitination. Physiologically, these CK1α-mediated 
phosphorylation events might be separated temporally or spatially. Jade-1 has been reported to 
ubiquitinate nuclear and cytosolic β-catenin, whereas CK1α is mainly considered to regulate β-catenin 
via its cytosolic role in the destruction complex (156, 157), although a larger CK1α splice variant may 
have a nuclear role (239) and many destruction complex components are also found in the nucleus 
(240). The influence of CK1α may therefore depend on other cellular events governing access of this 
kinase to each substrate. Temporal regulation may depend on the activation status of Wnt signaling 
and the β-catenin destruction complex. A prime example of temporal regulation within the Wnt 
pathway is given by the classical Wnt kinases CK1α and GSK3β. Phosphorylation of cytosolic β-
catenin requires CK1α and GSK3β to work cooperatively within the destruction complex. When a Wnt 
ligand binds to a Fz receptor, the entire destruction complex is relocated to bind with LRP5/6 and Fz 
at the plasma membrane, where CK1α and GSK3β are required to phosphorylate LRP5/6 and enable 
the LRP-mediated Wnt response (170, 171, 241). The role of CK1α in facilitating Wnt signaling 
appears to be limited to this immediate event: it is complexes with LRP and axin at 30 minutes but not 
2 hours after Wnt stimulation (242). Binding of a Wnt ligand recruits E-cadherin and p120-catenin to 
the LRP/Fz complex, creating a Wnt “signalosome” that is capable of phosphorylating Dsh and 
initiating the canonical Wnt signaling cascade. After the initial 30 minutes of signalosome function, 
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CK1α phosphorylates E-cadherin and this releases p120-catenin from the Wnt signalosome, 
preventing continued Dsh-2 phosphorylation and contributing to “turning off” the Wnt pathway (242). 
This series of events means that CK1α, a kinase that constitutively acts to restrain inappropriate β-
catenin activation, responds to a Wnt signaling event by temporally regulated opposing responses: 
initially CK1α contributes to signal propagation but it subsequently disables a prolonged response.  
 
7.4.2 Exogenous β-catenin causes CK1α and Jade-1 degradation at different thresholds 
  
 This duplicity of CK1α function might help to explain results showing that CK1α knockdown 
decreased Wnt3a-induced TOPflash reporter activity despite increasing β-catenin protein level (242). 
The current results show a converse contradiction: over-expression of CK1α increased TOPflash 
reporter Wnt gene activity. Based on the above discussion, without Wnt stimulation and LRP/Fz 
signalosome activation CK1α should be predominantly active at the destruction complex and act as a 
negative regulator. Further investigation of the current results yielded surprising data showing that 
exogenous β-catenin decreased expression of F.CK1α. The reduction of a negative regulator would 
therefore allow for increased reporter activity; however, because some of the over-expressed CK1α 
was nevertheless present, it is likely that the presence of high levels of β-catenin stimulated other 
cellular events which heightened reporter activity not only through repressing CK1α expression.  
 Recent mathematical modeling combined with experimental confirmation in Xenopus embryos 
has demonstrated Wnt gene transcription is sensitive to fold-change rather than absolute β-catenin 
levels, and can buffer response to β-catenin fluctuation of up to four-fold which would be present in 
naturally occurring noise (243). When exogenous β-catenin was increased five-fold, V5.Jade-1 was 
also decreased. These results suggest that an increase in cellular β-catenin not only initiates events 
leading to its destruction, such as increased rate of destruction complex turnover, but that it also 
stimulates events leading to the degradation of its negative regulators and the system targets different 
proteins depending on threshold levels of activation. For example, downregulation of protein levels of 
CK1α required only a low amount of β-catenin, and led to a dramatic increase in Wnt reporter activity, 
whereas downregulation of Jade-1 required a 5-fold increase in over-expressed β-catenin, and resulted 
in a comparatively mild signal augmentation. The difference in thresholds for these events may 
contribute to the temporal regulation necessary for operational transients of β-catenin activation to 
occur.  
 In general, a pattern has emerged over the last decade of research whereby Wnt signal itself 
has been shown to initiate its own downregulation. On a genetic level, Wnt signaling increases 
transcription rate of the secreted Wnt inhibitor Dickkopf 1 (244, 245) and the destruction complex 
rate-limiting factor Axin2 (246, 247). On a protein level, not only does the signalosome inactivate 
itself as described above, but also the destruction complex increases turnover rate in response to higher 
concentrations of β-catenin: in these conditions non-phosphorylated APC is also able to bind β-
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catenin, although this is with reduced affinity compared to phosphorylated APC in low β-catenin 
conditions thereby increasing the rate of β-catenin turnover at the destruction complex (248). While 
the multiple mechanisms in place to restrain β-catenin signaling have been extensively studied, the 
mechanisms that β-catenin uses to overcome these are less well understood. Perhaps, the evolution of 
this pathway to use the same players in different contexts ensures negative regulators were “otherwise 
engaged” for a specific amount of time so that an effective signal can be achieved when required. This 
activation then triggers multiple system termination processes; a phenomenon which is telling in terms 
of how important it is that the pathway does not remain in a prolonged active state. Indeed, disruption 
of this process is well known to contribute to multiple forms of carcinoma (155, 249, 250). If 
heightened Wnt signaling has the potential for disaster, why has activation of this pathway in adults 
been maintained by evolution?  Several lines of evidence exist to suggest that isolated re-activation of 
Wnt signaling is as critical for tissue maintenance in adults as gradient-based signaling is during tissue 
development in embryogenesis. A paradigm involving isolated and strictly controlled signaling 
activity may help to explain the complex roles of CK1α, Jade-1 and NPHP4. 
 
7.5 Requirement and regulation of Wnt/β-catenin signaling in the adult kidney: possible 
roles for Jade-1 and nephrocystin proteins. 
 
7.5.1 Wnt signaling defects during development do not explain cyst formation in NPH 
 
 In order to determine the roles for Jade-1 and NPH proteins in regulating canonical Wnt 
activity in healthy versus diseased adult tissue, the contributing factors regulating each of the Wnt 
signaling pathways during embryogenesis and in adulthood must be understood. Although much is yet 
to be discovered, the requirement for canonical Wnt/β-catenin signaling during kidney development is 
well known. Wnt9b and Wnt4 act sequentially through β-catenin signaling to induce uretic branching 
and generate epithelial renal vesicles within the metanephric mesenchyme (251–253). However, β-
catenin signaling must subsequently be attenuated in order to complete epithelial development (251, 
254). In mice, β-catenin signaling is downregulated in the first week of age and disappears completely 
by 3 weeks of age (179), which is accompanied by changes in gene expression including Wnt targets 
(255). As the current data has shown the NPH proteins to be involved in negative canonical Wnt 
regulation, it is possible that this switch critically relies on the NPH protein complex. However, 
kidneys in NPH are normal at birth, and cysts generally do not form until after the first several years of 
life. Therefore, the requirement of NPH complex function might be more critical in regulating events 
occuring after development. 
 After birth, directed cell movements contribute to the convergent extension required for 
elongation of kidney tubules. The intercalation of cells during convergent extension requires Wnt 
signaling via the β-catenin independent PCP pathway (167, 256). PCP signaling also contributes to 
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oriented cell division, disruption of which is associated with cyst formation as cells no longer divide 
along the plane of the tubule (162, 257–259). However, disruption of oriented cell division does not 
precede initial cyst expansion (163), and spindle orientation in dividing cells is random prior to birth 
despite decreasing cell number in tubule circumference (167), which indicates that pathological tubule 
expansion might result primarily from deficits in Wnt/PCP-controlled directed convergent extension 
(256). However, as mentioned above, in contrast to developmental cystic kidney diseases such as 
ARPKD, disruption of the required developmental switch between canonical Wnt and planar cell 
polarity signaling does not offer a ready explanation for inherited diseases in which kidney cysts are 
seen later in life, such as ADPKD or NPH. Cyst formation later in life might instead reflect a failure to 
maintain, rather than to form, polarized kidney tubules.  
 
7.5.2 The Wnt signaling pathways are required for injury repair 
 
 The data in the current work demonstrate a complex relationship between β-catenin and its 
negative regulators Jade-1, CK1α, and NPHP4. Each of these negative regulators can modify the 
efficiency of another, acting in concert or in competition. Furthermore, the efficiency of Jade-1 and 
CK1α to regulate β-catenin is dependent upon the amount of free β-catenin present, whilst NPHP4 did 
not appear to be affected by this. In order to clarify a biological role for these proteins, it appears that 
the cellular status regarding amount of free β-catenin must be taken into consideration. Although free 
β-catenin is kept at low levels in differentiated epithelia, activation of Wnt signaling during kidney 
tubule maintenance events might create “windows” of β-catenin activity which change the role of 
proteins regulating, or regulated by, the Wnt pathways. It is therefore important to understand the 
events contributing to β-catenin signaling activity in adult renal epithelia, in order to understand how a 
mutation altering the function of the NPH protein complex might disrupt this. 
 Throughout life, renal tubules are constantly subject to damage by obstructive, ischemic or 
toxic insults, and must be able to proliferate to replace lost cells. Current models suggest cyst 
expansion could occur due to disrupted injury repair in the kidney (260, 261). Indeed, conditional 
knockout of the Pkd1 gene causes adult mice to slowly develop focal kidney cysts over four months, 
but these mice show severe cyst progression only 4-10 weeks after nephrotoxic or ischemic renal 
injury (187, 262). In these mice, canonical Wnt activators were abnormally upregulated while negative 
regulators were downregulated compared to wild-type injured mice or knockouts without injury (187), 
indicating that cyst formation involves excessive canonical Wnt signaling. However, a similar 
phenotype was observed in Ahi1 knockout mice (263). Loss of the AHI1 in humans causes Joubert 
syndrome, a ciliopathy associated with NPH. Ahi1-null mice are born with normal kidneys but develop 
NPH at around 5 months of age, which is accelerated dramatically after nephrotoxic or ischemic renal 
injury. Surprisingly Jbn, the protein product of the Ahi1 gene, was required for activation of the 
canonical Wnt pathway, and this Wnt activation was required for repair after renal injury. Of interest, 
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in wild-type animals canonical Wnt reporter activity was specifically enhanced at the cortico-
medullary boundary after injury, which is the region prone to cyst formation in NPH. While this data 
seemingly contradicts the canonical Wnt overactivation reported in Pkd1 mutant mice, it mirrors the 
contradictory reports that either gain- or loss-of-function of β-catenin signaling can lead to renal cyst 
formation (158–161) and fits into a model whereby Wnt/β-catenin signaling is necessary for initial 
proliferation following renal injury but must be down-regulated to allow for PCP signaling required 
for differentiation of replacement cells (261). Data exists to suggest that injury-induced proliferating 
cells are de-differentiated tubular epithelial cells undergoing epithelial-mesenchymal-epithelial cycling 
(264). In support of this, fate-mapping of tubular repair in vivo demonstrated that de-differentiated 
epithelial cells are responsible for tubule repair (265) but revealed that these cells only share some 
features with fibroblasts and do not exit the tubule to contribute to the inter-stitial fibrotic response, 
which is due instead to pericyte-derived myofibroblasts also upregulated after injury (266). Although 
many of the processes contributing to these events are not yet known, evidence exists to support the 
requirement of both Wnt/β-catenin and Wnt/PCP signaling in injury repair (187, 259, 267–272). 
 
7.5.3 Different mechanisms of canonical Wnt activation during injury repair and 
development: roles for cystoproteins at the primary cilium and cell-to-cell contacts. 
 
 The localization of many NPH proteins to both the primary cilium and cell-to-cell contacts 
suggests that these cellular regions might play an important role in the ability of epithelial cells to 
initiate signaling pathways in response to injury. In this work, Jade-1 was demonstrated to also 
localize to primary cilia and to interact with several members of the NPH protein complex. Jade-1 
therefore may optimally contribute to the negative regulation of canonical Wnt signaling only in cells 
containing a functional NPH protein complex within a mature cilium. Primary cilia play an important 
role in the regulation of Wnt signaling and may be involved in changing the cell’s response from 
canonical Wnt to PCP (178, 182, 186, 273). Conditional knockout of Kif3a causes a loss of cilia in 
both adult and developing mice; however, like the models described above, severe cyst progression 
occurred only in young mice or after injury in adults (271). This data supports the idea that the 
“developmental profile” of the tubular epithelium contributes to cyst formation. However, if cells 
undergoing repair must revert to a developmental status capable of division and subsequently 
differentiate into a mature tubular cell, then it is curious that a genetic mutation interrupting this 
process would not interrupt the similar sequence of events occurring during development. In this 
context, the developmental role of the primary cilium might differ from its role during injury repair in 
adulthood. For example, urine flow disruption due to renal obstruction would reduce ciliary 
mechanosensation, which leads to to proteolytic cleavage of the polycystin-1 C-term fragment that 
translocates to the nucleus and upregulates β-catenin signaling (260). It has recently been shown that 
overexpression of the polycystin-1 C-term fragment degrades Jade-1 (274), which supports the current 
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data showing that high exogenous β-catenin degrades Jade-1. As the renal epithelium recovers from 
injury, renal cilia double in length which is normalized after injury is resolved (275, 276). This might 
render the cilium more sensitive to flow and restore Jade-1 levels by decreasing polycystin-1 cleavage. 
Bending of a longer cilium might also to enhance calcium influx (132, 133), possibly dependent on 
upregulation of the ciliary polycystin-1 / polystin -2 calcium channel (139). Of interest, the injury-
induced ciliary length increase in mice is preceded by increased mRNA expression of Invs and Pkd1 
(276). PKD1 encodes polycystin-1 which is required for correct localization of polycystin-2 (141), and 
INVS encodes NPHP2, known to be important for calcium-mediated Dsh regulation (178). Increased 
cellular calcium influx has been shown to play an important role in downregulating β-catenin 
activation via Protein-kinase-C (277) or via NPHP2/Dsh (178). During development, primary cilia 
might not be as critical in regulating calcium influx. Short cilia in Tg737 mutant mice impaired flow-
induced calcium influx at 2 weeks of age but not at 1 week of age (138), indicating that before post-
natal day 14 primary cilia are not required to regulate calcium levels. Notably, an atypical 
dihydropyridine-activated Ca2+ channel was apically localized in collecting duct cells and elicited a 
response in newborn but not adult rats (278).  
 Injury repair also differs greatly from developmental processes in that cell-to-cell contacts 
must be not only established but first disassembled to allow for cell division. As several NPH proteins 
localize to cell-to-cell contacts as well as to primary cilia there is likely to be crosstalk between these 
two locations. Also relevant to injury repair, β-catenin is an adhesion molecule which binds E-
cadherin at cell-to-cell contacts in addition to its effector role in the canonical Wnt signaling. 
Dissociation of the zonula adherens by ATP depletion was used to model ischemic injury in Opossum 
Kidney cells and resulted in β-catenin release from adherens junctions and concomitant accumulation 
in the nucleus (279). A loss of cell-to-cell contacts also decreases Hippo signaling pathway activation 
(280, 281), which leads to increased nuclear β-catenin due to two known mechanisms: first, the shift 
of Hippo effector TAZ to the nucleus decreases inhibitory cytosolic binding between TAZ and Dsh, 
allowing Dsh phosphorylation and subsequent inhibition of the β-catenin destruction complex (282); 
and second, the shift of Hippo effector YAP to the nucleus decreases inhibitory cytosolic binding with 
β-catenin, allowing nuclear translocation of β-catenin (283). Genetic mutation which disrupts an 
aspect of these processes might mitigate β-catenin signaling needed for repair, but might not effect 
Wnt ligand stimulated β-catenin signaling needed during development. Injury-specific responses also 
include increased expression of hepatocyte growth factor (HGF) in renal tubular cells, with the HGF 
target c-met upregulated specifically at the site of injury (284). HGF signaling increases nuclear β-
catenin accumulation independently of external Wnt signaling (285). In the bladder, injury stimulates 
Shh expression in basal cells which elicits stromal Wnt2 and Wnt4 expression stimulating 
proliferation in stromal and urothelial cells; this response was dependent on Gli1 which was not 
needed for normal development (286). As Shh signaling requires functional primary cilia, a genetic 
mutation disrupting ciliary function could impede this mechanism should a similar injury response 
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occur in the renal tubules. After ischemic renal injury, invading macrophages secrete Wnt7b which is 
critical to drive dividing cells through the G2 checkpoint during the repair process  (272). Of interest, 
G2/M arrest after kidney injury causes tubulointerstitial fibrosis (287), a hallmark symptom of NPH. 
The injury-induced presence of secreted ligands suggests that neighbouring healthy cells must be able 
to resist Wnt/β-catenin- or HGF/β-catenin-stimulated cell division. In contrast to sub-confluent cells, 
confluent epithelial cells do not upregulate Rac or AKT activity in response to HGF stimulation, and 
this results in a decreased β-catenin signaling response due to a lack of AKT-mediated GSK3β 
inhibition (288). Established adherens junction complexes in confluent cells may also play a key role 
by stabilizing membrane bound E-cadheren allowing for its interaction with β-catenin (289), which 
reduces the potential for β-catenin signaling (290, 291) and regulates proliferation via the Hippo 
signaling pathway (292). Loss of contact inhibition in tumour cells leads to increased proliferation via 
β-catenin signaling caused by impaired adherens junctions and increased Rac activity (293, 294). An 
isolated lack of confluency in injured tubular cells may therefore help to create a localized response to 
a secreted ligand. A mutation impairing the ability of confluent cells to resist this signal would 
compromise injury repair by expanding the area of cell proliferation. 
 
7.5.4 Re-establishing polarity after injury: roles for cystoproteins and the primary cilium  
 
 The current data highlights a negative canonical Wnt regulating role for NPH proteins, which 
suggests that opposed to the lack of Wnt signaling due to NPH-causing Jbn dysfunction, NPH proteins 
may be more critical in events allowing PCP signaling to occur, including “turning off” canonical Wnt 
signaling after injury. Again, evidence exists to support that there may be injury-specific mechanisms 
in place regulating PCP that differ from a whole tissue processes used during development. For 
instance, the Wnt receptor Fz3, which is important in Wnt/calcium and Wnt/PCP signaling, relocates 
from the tight junctions to the apical plasma membrane after renal injury (270). Cystic kidneys of 
Pkd1 knockout mice retain upregulated Fz3 at the apical membrane of collecting duct cells and 
specifically in primary cilia (259), perhaps suggesting a failure to restore Fz3 to the tight junctions. 
Altered PCP in mouse Pkd1 pre-cystic kidneys is also indicated by increased variability in centrosome 
positioning after injury, which the authors suggest reflect a lack of ciliary communication, since Ift20 
ciliary knockout mice also show mislocalized centrosomes in non-dividing cells (295). Indeed, mitotic 
spindle orientation shows increased randomization in precystic tubules of Kif3a knockout mice 
lacking primary cilia (271). As loss of the essential vertebrate PCP gene Fat4 also causes misoriented 
cell division and cystic kidneys (257), it is apparent that disruption of PCP signaling as well as 
canonical Wnt signaling can contribute to cyst formation which may be particularly relvant after 
injury. The exact roles that ciliary proteins including NPHP4 or Jade-1 might play in this process are 
unknown. 
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 The primary cilium is important in regulation of each of the Wnt signaling pathways, and 
many cystoproteins, including NPH proteins, share a common localization at this organelle. However, 
the role of NPH proteins in injury repair is largely unexplored. Possibly, the primary cilium is 
important in mediating cellular responses due to its small size which could allow a sustained second 
messenger signal compared to within the soma where such a signal would be quickly diluted (131). 
Alternatively, the primary cilium could enhance the speed of response, due to the proximity of 
molecules in the ciliary lumen compared to the cell soma. In the context of injury repair, NPH proteins 
might be required to fulfill a role as ciliary “gate-keepers”, limiting or selectively enhancing signal 
transmission to the rest of the cell, or to mediate cross-talk with pathways monitoring the status of cell 
contacts or the cell cycle. Based on their association with actin as well as microtubule-based 
structures, it has been proposed that “the nephrocystins integrate signals related to cell adhesion with 
those controling cell cycle progression through the cilia sensor”(233). Relevant to PCP versus β-
catenin signaling events, NPHP1 and NPHP4 mRNA is significantly upregulated during polarization, 
while knock-down of these proteins delays tight junction and cilia formation in MDCK cells (296). As 
mentioned, the current data as well as previous publications demonstrate that many of the NPH 
proteins also play a role in the negative regulation of canonical Wnt signaling (178, 192, 193, 195). 
Taken together, these data indicate that during a repair scenario NPH proteins might play an important 
role in the final stages rather than initiation of these events.  
 In light of this, it is interesting to consider the current data showing that high expression of β-
catenin decreases expression of its negative regulator Jade-1, while expression of NPHP4 is able to 
stabilize this Jade-1 and decrease β-catenin signaling. In interphase cells, phosphorylated β-catenin 
accumulates at the centrosome while β-catenin localizes within the ciliary lumen (182). Jade-1 also 
accumulates at the centrosome, and its role in ubiquitinating this pool of β-catenin could be mediated 
by many of the NPH proteins. The Wnt co-receptor LRP6 is not detected in the healthy adult kidney 
cortex but is detected robustly in this region following injury (272), and the competence of LRP6 to 
respond to Wnt ligands reaches a maximum during the G2/M phase of cell division (154). An initial 
increase in β-catenin during this time could destabilize CK1α and disrupt destruction complex 
function, which could further increase β-catenin expression to a level where Jade-1 protein is also 
decreased. Whether this might occur at the centrosome or also at the nucleus is unknown. In either 
case, as discussed above even as cells initiate a response to β-catenin signaling termination signals are 
activated. In this light it is of interest that CK1α  accumulates at the centrosome when cells enter 
prophase (297), which could have the effect of either phosphorylating β-catenin to reduce a Wnt 
response, or phosphorylating Jade-1 and LRP6 to enhance it. The balance between these two 
possibilities might be tipped by NPHP4, which is shown by the current data to modify the same N-
terminal fragment of Jade-1 in the opposite fashion as does CK1α. NPHP4 localizes to centrosome in 
confluent cells (233), and might play a role when cells reach confluence in “turning off” an injury-
induced Wnt response. In subconfluent cells, NPHP4 is dispersed throughout the cytoplasm, and it 
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might play an earlier role during this time in enhancing Jade-1 nuclear translocation. As Jade-1 can 
also ubiquitinate non-phosphorylated β-catenin (198), the ability of cytosolic NPHP4 to enhance this 
might be particularly important during injury repair.  
 Accumulation of CK1α at the centrosome just prior to cell division has opened one other 
interesting possibility for Jade-1 function. CK1α phosphorylation of Jade-1 creates a binding site for 
PLK1, which allows the phosphorylation of Jade-1 at a site which is similar to the PLK1 consensus 
phosphorylation motif. PLK1 is an important kinase for cell cycle progression, and was recently 
shown to co-localize with NPHP1 at the transition zone and to be activated during ciliary disassembly 
(298). PLK1 has further been demonstrated to complex with Dsh and activate Aurora-A kinase during 
Wnt-mediated ciliary disassembly (299). Results from the current work demonstrate that PLK1 also 
interacts with Jade-1, and the Plk-associated protein smears in these experiments suggest that PLK1 
may be ubiquitinated by Jade-1. Downstream effects of this CK1α-mediated Jade-1 /PLK1 interaction 
are unknown, but the timing of CK1α accumulation at the centrosome suggests that Jade-1 could be 
important in regulating PLK1-mediated ciliary disassembly. PLK1-mediated phosphorylation of Dsh 
has also been shown to be required for spindle orientation (300), opening an alternative possibility of 
Jade-1 and CK1α involvement in this event. Both of these PLK1-mediated spindle orientation and 
ciliary disassembly are relevant to renal injury repair, and it will be exciting to tease apart further roles 
for these proteins in these events. 
 
7.6 Conclusion 
 
 Cystic kidneys are a common occurrence in several different diseases and represent a major 
burden on the health care system. Although much remains to be elucidated, it is obvious that renal 
injury can markedly exacerbate cyst progression, and that repair pathways involve Wnt/β-catenin, 
Wnt/PCP, and Wnt/calcium signaling. Both primary cilia and the integrity of cell-contacts play a role 
in each of these pathways, and it is likely no coincidence that protein products of ciliopathy-causing 
genes localize to both of these regions. If failure to repair renal injury is a key instigator of cyst 
formation, this would account for the wide variety of protein dysfunction which can lead to a similar 
renal cystic phenotype. Conversely, so many ways by which to interfere with this process would 
account for the variations in the exact cystic phenotype seen as a result of different gene mutations. 
The requirement for an environmental co-factor would furthermore account for variation in time of 
disease onset between patients with the same genetic mutation.   
 The current work explores a detailed relationship between β-catenin regulation by Jade-1 and 
the NPH protein complex. As the data indicate, the regulation of β-catenin by these proteins depends 
on the amount of free β-catenin and results in a complex interplay between the negative Wnt 
regulators NPHP4, CK1α, and Jade-1. The efficacy of β-catenin regulation by these proteins may very 
well be temporally regulated and dependent on the status of cell division and the maturation of the 
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primary cilium. While much knowledge has been gained in the last decades regarding ciliopathy 
research, detailed understanding of the role that these organelles play in healthy and diseased tissue 
will be required to fully understand ciliopathy-related diseases. Understanding the molecular 
mechanisms underlying injury repair will provide powerful new tools to treat these diseases as well as 
other diseases which may result from aberrant injury repair. Understanding the molecular mechanisms 
controlling Wnt signaling, cell adhesion, and cell division will also be of critical importance in 
designing next generation therapies for diseases caused by deregulation of these processes such as 
cancer. 
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